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Part 1. Intramolecular Ketene-Imine Cycloaddition 
 
 
The ketene-imine cycloaddition reactions, developed previously by the Nelson group, have been 
extended to the intramolecular ketene-imine cycloaddition. Initial results showed that the 
intramolecular cycloaddition exhibited excellent enantioselectivity, but it was suffered from poor 
diastereoselectivity. Later, it was shown that proper functionality on the tether of the substrate 
could improve diastereoselectivity. 
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 v 
Part 2. Iminium Ion-Mediated [4+2] Cycloaddition 
 
 
 
The N-alkenyl iminium ion cycloaddition reaction (AIC reaction), developed previously by the 
Nelson group, was further investigated for a more detailed understanding. As a result, two 
reaction pathways (Diels-Alder pathway and oxo-Diels-Alder pathway) of the AIC reaction were 
found when carbamate-protected N-alkenyl iminium ion was employed as a 4-electron 
component. Based on this observation, efficient methods to turn off either one of the two 
reaction pathways were proposed.  
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1.0  INTRAMOLECULAR KETENE-IMINE CYCLOADDITION 
1.1 INTRODUCTION 
1.1.1 Cyclic -amino acid 
During the last years, -amino acids have been explored due to their antibiotic, antifungal, 
cytotoxic and other important pharmacological properties.
1,2
 In this context, cyclic -amino acid 
also has been an interesting subject of research due to its appearance in natural product as well as 
other biologically important molecules.
3-6
 Recently, the pioneering works of Gellman
7,8
 and 
Seebach
9-12
 have intensified the importance of  cyclic -amino acid, proving that -peptides  
which consist of conformationally constrained -amino acids exhibited stable and predictable 
secondary structures.
7,13
 Those secondary structures of -peptides were especially intriguing, 
since it was known that complex chemical operations of biopolymers, such as catalysis and 
highly selective recognition of proteins and RNA, are linked to folding of the biopolymers to 
create active sites with proper juxtaposition of reactive groups.
14,15
 Gellman and co-workers
8
 
showed that short peptides of trans-ACPC exhibited high propensity to adopt the 12-helical 
folding pattern, which was different from the -helical modif of proteins (Figure 1).  Since they 
had already shown that -peptides constructed from carefully chosen -amino acids could adopt 
a different, stable 14-helix secondary structure,
7,10,13,16
 this result demonstrated that rational 
 2 
control over the secondary structure of -peptides was available by altering the nature of -
peptide residues. 
 
 
Figure 1. Conformational property of -peptides 1 
 
In the following work, Gellman and co-workers
17
 also showed that a -amino acid 
oligomer (-peptide) could be used as a mimic to the natural antibiotics (Figure 2). They showed 
that the cationic oligomer -17 exhibited not only comparable antimicrobial activity to that of 
common biotics, but also less hemolytic activity. Analogous -amino acid oligomers which 
consist of acyclic -amino acids showed higher hemolytic activities compared to that of -17, 
limiting their therapeutic application. 
 
 
Figure 2. Structure of cationic oligomer -17 
 
 3 
The pioneering works of Gellman and Seebach put cyclic -amino acid as the major 
subject of the synthetic and biological investigation related to discovery of the novel 
biofunctional material. Indeed, the literature is enriched with various asymmetric syntheses of 
cyclic -amino acids.3,18-22 Intramolecular cycloaddition to afford cyclic -amino acids is one of 
the conceivable pathways to those entities. However, examples of this methodology being used 
for the preparation of cyclic -amino acid are very scarce. To date, only a few reports have been 
published on the synthesis of this entity. Fustero and co-workers
23
 reported the synthesis of 
several fluorinated cis-2-aminocycloalkane carboxylic acids including 3 with a cross metathesis 
reaction as the key step. The asymmetric version of the process was achieved by using a chiral 
auxiliary such as 2 (Scheme 1). 
 
Scheme 1. Synthesis of fluorinated cis-2-aminocycloalkane carboxylic acids 
 
Aggarwal and co-workers
24
 reported intramolecular 1,3-dipolar nitrone cycloaddition 
onto an enantiomerically pure ketene dithioacetal dioxide 4 using a three-carbon tether. The 
 4 
resulting 5,5-disubstituted isoxazolidine 5 was further derivatized  to the naturally occurring 
antibiotic, ()-cispentacin 6 (Scheme 2).  
 
Scheme 2. Synthesis of ()-cispentacin 
 
1.1.2 Bicyclic lactam 
Bicyclic -lactam has also gained considerable attention as a precursor of bicyclic -amino acid 
via facile ring opening reaction,
21,22
 and a reliable protocol to synthetically provide enantiopure 
bicyclic -lactam has become highly desirable. This requirement has challenged chemists with 
the task of asymmetric synthesis of bicyclic -lactam.25 One of the most frequently used 
strategies to achieve this objective is the intramolecular ring closing reaction of the 
functionalized lactam. Alcaide and co-workers26 established a methodology to access 
functionalized bicyclic lactam via intramolecular cyclization. They showed that triphenyltin 
hydride-promoted reaction of lactam-tethered bromodiene 7 provided bicyclic lactam 8 
 5 
through intramolecular free radical cyclization (eq 1).  Subsequently, they demonstrated that 
intramolecular allenic hydroamination in azetidinone-tethered azide 9 could be utilized to afford 
bicyclic lactam 10 (Scheme 3). 
 
 
(1) 
 
 
Scheme 3. Intramolecular allenic hydroamination in azetidinone-tethered azide 
 
 
In another study, they also showed that novel bicyclic -lactams were obtained from 4-
oxoazetidine-2-carbaldehydes 12 as a key intermediate (Scheme 4).
27
 After cleavage of one of 
the diol groups in 11, they showed that hemiacetal 13 was formed by intramolecular attack of the 
-hydroxyl group on the aldehyde function in compound 12. 
 6 
Scheme 4. Intramolecular ring closure of 12 to 13 
 
 
De Kimp and co-workers
28
 showed that 3-hydroxy lactam 14 was transformed to the 
corresponding bicyclic lactam 15 by the intramolecular nucleophilic substitution reaction 
utilizing triethylamine in benzene. Interestingly, they observed complete transformation of trans-
-lactam 16 into the corresponding cis isomer of bicyclic lactam 15 in 54% yield. This result 
suggested that trans--lactam 16 was initially isomerized in the basic condition, then cyclized to 
afford cis-isomer of 15 (Scheme 5). 
 
Scheme 5. Intramolecular nucleophilic substitution to bicyclic lactam 15 
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Despite the successful examples of the intramolecular ring closing reaction of 
functionalized lactams, these methodologies still suffer from limited scope of the substrates 
and use of chiral auxiliaries for their asymmetric variants. Therefore, catalytic and asymmetric 
protocols for the synthesis of bicyclic -lactams have been highly required. Surprisingly, such 
syntheses for bicyclic -lactams still remain relatively undocumented with very few examples. 
The lack of a general and efficient methodology to access enantioenriched bicyclic 
lactam/cyclic -amino acid prompted us to investigate a catalytic, enantioselective synthesis 
of bicyclic lactam. 
1.2 DEVELOPMENT OF STRATEGY FOR INTRAMOLECULAR KETENE-IMINE 
CYCLOADDITION 
In 2007, the Nelson group reported catalytic asymmetric [4 + 2] cycloaddition of ketenes and N-
thioacyl imines.
29
 In this report, it was shown that enolizable imines could be generated in situ
30
 
and reacted with ketenes, which were also generated in situ,
31
 to provide enantioenriched 
thiazinones as surrogates for traditional Mannich products (eq 2).  -amido sulfones were used 
as precursors for enolizable imines which were generated in situ via base mediated elimination of 
-amido sulfones. In situ generation of enolizable imines from -amido sulfones was designed 
to afford low concentration of imines throughout the reaction, minimizing the exposure of imines 
to the reaction condition and preventing tautomerization of imines to enamines. We envisioned 
that our intermolecular ketene-imine cycloaddition design to be applicable to the development of 
an intramolecular variant. For example, -amido sulfone moieties32 in 19 should be stable to 
 8 
deprotection and activation of attendant carboxylic acid 20 providing access to acyl halide 
attached -amido sulfone 21. Cycloaddition of 21 under the ketene-imine cycloaddition 
conditions was expected to proceed with high stereoselectivity as shown in the intermolecular 
variant. The desired product would be a [4+2] cycloadduct
33-35
 22, an oxazinone, and/or a [2+2] 
cycloadduct
36,37
 23, a protected -lactam. Ring opening of either product with an external 
nucleophile should give the same cyclic -amino acid product 24 (Scheme 6). 
 
  (2) 
 
 
 
 
 
 
 
Scheme 6. Proposed synthetic method to access the cyclic -amino acid 24 
 
 9 
For systematic investigation on the proposed intramolecular ketene-imine cycloaddition 
reaction, we analyzed and identified the reaction parameters which would have significant 
impacts on the proposed intramolecular cycloaddition reaction. They were identity of the 
nitrogen protection group P, length of tether, and identity of chain substitution Y in the tether 
(Figure 3). Among these reaction parameters, impact of the protecting group P on the ketene-
imine cycloaddition was already recognized in our previous study on the intermolecular ketene-
imine cycloaddition.
29
 We reported that attempts to employ the carbamate-derived sulfone 25 as 
the imine precursor afforded no cycloadduct, providing only complex mixture (Figure 4). This 
suggested that nucleophilicity of the thiocarbonyl moiety in 26 was critical to the success of the 
intermolecular ketene-imine cycloaddition reaction. It was believed that sulfur in the 
thiocarbamate moiety was nucleophilic enough to react with acylammonium moiety in 26 to 
regenerate the catalyst, while oxygen in carbamate moiety in 25 was not nucleophilic enough to 
regenerate the catalyst and failed to realize a catalytic cycle. 
 
 
Figure 3. Important reaction parameters for intramolecular ketene-imine cycloaddition 
 10 
 
Figure 4. Reactivity difference between thiocarbamate and carbamate protecting group 
 
In spite of the previous unsuccessful result with carbamate nucleophiles 25 in the 
intermolecular cycloaddition reaction, we planned to investigate the impact of the carbamate 
protecting groups in the intramolecular cycloaddition reaction. Unlike intermolecular 
cycloaddition, the intramolecular variant should enjoy the entropic benefit in cycloaddition event 
because the reacting electrophile (imine) and nucleophile (ammonium enolate) exist in the same 
molecule (Figure 5). We expected that such entropic benefit from intramolecularity should 
promote the intramolecular cycloaddition reaction even with carbamate protecting groups. We 
also believed that employing the carbamate protecting group would make intramolecular ketene-
imine cycloaddition synthetically more valuable, since the carbamate protecting group is much 
easier to be deprotected than the dithiocarbamate protecting group.   
 
 11 
 
Figure 5. Intermolecular vs. intramolecular cycloaddition 
 
We anticipated that tether length would also have an impact on the reactivity of the 
proposed intramolecular cycloaddition reaction. While 5 and 6-membered ring formation was 
expected to be facile via 5 or 6-exo-trig fashion,
38
 7-membered and larger ring formation was 
anticipated to be inefficient due to entropic disadvantage of large ring formation (Figure 6). It 
was also reasonable to expect that the identity of Y in the tether could hold an influence on 
reactivity because, in the case of Y being a heteroatom, the shorter heteroatom-carbon bond 
length should facilitate the desired cycloaddition due to the entropic benefit. In addition, the 
Thorpe-Ingold effect should promote cycloaddition when Y has a geminally disubstituted carbon 
(Figure 7). We believed that detailed understanding of these variables in the intramolecular 
ketene-imine cycloaddition reaction should benefit the reasonable design for an effective method 
for the catalytic asymmetric synthesis of cyclic -lactam/bicyclic -amino acid derivatives. 
   
 12 
 
Figure 6. Variation of the tether length and the corresponding -amino acids 
 
 
Figure 7. Incorporation of the heteroatoms and geminally substituted carbon in the tether 
1.3 RESULTS AND DISCUSSION 
1.3.1 Dithiocarbamate-containing -amido sulfone carboxylic acid 
In order to evaluate the validity of the intramolecular ketene-imine cycloaddition, we designed a 
short route to representative -amido sulfone carboxylic acids. To this end, -amido sulfone 
carboxylic acid 30 was prepared without any complication. The benzyl group of tert-butyl 6-
benzyloxyhexanoate 27
39
 was removed by hydrogenolysis in 99% yield. The hydroxy group of 
the resulting tert-butyl 6-hydroxyhexanoate 28 was converted into aldehyde via Swern oxidation, 
and the resulting crude aldehyde was condensed with benzyl dithiocarbamate in the presence of 
 13 
aqueous formic acid and sodium p-toluenesulfinate to afford tert-butyl 6-
(benzyloxycarbonylamino)-6-p-toluenesulfonyl hexanoate 29 in 58% yield.  Finally, the tert-
butyl moiety of 29 was removed by treatment with anhydrous formic acid to afford the desired 6-
(benzyloxycarbonylamino)-6-p-toluenesulfonyl hexanoic acid 30 in 57% yield (Scheme 7). 
 
Scheme 7. Synthetic route to 30 
 
 
With a representative -amido sulfone carboxylic acid 30, the conversion of 30 to the 
corresponding acid chloride was investigated. Various acid chloride formation conditions were 
attempted, and it was discovered that, with 3.0 equiv thionyl chloride for 45 min at ambient 
temperature, chemical shift of protons to the carboxylic acid in 30 was completely shifted 
from 2.3 ppm to 3.0 ppm (Figure 8). Since no by-product was observed in the conversion of 30 
to the corresponding acid chloride, it was concluded that 3.0 equiv thionyl chloride was effective 
for the complete conversion of 30 to the corresponding acid chloride. 
 
 
Figure 8. Conversion of 30 to the corresponding acid chloride 
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With the efficient method for the conversion of  to the corresponding acid chloride, the 
intramolecular ketene-imine cycloaddition of 30 was attempted. After treating 30 with thionyl 
chloride (3.0 equiv) at ambient temperature, the resulting crude acid chloride was subjected to 
the condition for the intermolecular ketene-imine cycloaddition for thiazinone synthesis which 
was previously reported by our group.
29
 The condition for the intermolecular ketene-imine 
cycloaddition was chosen as a standard condition A, since the intramolecular cycloaddition was 
anticipated to be similar to its intermolecular counterpart. After the formation of the acid 
chloride, CH2Cl2 and excess thionyl chloride was removed in vacuo and the flask was backfilled 
with nitrogen gas. The resulting acid chloride was taken into CH2Cl2 (0.1 M) and, according to 
the condition for the intermolecular ketene-imine cycloaddition, the solution of the acid chloride 
was added into a 50 C solution of 17 (TMSQn, 20 mol%), LiClO4 (2.0 equiv), and 
i
Pr2NEt (3.5 
equiv) in 4:1 CH2Cl2:Et2O (final concentration of the acid chloride = 0.044M). The resulting 
reaction mixture was stirred for 12 h at 50 C. The resulting reaction mixture was then diluted 
with Et2O, and filtered through short silica gel pad with Et2O as an eluent. After analysis of the 
result of the reaction, it was found that the reaction provided complete conversion, giving 15% of 
thiazinone 31, 10% of -lactam 32, and 25% of macrocycle 33 (eq 3). From this result, it was 
concluded that the intramolecular ketene-imine cycloaddition provided the desired products, but 
highly nucleophilic sulfur in the dithiocarbamate moiety was responsible for interception of the 
in-situ prepared ketene to afford macrocycle 118 (Figure 9). It was also noted that the crude 
1
H 
NMR spectrum of the reaction showed a considerable amount of polymer-like by-product, which 
was probably the reason for the low percentage of the mass recovery.  
 
 
 15 
 
(3) 
 
 
 
 
 
Figure 9. Proposed explanation of the formation of the macrocycle 33 
 
Based on mechanistic hypothesis shown in Figure 9, we changed reaction parameters to 
suppress the undesirable macrocycle formation. Firstly, we tried to accelerate imine formation by 
employing higher reaction temperature (Table 1, entry a), stronger Lewis acid (entry b), and 
stronger proton scavenger (Table 1, entry c). We also tried to accelerate the desired 
intramolecular cycloaddition by increasing the catalyst loading (Table 1, entry d and e). Lower 
reaction temperature was also tested in the hypothesis that it might decelerate macrocycle 
formation (Table 1, entry f, g, and h). To our disappointment, no dramatic improvement in the 
product distribution was observed upon modification of the reaction condition, providing 
between 1:1 and ~2:1 of the desired products (31 + 32) to the macrocycle (33). Therefore, we 
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concluded that it was difficult to suppress the undesired macrocyclization by modifying simple 
reaction conditions. 
 
Table 1. Product distribution of cycloaddition of 30 
 
1.3.2 Simple carbamate-containing starting material: preliminary results 
Since we were not able to suppress the undesired macrocyclization by modifying the reaction 
conditions, we turned our attention to the different -amido sulfone carboxylic acids for 
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cycloaddition. We supposed that switching the nitrogen protecting group in the substrate from 
the dithiocarbamate group to a simple carbamate group would help reduce nucleophilic attack on 
the ketene so that the undesired macrocyclization would be suppressed. We also anticipated that 
the simple carbamate group is useful not only for the control of the nucleophilicity of the 
nitrogen protecting group, but also for synthetic utility of the resulting product due to the simple 
deprotection procedures for the simple carbamate groups. For this purpose, -amido sulfone 
carboxylic acid 35 with a Cbz protecting group was prepared as a test substrate. The benzyl 
group of 27 was removed by hydrogenolysis in quantitative yield. The resulting alcohol 28 was 
then converted into aldehyde via Swern oxidation, and the crude aldehyde was condensed with 
benzyl carbamate in the presence of formic acid and sodium p-toluenesulfinate to afford tert-
butyl ester 34 in 69% yield for 2 steps.  Finally, the tert-butyl moiety of 34 was removed by 
treatment with anhydrous formic acid to afford the desired -amido sulfone carboxylic acid 35 in 
85% yield (Scheme 8). 
 
Scheme 8. Synthetic route to 35 
 
 
Initially, thionyl chloride was found to be ineffective for the conversion of 35 to the 
corresponding acid chloride, probably because the carbamate oxygen atom on 35 was not able to 
activate thionyl chloride due to its insufficient nucleophilicity. Fortunately, with 2.0 equiv oxalyl 
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chloride with a catalytic amount of DMF, chemical shift of -protons to carboxylic acid of 35 
was completely shifted from 2.3 ppm to 3.0 ppm in 30 min at ambient temperature (Figure 10). 
Since no by-product was observed during the conversion monitored by 
1
H NMR, it was 
concluded that oxalyl chloride with catalytic amount of DMF was effective for the complete 
conversion of 35 to the corresponding acid chloride.  
 
 
Figure 10. Acid chloride corresponding to 35 
 
After the formation of the acid chloride from 35, CH2Cl2 and excess oxalyl chloride was 
removed in vacuo and the flask was backfilled with nitrogen gas. The resulting acid chloride was 
taken into CH2Cl2 (0.1 M), and according to the condition for the intermolecular ketene-imine 
cycloaddition, the solution of the acid chloride was added for 1 h into a 50 C solution of 17 
(TMSQn, 20 mol%), LiClO4 (2.0 equiv), and 
i
Pr2NEt (3.5 equiv) in 4:1 CH2Cl2:Et2O (final 
concentration of the acid chloride = 0.044M). The resulting reaction mixture was stirred for 12 h 
at 50 C. The resulting reaction mixture was then diluted with Et2O, and filtered through short 
silica gel pad. Upon analysis of the result of the reaction, the desired bicyclic -lactam 36 was 
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acquired in 16% yield. To determine the ee value of 36, the enantiomer of 36 was separately 
prepared and its HPLC trail was compared to that of 36. It was found that the ee value of 36 was 
better than 99%. From the crude 
1
H NMR spectrum of the reaction, we also found that 
cycloaddition of 35 afforded no macrocycle 37 (eq 4). 
 
 
          (4) 
 
 
 
Despite the poor yield of , complete suppression of formation of 37, as well as high 
level of enantioselection in the synthesis of 36, was encouraging enough for the further 
investigation. Careful examination of the crude 
1
H NMR spectrum of the reaction in eq 4 showed 
unidentified by-products with p-toluenesulfonyl moiety, which was suggestive of incomplete 
imine formation. Based on this observation, we increased the loading of lithium perchlorate to 
further activate the tosyl group in 35, which should accelerate base-mediated elimination of -
amido sulfone 35. It was found that this increase of lithium perchlorate (2.0 equiv) improved the 
yield of cycloaddition 35, providing -lactam 36 in 25% yield. The enantioselectivity of the 
cycloaddition 35 (>99%) was not affected by the increased loading of lithium perchlorate. 
Further optimization of the reaction revealed that fast addition of acid chloride (< 1 min) and 
shorter reaction time (4 h) did not cause significant difference in efficiency of the reaction. 
Therefore, the rate of acid chloride addition (< 1 min) and reaction time (4 h) were adopted as a 
standard condition B (eq 5). 
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   (5) 
 
 
 
Upon examination of the crude 
1
H NMR spectrum of the cycloaddition of 35 under the 
standard condition B, it became apparent that all of the -amido sulfone carboxylic acid 35 was 
completely consumed, and only 2 products (36 and the unknown product) were found in the 
crude 
1
H NMR spectrum of the reaction (Figure 11). Unfortunately, all attempts to isolate the 
unknown product by column chromatography failed, providing as the only product. 
 
 
 
Figure 11. Crude 
1
H NMR spectrum of cycloaddition of 35 
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Based on this observation, we speculated that the unidentified compound was unstable on 
the silica gel. Accordingly, derivatization of the by-product was considered as an alternative way 
for the characterization of the by-product. During this investigation, it was observed that attempt 
to purify the crude product of the cycloaddition of 35 via column chromatography using 
methanol as eluent afforded an unexpected product, which was eventually assigned as cyclic -
amino ester 38. Based on this observation, the reaction of 35 with the standard condition B (20 
mol% 17, 2.0 equiv LiClO4, 3.5 equiv 
i
Pr2NEt, 50

C, 4 h reaction) was quenched with 
methanol and warmed up to ambient temperature. Indeed, quenching the reaction with methanol 
provided the  isolatable product of cyclic -amino ester 38,40 which was isolated in 28% yield as 
a 7.1:1 mixture of diastereomers, along with 36 which was isolated in 26% yield. To determine 
the major diastereomer of diastereomeric mixture 38, its relative stereochemistry at C1 and C2 
was determined by comparison with cis-38, which was acquired via the ring opening of  using 
methanol and iPr2NEt. To our disappointment, the major diastereomer of diastereomeric mixture 
38 from the cycloaddition reaction was found to be a trans-diastereomer (Scheme 9). 
 
Scheme 9. Isolation of -amino ester 38 
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Based on the identification of diastereomeric mixture 38, along with confirmation of its 
major diastereomer and information from the crude 
1
H and 
13
C NMR spectra of the reaction 
shown in Scheme 9, we assigned the unstable by-product found in the crude 
1
H NMR spectrum 
as oxazinone 43 which should be formed via formal [4+2] cycloaddition pathway, rather than the 
desired [2+2] cycloaddition pathway (Figure 12). We believed that intramolecular ketene-imine 
cycloaddition for 5-membered ring formation exhibited poor diastereoselectivity, presumably 
because of the small energy difference between cis-rotamer 39 and trans-rotamer 40. While 41 
from cis-rotamer 39 provided -lactam 36, 42 from trans-rotamer 40 could not undergo -lactam 
formation due to the ring strain of 4,5-bicyclic system. Therefore, 42 cyclized to trans-43 which 
was unstable on silica gel and could not be isolated by flash chromatography. However, 
quenching the crude reaction mixture with methanol derivatized trans-43 to stable trans-38. In 
addition, it cannot be ruled out that C-C bond formation in 39 and 40 might be reversible and 36 
is the major product because the loss of catalyst in 41 to afford 36 is faster than the loss of the 
catalyst to afford cis-43 and trans-43. 
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Figure 12. Proposed explanation for formation of trans-38 
1.3.3 Origin of poor diastereoselectivity 
Considering that intermolecular ketene-imine cycloaddition reported by our group
29
 
exhibited near perfect diastereoselection (>95:5 cis:trans),  poor diastereoselectivity of its 
intramolecular variant was unexpected. Therefore, judicious analysis of the reaction pathway 
was required for a better understanding of the intramolecular cycloaddition reaction. In this 
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context, computational minimization (MM2) was performed on both 41 and 42 to aid in the 
elucidation of the origin of poor diastereoselectivity in the intramolecular cycloaddition (Figure 
13). Indeed, the difference of the minimized energy between 41 and 42 was only 0.59 kcal/mol, 
which explains the poor diastereoselectivity. We believe that intramolecularity played an 
important role in limiting the conformations which the substrate rotamer could adopt, thereby 
reducing the energy difference between 41 and 42. 
 
Figure 13. Results of MM2 calculation for 41 and 42 
 25 
1.3.4 Improving diastereoselectivity: tether length 
In the light of the new information regarding diastereoselectivity of the intramolecular 
cycloaddition, a range of reaction parameters was investigated to evaluate their impacts on 
diastereoselectivity (Table 2). Firstly, the reaction temperature of 65 C, rather than 50 C, 
was tested with expectation that lower reaction temperature might be helpful to expand the 
energy difference between cis-rotamer 39 and trans-rotamer 40 (entry a, Table 2). A higher 
catalyst loading was also employed to increase syn-selectivity, which is the preferred 
diastereoselectivity induced by the catalyst (entry b, Table 2). An increased loading of lithium 
perchlorate was also tested in the hypothesis that the lithium-coordinated carbamate moiety 
should be sterically demanding, creating more energy difference between cis-rotamer 39 and 
trans-rotamer 40 (entry c, Table 2). To our disappointment, no dramatic change in 
diastereoselectivity was observed, providing virtually the same diastereoselectivity of 1:1. 
Therefore, we conclude that it was difficult to control diastereoselectivity of the cycloaddition 
reaction of 35 by simple modification of the reaction conditions. 
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Table 2. Diastereoselectivity according to the modification of the reaction condition 
 
Facing difficulty in controlling diastereoselectivity in the cycloaddition of our test 
substrate 35, we turned our attention to other -amido sulfone carboxylic acids to acquire 
supplementary information on the diastereoselectivity of intramolecular ketene-imine 
cycloadditions. Since the bond length between carbon and heteroatom (143~147 pm) is shorter 
than that between carbon and another carbon (154 pm), we speculated that intramolecular 
cycloaddition of an -amido sulfone carboxylic acid containing a short carbon-heteroatom bond 
should exhibit different diastereoselectivity from that of 35. In this context, -amido sulfone 
carboxylic acids with heteroatom-containing tethers were prepared. For the substrate with a 
nitrogen-containing tether, N,O-protected ethanolamine 44 was employed to prepare alcohol 46 
via Michael addition to tert-butyl acrylate. The alcohol 46 was converted into aldehyde via 
Swern oxidation, and the resulting crude aldehyde was condensed with benzyl carbamate in the 
presence of aqueous formic acid and sodium p-toluenesulfinate to afford tert-butyl ester 47 in 
63% yield for 2 steps.  Finally, the tert-butyl moiety of 47 was removed by treatment with 
anhydrous formic acid to afford the desired -amido sulfone carboxylic acid 48 in 72% yield 
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(Scheme 10). For the substrate with an oxygen-containing tether, the known compound 49
41
 was 
employed to prepare tert-butyl ester 50 via Swern oxidation followed by condensation of the 
resulting crude aldehyde with benzyl carbamate in the presence of aqueous formic acid and 
sodium p-toluenesulfinate in 77% yield for 2 steps. The resulting tert-butyl moiety of 50 was 
removed by treatment with anhydrous formic acid to afford the desired -amido sulfone 
carboxylic acid 51 in 87% yield (Scheme 11). 
 
Scheme 10. Synthetic route to 48 
 
 
Scheme 11. Synthetic route to 51 
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Applying the alkaloid-catalyzed cycloaddition (20 mol% 17, 2.0 equiv lithium 
perchlorate, 3.5 equiv 
i
Pr2NEt, 50 

C, 4 h) to the oxygen-tethered substrate 51 followed by 
quenching the reaction with MeOH provided the desired products 52 and 53 in 37% combined 
yield (eq 6), which is lower than the yield of the cycloaddition of carbon-tethered 35 (54%, 
Scheme 9). This deterioration of the chemical yield was presumably due to the basic lone pair of 
oxygen interacting with the Lewis acid, hampering its role to activate the p-toluenesulfonyl 
leaving group on 51. It was also noteworthy that the diastereoselectivity was improved to 1.6:1, 
compared to the diastereoselectivity of 1:1 for the cycloaddition of carbon-tethered 35 (Scheme 
9). Applying the same reaction conditions to the cycloaddition of the nitrogen-tethered substrate 
48 resulted in a 63% combined yield of 54 and 55 (eq 7). The diastereoselectivity was 
determined as 2.3:1, which was also improved in comparison to the diastereoselectivity of 1:1 for 
the cycloaddition of carbon-tethered 35 in Scheme 9. From these results, it was concluded that 
the tether length plays an important role in diastereoselectivity, since shorter the carbon-
heteroatom bond length is beneficial to improve diastereoselectivity of the ketene-imine 
intramolecular cycloaddition. 
 
            (6) 
 
 
 
         (7) 
 
 
 29 
1.3.5 Improving diastereoselectivity: geminally disubstituted carbon tether 
The comparison of diastereoselectivities exhibited in the cycloaddition of 48 and 51 raised a 
question of the factors making an impact on the diastereoselectivities. Since the 
diastereoselectivity of cycloaddition of nitrogen-tethered 48 (cis:trans = 2.3:1) was better than 
that of cycloaddition of oxygen-tethered 51 (cis:trans = 1.6:1), despite the longer carbon-
nitrogen bond length in 48 than the carbon-oxygen bond length in 51, it was obvious that 
improvement of diastereoselectivity was not proportionally affected by bond length.  Therefore, 
it was reasonable to assume that other variables as well as the tether length were involved in 
influencing the diastereoselectivity. One of the variables that attracted our attention was steric 
bulkiness of the tosyl group on the nitrogen in the tether of 48, which makes the sulfonamide 
group more sterically demanding than oxygen in the tether of 51. Figure 14 shows a possible 
explanation of the improved diastereoselectivity relating to steric bulkiness of the heteroatoms in 
the tether. It was postulated that the sterically demanding tosyl group on nitrogen conferred 
additional destabilizing interactions with the Cbz group, resulting in further destabilization of the 
trans-rotamer to achieve better diastereoselectivity.  
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Figure 14. Proposed explanation for the improved diastereoselectivity of 48 over 51 
 
Based on the hypothesis for improved diastereoselectivity in the cycloaddition of 48, we 
realized that a geminally disubstituted carbon atom incorporated on the tether of an -amido 
sulfone carboxylic acid could also play the same role as the sulfonamide moiety of 48 for 
improvement of diastereoselectivity of the cycloaddition reaction. A geminally disubstituted 
carbon on the tether was initially considered to take advantage of the Thorpe-Ingold effect for 
more facile cycloaddition. However, the geminally disubstituted carbon would also create 
additional destabilizing interaction with the Cbz group as sulfonamide moiety in 48 did (Figure 
15).  Therefore, we anticipated that the geminally disubstituted carbon on the tether could 
improve diastereoselectivity of the cycloaddition reaction as well.  
 
 
Figure 15. Geminally disubstituted carbon in the tether to improve diastereoselectivity 
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To test this hypothesis, the required -amido sulfone carboxylic acid with a gem-diester 
moiety was prepared. Deprotonation of 56
42
 followed by SN2 reaction with tert-butyl 3-
bromopropionate afforded crude benzyloxy tert-butyl ester, whose benzyl group was deprotected 
via hydrogenolysis to alcohol 57 in 53% yield for 2 steps. The resulting alcohol 57 was 
converted into aldehyde via Swern oxidation, and the crude aldehyde was condensed with benzyl 
carbamate in the presence of aqueous formic acid and sodium p-toluenesulfinate to afford tert-
butyl ester 58 in 43% yield.  Finally, the tert-butyl moiety of 58 was removed by treatment with 
anhydrous formic acid to afford the desired -amido sulfone carboxylic acid 59 in 79% yield 
(Scheme 12). 
 
Scheme 12. Synthetic route to 59 
 
The synthesis of the substrate with the germinal dimethyl substituents was initiated by 
Baeyer-Villiger oxidation
43,44
 of 4,4-dimethyl cyclohexanone 60, followed by basic ring opening 
reaction in the presence of K2CO3 to provide ω-benzyloxy acid 61 in 50% yield for 2 steps. 
Protection of the acid moiety in 61 with tert-butyl alcohol in acidic condition provided the 
corresponding tert-butyl ester 62 in 48% yield. Benzyl moiety of 62 was then deprotected with 
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hydrogenolysis to alcohol 63 in 97% yield. The resulting alcohol 63 was then oxidized by Swern 
oxidation, and the resulting crude aldehyde was condensed with benzyl carbamate in the 
presence of aqueous formic acid and sodium p-toluenesulfinate to afford tert-butyl ester 64 in 
76% yield for 2 steps. The ester moiety of 64 was then deprotected with anhydrous formic acid 
to afford desired -amido sulfone carboxylic acid 65 in 85% yield (Scheme 13). 
 
Scheme 13. Synthetic route to 65 
 
 
A similar procedure was employed for the synthesis of the -amido sulfone carboxylic 
acid 72 with germinal diphenyl substituents. The synthesis of the substrate with gem-diphenyl 
group was initiated with Baeyer-Villiger oxidation
43
 of 4,4-diphenyl cyclohexanone 66 to 
provide lactone 67 in 76% yield. The resulting lactone 67 was then subjected to basic ring 
opening reaction in the presence of K2CO3 to provide ω-benzyloxy acid 68 in 93% yield. 
Protection of the acid moiety in 68 with tert-butyl alcohol in acidic condition provided the 
corresponding tert-butyl ester 69 in 61% yield. Benzyl deprotection of 69 via hydrogenolysis 
afforded alcohol 70 in quantitative yield. The resulting alcohol 70 was then oxidized to the 
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corresponding aldehyde by Swern oxidation, and the crude aldehyde was condensed with benzyl 
carbamate in the presence of aqueous formic acid and sodium p-toluenesulfinate to afford tert-
butyl ester 71 in 33% yield for 2 steps.. The tert-butyl group was then deprotected to the 
corresponding acid with anhydrous formic acid to afford desired -amido sulfone carboxylic 
acid 72 in 47% yield (Scheme 14). 
 
Scheme 14. Synthetic route to 72 
 
 
With the required -amido sulfone carboxylic acids with geminally disubstituted carbon 
atoms, our current standard conditions (20 mol% 17, 2.0 equiv lithium perchlorate or lithium 
iodide, 3.5 equiv 
i
Pr2NEt, 50 

C, 4 h) for intramolecular ketene-imine cycloaddition were 
applied. For each -amido sulfone carboxylic acid, two different quenching methods were used. 
The first quenching method was to dilute the reaction mixture with Et2O and then to filter the 
resulting mixture through a short silica gel path with Et2O eluent (silica gel filtration). The 
second quenching method was to add methanol to the cold reaction mixture, to dilute the 
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resulting reaction mixture with Et2O and then to filter the resulting mixture through a short silica 
gel path with Et2O eluent (MeOH quenching). The results of those reactions were summarized in 
Table 3. We learned that gem-disubstitution on the tether was effective in improving 
diastereoselectivity of cycloaddition, providing from 2.4:1 cis:trans (Table 3, entry d) to 
complete diastereoselection for the cis-product (Table 3, entry f). The efficiencies of the 
reactions measured by the chemical yields were also improved due to the Thorpe-Ingold effect 
(Table 3, 59 and 72).  In the case of 65 with germinal dimethyl substituents, diastereoselectivity 
was not improved (cis:trans = 2.4:1) as much as in the cases of 59 with germinal diester 
substituents (cis:trans = 4.2:1) and 72 with germinal diphenyl substituents (only cis), indicating 
less steric demand created by germinal dimethyl substituents compared to diethyl ester or 
diphenyl substituents. Careful examination of the crude 
1
H NMR spectrum of the reaction of  65 
suggested that imine formation might be incomplete, showing a distinctive singlet corresponding 
to methyl group on the p-toluenesulfonyl moiety. To facilitate imine formation, a reaction of 65 
with germinal dimethyl substituents was rerun with an increased loading (3.5 eq) of LiI. It was 
found that an increased loading of LiI improved diastereoselectivity to 5.5:1 (cis:trans). From 
those results, we concluded that the geminally disubstituted carbons in the tether of the -amido 
sulfone carboxylic acids were beneficial in improvement of the intramolecular ketene-imine 
cycloadditions. 
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Table 3. Results of the ketene-imine cycloaddition reactions (5-membered rings) 
 
1.3.6 Improving enantioselectivity  
While enantioselectivities of the reactions for the syntheses of -lactams range from 73% (Table 
3, entry a) to over 99% (Table 3, entry c), it was noteworthy that cycloadditions of 48 and 51, 
where the length of the tether is shorter than others because of the short carbon-heteroatom bond 
length, exhibited distinctively lower enantioselectivity (73% and 79%, respectively). Since our 
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group previously reported that intermolecular ketene-imine cycloaddition provided near perfect 
enantioselectivity
29
 (>99%) with the same catalyst 17 (TMSQn), we speculated that low 
enantioselectivities of cycloaddition of 48 and 51 should originate from the uncatalyzed 
cycloadditions. We hypothesized that the nitrogen in the acyl imine moiety is not close enough to 
react with the ketene moiety when X is carbon (Figure 16). In this case, the undesired 
unimolecular cycloaddition (pathway B, Figure 16) is slow and not a competitive pathway with 
the desired catalyzed bimolecular process (pathway A, Figure 16). When X is a heteroatom, 
however, the intramolecular reaction between ketene and acyl imine (pathway B) becomes 
entropically more favorable by virtue of the proximity effect and fast enough to compete with the 
catalyzed reaction (pathway A). This undesired unimolecular process should be translated into 
the low enantioselectivities of the cycloaddition reactions of 48 and 51. 
 
 
Figure 16. Poor enantioselectivities for the reactions of the shorter-tethered substrates 
 
Based on this hypothesis, reactions with moderate ee values (Table 3, entry a, b, and d) 
were rerun with increased catalyst loadings (100 mol%) in order to facilitate the desired 
bimolecular process between substrate and catalyst (pathway A, Figure 16). It was found that 
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increased catalyst loading did help improve enantioselectivities for all of the three reactions 
(Table 4), which supported our hypothesis in Figure 16. It was also found that increased catalyst 
loading helped improve the yields of the reactions as well as enantioselectivities (Table 4, entry b 
and c).  Since the cinchona alkaloid catalyst 17 can be efficiently recovered from the reaction 
mixtures by standard acid-base extraction techniques,
29
 enhanced reaction efficiency offsets the 
need for higher catalyst loadings. As shown in entry a, however, increased catalyst loading did 
not benefit the efficiency of cycloaddition of oxygen-tethered 51, providing the same level of 
chemical yield as 20 mol% catalyst did. This illustrated that our current Lewis-acidic condition 
was not compatible with intramolecular cycloaddition of oxygen-tethered 51. 
 
Table 4. Improved enantioselectivities by using increased amount of the catalyst 17 
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1.3.7 6-Membered ring formation 
Inspired by the successful results in cycloaddition for the 5-membered ring formation, we 
expanded the scope of the substrate to cycloaddition for the 6-membered ring formation. Firstly, 
the desired -amido sulfone carboxylic acids for 6-membered ring formation were prepared in 
analogous ways to the syntheses of the 5-membered ring precursors. For example, oxidation of 
alcohol 78 followed by condensation of the resulting aldehyde with benzyl carbamate in the 
presence of aqueous formic acid and sodium p-toluenesulfinate afforded tert-butyl ester 79 in 
43% yield for 2 steps.  The tert-butyl group of 79 was then deprotected with anhydrous formic 
acid to afford desired -amido sulfone carboxylic acid 80 in 76% yield (Scheme 15). 
 
Scheme 15. Synthetic route to 80 
 
 
For the substrate with the nitrogen-containing tether, N,O-protected propanolamine 81 
was employed to prepare alcohol 82 via Michael addition to tert-butyl acrylate. The resulting 
alcohol species 83 was converted into aldehyde via Swern oxidation, and the crude aldehyde was 
condensed with benzyl carbamate in the presence of aqueous formic acid and sodium p-
toluenesulfinate to afford tert-butyl ester 84 in 68% yield for 2 steps.  Finally, the tert-butyl 
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group of 84 was removed by treatment with anhydrous formic acid to afford the desired -amido 
sulfone carboxylic acid 85 in 72% yield (Scheme 16). 
 
Scheme 16. Synthetic route to 85 
 
Synthesis of 89 with the gemimal diester substituents was initiated with deprotonation of 
86
42
  followed by SN2 reaction with tert-butyl 3-bromopropionate to afford crude benzyloxy tert-
butyl ester. The benzyl group of the resulting benzyloxy tert-butyl ester was deprotected via 
hydrogenolysis to provide alcohol 87 in 45% yield for 2 steps. Alcohol 87 was then converted 
into aldehyde via Swern oxidation, and the resulting crude aldehyde was condensed with benzyl 
carbamate in the presence of aqueous formic acid and sodium p-toluenesulfinate to afford tert-
butyl ester 88 in 72% yield.  Finally, the tert-butyl group of 88 was removed by treatment with 
anhydrous formic acid to afford the desired -amido sulfone carboxylic acid 89 in 73% yield 
(Scheme 17). 
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Scheme 17. Synthetic route to 89 
  
With the required -amido sulfone carboxylic acid for the 6-membered ring prepared, 
current standard condition (20 mol% 17, 2.0 equiv lithium perchlorate or lithium iodide, 3.5 
equiv 
i
Pr2NEt, 50 

C, 4 h) for the intramolecular ketene-imine cycloaddition were applied to 80, 
85, and 89 respectively. For each cycloaddition of -amido sulfone carboxylic acid, ‘silica gel 
filtration’ and ‘MeOH quenching’ methods were used to quench the reactions. Those results are 
summarized in Table 5. It was found that 6-membered ring formation proceeded smoothly to 
provide the desired cyclized products (-lactam and -amino ester) with excellent 
enantioselectivities and much improved diastereoselectivities compared to that of the 
corresponding 5-membered ring formation. As was observed in the 5-membered ring formation, 
gem disubstitutions on the tethers helped improve diastereoselectivities (Table 5, entry a vs. 
entry b and c). This result indicated that both tether length and its substitution pattern made a 
significant impact on diastereoselecitivty of the intramolecular ketene-imine cycloaddition. It 
was also notable that, in the reaction of 80, a trace amount of oxazinone 96 was isolated (Scheme 
18). This result clarified the origin of bicyclic -amino acids when the ‘MeOH quenching’ 
method was used to quench the cycloaddition reactions. Based on the observation of 96 from the 
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reaction, it was reasonable to establish a hypothesis that the cycloaddition of 80 diverged into 
two reaction pathways, formal [2+2] (pathway A, Figure 17) and formal [4+2] pathway (pathway 
B, Figure 17). When MeOH was introduced to quench the reaction to quench the reaction, 90 
from formal [2+2] pathway was stable to MeOH and isolated without further derivatization. 
However, 96 from formal [4+2] pathway was unstable and reacted with MeOH to afford bicyclic 
-amino ester 91 through the ring opening process of 96. 
 
Table 5. Results of the ketene-imine cycloaddition reactions (6-membered rings) 
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Scheme 18. Identification of the oxazinone by-product 96 
 
 
 
Figure 17. Origin of 91 
 
1.3.8 Cycloaddition of -amido sulfone with stereogenic center 
Encouraged by the successful results with cycloaddition of achiral -amido sulfone carboxylic 
acids, we expanded our scope of investigation to the substrates with a stereogenic center. Since it 
was shown that a functional group on the tether made a significant impact on both efficiency and 
stereoselectivity of the cycloaddition reaction, it was reasonable to postulate that a stereogenic 
center on the tether would also hold an impact on cycloaddition. We hypothesized that, under 
similar reaction conditions, cycloaddition of one enantiomer of -amido sulfone carboxylic acid 
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97 would readily react to afford the desired product, while cycloaddition of the other enantiomer 
would be slow due to unfavorable 1,3-diaxial interaction between acyl imine and the substituent 
R’ (Figure 18). We were also intrigued in probing matched vs. mismatched diastereoselectivities 
between the substrate and the catalyst. Since an -amido sulfone with a stereogenic center 
should exhibit its own stereochemical preference for the cycloaddition event, we became 
interested in the result of the reaction when the stereochemical preference of the substrate 
worked against that of the catalyst (Figure 19). Therefore, we planned to investigate 
diastereoselectivities of the matched/mismatched reactions employing -amido sulfone 98 with a 
stereogenic center and catalysts 17 (TMSQn) and 18 (TMSQd). 
 
 
Figure 18. Two possible conformations in the cycloaddition of 182 
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Figure 19. Mismatched case between 183 and catalyst TMSQd 
 
Preparation of the desired test substrate with a stereogenic center was initiated by 
employing the -amino acid synthesis we have previously reported45 (Scheme 19). The amino 
group of enatiomeric -amino ester 99 was tosylated using TsCl and triethylamine to afford 
sulfonamide 100 in 77% yield. The methyl ester group of 100 then was reduced to primary 
alcohol with LAH, and the resulting alcohol was protected with TBDMSCl to afford silyl ether 
101 in 56% yield for 2 steps. Michael addition of 101 to tert-butyl acrylate in the presence of 
K2CO3 afforded the tert-butyl ester 102 in 63% yield. The TBDMS group in 102 was then 
removed with TBAF in quantitative yield to provide alcohol 103. The resulting alcohol 103 was 
converted into aldehyde via Swern oxidation, and the crude aldehyde was condensed with benzyl 
carbamate in the presence of aqueous formic acid and sodium p-toluenesulfinate to afford tert-
butyl ester 104 in 58% yield for 2 steps.  Finally, the tert-butyl group of 104 was removed by 
treatment with anhydrous formic acid to afford 105 in 60% yield. 
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Scheme 19. Synthetic route to 105 
 
With the desired -amido sulfone carboxylic acid 105 with a stereogenic center, the 
current standard conditions (20 mol% 17, 2.0 equiv lithium perchlorate or lithium iodide, 3.5 
equiv 
i
Pr2NEt, 50 

C, 4 h) and ‘MeOH quenching’ were applied for the intramolecular ketene-
imine cycloaddition of 105. As a catalyst, 17 (TMSQn) was selected because it was expected to 
adopt the matched transition state (TS-1 in Figure 18) with 105. After analysis of the result of the 
reaction of 105, we found that the reaction afforded -amino ester trans-106 as a major product 
(Scheme 20). It was an unexpected result, since the catalyst 17 should exhibit preferentially cis-
diastereoselectivity according to the previous results in this study. Reaction efficiency and 
enantioselectivity for the cycloaddition of 105 remained good, providing 68% combined yield 
and 92% ee. After careful review of our working transition state model, we proposed a 
mechanistic explanation of the observed selectivity (Figure 20). Using 17 (TMSQn) as a catalyst, 
the facial selectivity of the cycloaddition should be dictated by the catalyst as well as the 
substrate. Therefore, the cycloaddition would proceed through conformations shown in Figure 20. 
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In the course of cycloaddition, 108 should be less accessible due to the unfavorable 1,2-
interaction between the tosyl group and the adjacent 2-phenylethyl group. This unfavorable 
interaction should force the tosyl group to occupy the pseudo-axial position as shown in 109 and 
110, which changes the overall conformation of the substrate to adopt a conformation close to 
110. We believe that the conformational change caused by 1,2-interaction between the tosyl 
group and the adjacent 2-phenylethyl group was responsible for the unexpected trans-
diastereoselectivity of the cycloaddition of 105. 
 
Scheme 20. Result of the cycloaddition reaction of 105 using TMSQn as a catalyst  
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Figure 20. Proposed explanation of the formation of trans-106 as a major product 
 
Computational minimization (MM2) was performed on cis-conformer 111 and trans-
conformer 112 to aid in the elucidation or the origin of selectivity favoring the observed major 
product 106. Indeed, the difference between the minimized energy of 111 and 112 was 
approximately 7 kcal/mol, favoring 112 (Figure 21). Examination of 111 and 112 suggested that 
the pseudo-axial tosyl group on nitrogen could create steric interaction with the aromatic moiety 
of the catalyst, forcing the catalyst to occupy the -face of the piperidine ring. The catalyst on 
the -face of the ring creates an unfavorable steric interaction with the axial acyl imine moiety in 
111, while the equatorial acyl moiety in 112 did not experience such an unfavorable interaction. 
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Figure 21. Result of the MM2 calculation of 111 and 112 
 
The unexpected result of the matched case of the cycloaddition 105 prompted us to 
investigate the mismatched case with 18 (TMSQd), the pseudo enantiomer of 17 (TMSQn), as a 
catalyst. Interestingly, the cycloaddition of 105 catalyzed by 18 afforded -lactam 113 as a sole 
product with 41% yield and >99% ee (Scheme 21). When 18 was used as a catalyst, the facial 
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selectivity of the cycloaddition of 105 would proceed through a conformation shown in Figure 
22. In this case, however, there was no destabilizing 1,2-interaction as there was in Figure 21. 
Therefore, the reaction should proceed through a chair-like transition state, which should 
preserve the cis selectivity of the catalyst and afford the observed -lactam 113. The lower yield 
of the mismatched 18-catalyzed reaction 41%, compared to 68% combined yield of the matched 
117-catalyzed reaction, reflected the high-energy of the transition state of the mismatched 
reaction due to 1,3-diaxial interaction of pseudo-axial 2-phenylethyl group, resulting in the slow 
reaction (Figure 22). 
 
Scheme 21. Result of the cycloaddition reaction of 105 using TMSQd as a catalyst 
 
 
 
Figure 22. Proposed explanation of the formation of 113 as a major product 
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1.3.9 7-Membered ring formation 
Encouraged by successful results with cycloaddition of -amido sulfone carboxylic acids for the 
preparation of 5- and 6-membered rings, we expanded our scope of investigation to substrates for 
7-membered ring formation.   Since it is known that 7-membered ring formation is entropically 
much less favored than 5- or 6-membered ring formation, we planned to apply various reaction 
conditions by modifying the current standard condition for 5- or 6-membered ring formation. 
Synthesis of the required starting material started with a known compound: diethyl 2-(4-
(benzyloxy)butyl)malonate (114).
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 From 114, synthesis of the desired -amido sulfone 
carboxylic acid 118 was analogous to the corresponding 6-membered ring precursor. 
Deprotonation of the -proton to the ester groups in 114 with NaH, followed by SN2 reaction 
between the resulting anion and tert-butyl 2-bromopropionate, afforded the inseparable mixture 
of the desired tert-butyl ester 115 and the unreacted 114. The resulting mixture was subjected to 
hydrogenolysis to afford isolatable alcohol 116 in 45% yield for 2 steps. The resulting alcohol 
116 was converted into aldehyde via Swern oxidation, and the crude aldehyde was condensed 
with benzyl carbamate in the presence of aqueous formic acid and sodium p-toluenesulfinate to 
afford tert-butyl ester 117 in 72% yield for 2 steps.  Finally, the tert-butyl group of 117 was 
removed by treatment with anhydrous formic acid to afford the desired -amido sulfone 
carboxylic acid 118 in 73% yield (Scheme 22). 
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Scheme 22. Synthetic route to 118 
 
With the desired -amido sulfone carboxylic acid in hand, the current standard conditions 
(20 mol% 17, 2.0 equiv lithium perchlorate or lithium iodide, 3.5 equiv 
i
Pr2NEt, 50 

C, 4 h) 
were applied along with various modifications. Those results are summarized in Table 6. To our 
disappointment, no desired cyclized products were observed from the reactions. In the case of 
entry a, trace amount of uncyclized enamine 119 was isolated, which indicated that cycloaddition 
for 7-membered ring formation did not occur under the reaction condition (Scheme 23). Based 
on those observations, it was concluded that 7-membered ring formation is an unfavorable 
process under the current reaction conditions. 
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Table 6. Results of the cycloaddition of 118 
 
 
Scheme 23. Isolation of the enamine species 119 from the cycloaddition of 118 
 
1.4 CONCLUSION 
A variety of -amido sulfone carboxylic acids was synthesized as precursors for 
intramolecular ketene-imine cycloaddition (Figure 23). Various germinal disubstitutions were 
incorporated to the tether of the -amido sulfone carboxylic acids. In general, intramolecular 
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ketene-imine cycloadditions of those -amido sulfone carboxylic acids were found to be 
efficient and highly enantioselective. It was also shown that germinal disubstitution in the tether 
was helpful to improve diastereoselectivity. 
 
 
Figure 23. Results for the intramolecular ketene-imine cycloaddition 
1.5 EXPERIMENTAL 
General Information: All reactions involving moisture sensitive reagents were performed 
under an inert atmosphere via standard vacuum line techniques and with freshly dried solvents. 
All glassware was flame dried and allowed to cool under vacuum. Tetrahydrofuran (THF) was 
distilled from sodium/benzophenone under an inert atmosphere or obtained dry from a solvent 
purification system (MBraun, SPS-800). Dichloromethane was obtained dry from a solvent 
purification system (MBraun, SPS-800). Acetonitrile was distilled on calcium hydride under an 
inert atmosphere. All solvents and commercial reagents were used as supplied without further 
purification unless stated otherwise. Ambient temperature refers to 20-25 °C. Temperature of 0 
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°C was obtained using an ice/water bath and reaction reflux conditions using an oil bath 
equipped with a contact thermometer. Lower temperatures were obtained using an immersion 
cooler (HAAKE EK 90). In vacuo refers to the use of a Büchi Rotavapor R-2000 rotary 
evaporator with a Vacubrand CVC2 vacuum controller or a Heidolph Laborota 4001 rotary 
evaporator with a vacuum controller.  
Analytical thin layer chromatography was performed on aluminum sheets coated with 
60 F254 silica. TLC visualization was carried out with ultraviolet light (254 nm), followed by 
staining 1% aqueous KMnO4 solution. Flash column chromatography was performed on 
Kieselgel 60 silica in the solvent system stated. 
1
H and 
13
C nuclear magnetic resonance (NMR) spectra were acquired on either a Bruker 
Avance 300 (300 MHz 
1
H, 75.4 MHz 
13
C) or a Bruker Avance II 400 (400 MHz 
1
H, 100 MHz 
13
C) spectrometer at ambient temperature and in the deuterated solvent stated. Coupling 
constants (J) are reported in Hz. Data are expressed in chemical shifts in parts per million (ppm) 
relative to residual solvent as internal standard. Multiplicities are indicated by: s (singlet), d 
(doublet), t (triplet), q (quartet), quint (quintuplet), sextet, sept (septet) and m (multiplet). The 
abbreviation Ar is used to denote aromatic, br to denote broad and app. To denote apparent. 
Infrared spectra (υmax) were recorded on a Perkin-Elmer Spectrum GX FT-IR 
Spectrometer using either thin films on NaCl plates or KBr discs as stated. Only the 
characteristic peaks are quoted. Melting points were recorded on an Electrothermal apparatus 
and are uncorrected. 
HPLC analyses were obtained using a variable wavelength UV detector (deuterium 
lamp, 190-600 nm) using Chiracel OD-H, ChiralpakTM AD columns (250 x 4.6 mm) (Daicel 
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Inc.) or ChiralpakTM AD column (250 x 4.6 mm) (Daicel Inc.) and HPLC-grade isopropanol 
and hexanes as the eluting solvents. 
Mass spectrometric (m/z) data was acquired by electrospray ionization (ESI), electron 
impact (EI) or chemical ionization (CI). 
Optical rotations were measured on a Perkin Elmer Precisely/Model-341 digital 
polarimeter operating at the sodium D line with a 100 mm path cell. 
 
General Procedure A.  Preparation of -amidosulfonyl tert-butyl ester (B) 
 
 
 
To 0.8 M solution of oxalyl chloride (1.2 equiv) in CH2Cl2 at 78 C was added a DMSO (2.6 
equiv).  Once addition was complete, the resulting mixture was stirred for 1 min.  To the 
resulting reaction mixture was added 0.6 M solution of the corresponding alcohol A (1.0 equiv) 
in CH2Cl2 dropwise by syringe. The reaction was stirred for 1 h at 78 C.  The reaction was 
quenched by adding triethylamine (5.2 equiv) and warmed to ambient temperature and stirred for 
1 h. To the resulting reaction mixture was added water and the resulting mixture was extracted 
with CH2Cl2 (3×). Combined organic extracts were washed with brine, dried over MgSO4, and 
concentrated.  The crude product mixture was mixed with 1.0 equiv benzyl carbamate (or benzyl 
dithiocarbamate) and sodium p-toluenesulfinate (1.3 equiv). To the resulting slurry was added 
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water/HCOOH mixture (1/2 v/v, 0.2 M). The reaction was stirred at ambient temperature for 12 
h. To the resulting reaction mixture was added water, and the resulting crude product (B) was 
purified by filtration or extraction with ethyl acetate followed by flash chromatography. 
 
General Procedure B.  Deprotection of -amidosulfonyl tert-butyl ester (C) to the 
corresponding -amidosulfonyl acid (D) 
 
 
 
-amidosulfonyl tert-butyl ester (C) was dissolved into anhydrous HCOOH (concentration of C 
in HCOOH = 0.2 M). The resulting reaction mixture was stirred at ambient temperature until the 
reaction was complete (determined by 
1
H NMR analysis of reaction aliquots). HCOOH was 
removed in vacuo to provide crude acid product (D), which was purified by either washing with 
cold ethyl ether or flash chromatography.   
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General Procedure C. Cycloaddition of -amidosulfonyl acid (D) 
 
 
To 0.1 M solution of the starting material D (1.0 equiv) in CH2Cl2 with catalytic amount of DMF 
at 0 

C was added 2.0 M solution of oxalyl chloride (2.0 equiv) in CH2Cl2. The ice bath was 
removed and the reaction mixture was stirred for 20 min or until no further gas evolution is 
observed. The solvent and excess oxalyl chloride was removed in vacuo and the flask was 
backfilled with nitrogen. The resulting acid chloride was taken into CH2Cl2 (concentration of 
acid chloride = 0.1 M), and the resulting solution was added into 50 C solution of TMSQn (0.2 
equiv), LiI (2.0 equiv), and iPr2NEt (3.5 equiv) in 4:1 CH2Cl2:Et2O (final concentration of the 
acid chloride = 0.044M). The resulting reaction mixture was stirred at 50 C. After 4 h, the 
reaction was quenched according to one of the following methods. 
 
Work-up Method 1 (SiO2 filtration): The cold reaction mixture was diluted with Et2O, and the 
resulting heterogeneous mixture was filtered through short silica gel pad with Et2O. The resulting 
homogeneous solution was concentrated in vacuo, and flashed to afford -lactam E. 
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Work-up Method 2 (MeOH quenching): To the cold reaction mixture was added 5.0 equiv 
anhydrous MeOH. The resulting reaction mixture was warmed to ambient temperature, and 
heated at 40 

C for 1 min. The reaction mixture was diluted with Et2O, and the resulting 
heterogeneous mixture was filtered through short silica gel pad with Et2O. The resulting 
homogeneous solution was concentrated in vacuo, and flashed to afford -lactam E and the ring-
opened product F. 
 
Cycloaddition of 30 
 
To a 0 

C solution of 30 (100mg, 0.22 mmol) in 2.2 mL CH2Cl2 was added thionyl chloride (48 
L, 0.66 mmol) dropwise. The ice bath was removed and the reaction mixture was stirred for 40 
min. The solvent and excess thionyl chloride was removed in vacuo and the flask was backfilled 
with nitrogen. The resulting acid chloride was taken into 2.0 mL CH2Cl2, and the resulting 
solution was added via syringe pump for 1 h into a50 C solution of TMSQn (17 mg, 0.044 
mmol), LiI (29 mg, 0.22 mmol), and iPr2NEt (127 L, 0.77 mmol) in 4:1 CH2Cl2:Et2O (final 
concentration of the acid chloride = 0.044 M) The resulting reaction mixture was stirred at 50 

C. After 4 h, the cold reaction mixture was diluted with Et2O, and the resulting heterogeneous 
mixture was filtered through short silica gel pad with Et2O. The resulting homogeneous solution 
was concentrated in vacuo, and flashed to afford 11 mg of 31 (19% yield), 6 mg of 32 (8% yield), 
and 26 mg of 33 (27% yield). 
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(4aR,7aS)-2-(Benzylthio)-5,6,7,7a-tetrahydrocyclopenta[d][1,3]thiazin-
4(4aH)-one (cis-31): IR (thin film): 3433, 2360, 2113, 1645, 1494, 1453, 1340, 
1020, 957, 894 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.38-7.29 (m, 5H), 4.37 (d, 
J = 13.5, 1H), 4.30 (d, J = 13.5, 1H),  3.75-3.65 (m, 1H), 2.47-2.32 (m, 2H), 2.03-1.83 (m, 4H), 
1.78-1.73 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  196.7, 158.5, 136.5, 129.2, 128.6, 127.5, 67.9, 
52.2, 35.6, 31.6, 21.7, 20.0; Mass spectrum was not acquired due to the instability of the 
compound. 
 
(4aR,7aR)-2-(Benzylthio)-5,6,7,7a-tetrahydrocyclopenta[d][1,3]thiazin-
4(4aH)-one (trans-31): IR (thin film): 3392, 2921, 2872, 1698, 1611, 1494, 
1452, 1316, 1158, 1114, 1073, 1028, 936, 910 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.38-7.26 (m, 5H), 4.37 (d, J = 13.5, 1H), 4.29 (d, J = 13.5, 1H), 2.73-2.65 (m, 1H), 
2.30-2.20 (m, 1H), 2.08-1.96 (m, 2H), 1.79-1.64 (m, 4H); 
13
C NMR (75 MHz, CDCl3)  197.9, 
151.7, 136.9, 129.0, 128.5, 127.4, 66.7, 49.2, 35.0, 34.0, 27.6, 21.6; Mass spectrum was not 
acquired due to the instability of the compound. 
 
Benzyl (1R,5S)-7-oxo-6-azabicyclo[3.2.0]heptane-6-dithiocarboxylate (32): 
IR (thin film): 3438, 1776, 1646, 1308, 1237, 1186, 1129, 1104, 1083 cm
1
; 
1
H 
NMR (300 MHz, CDCl3)  7.39-7.29 (m, 5H), 4.72 (t, J = 4.5, 1H), 4.54 (d, J = 
13.2, 1H), 4.48 (d, J = 13.2, 1H), 3.58 (dd, J = 7.5, 4.8, 1H), 2.62 (dd, J = 13.5, 4.5, 1H), 2.25-
2.13 (m, 1H), 1.92-1.90 (m, 1H), 1.67-1.44 (m, 3H); 
13
C NMR (75 MHz, CDCl3)  196.5, 164.6, 
134.8, 129.5, 128.6, 127.7, 62.6, 53.0, 40.0, 28.3, 25.9, 22.9; Mass spectrum was not acquired 
due to the instability of the compound 
 60 
(Z)-2-(Benzylthio)-4-tosyl-5,6,7,8-tetrahydro-1,3-thiazonin-9(4H)-one (33): 
IR (thin film): 2923, 2360, 1708, 1596, 1494, 1453, 1357, 1318, 1204, 1155, 
1103, 1085, 1071, 984, 959, 888, 838, 814, 776 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.75 (d, J = 8.4, 2H), 7.53 (t, J = 6.3, 1H), 7.35-7.23 (m, 7H), 4.22 (d, J = 12.9, 1H), 
4.05 (d, J = 12.9, 1H), 3.64 (ddd, J = 15.3, 12.6, 3.9, 1H), 2.84 (ddd, J = 15.6, 5.4, 3, 1H), 2.78-
2.69 (m, 1H), 2.45 (s, 3H), 2.23-2.14 (m, 2H), 1.93-1.87 (m, 1H), 1.80-1.66 (m, 3H); 
13
C NMR 
(75 MHz, CDCl3)  207.7, 176.2, 145.3, 134.8, 134.0, 129.9, 129.6, 129.2, 128.6, 127.8, 76.0, 
45.3, 37.7, 25.3, 22.7, 22.6, 21.8; HRMS (Q-TOF) m/z calcd for C21H23NO3 S3Na (M+Na)
+
: 
456.0738; found: 456.0745. 
 
Cycloaddition of 35 followed by silica gel filtration 
 
 General Procedure C and work-up method 1 were followed employing (100 mg, 0.24 mmol) 35 
to afford 17 mg of 36 (0.070 mmol, 29%) as a colorless oil. 
 
Benzyl (1R,5S)-7-oxo-6-azabicyclo[3.2.0]heptane-6-carboxylate(36): []D 
+50.8 (c 0.34, CHCl3); IR (thin film): 2958, 2923, 2852, 2360, 1801, 1724, 1520, 
1455, 1385, 1325, 1268, 1238, 1195, 1170, 1094, 1052, 996, 740 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.43-7.34 (m, 5H), 5.29 (d, J = 12.3, 1H), 5.23 (d, J = 12.3, 1H), 4.41 (t, J = 
4.5, 1H), 3.54 (dd, J = 8.1, 4.2, 1H), 2.26 (dd, 13.8, 5.7, 1H), 2.12 (dd, 12.9, 6.0, 1H), 1.90 (m, 
1H), 1.75-1.41 (m, 3H); 
13
C NMR (75 MHz, CDCl3)  167.3, 148.6, 135.2, 128.6, 128.4, 128.2, 
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67.8, 57.6, 54.7, 28.7, 25.8, 22.6; HRMS (EI) m/z calcd for C14H15NO3 (M
+
): 245.1052; found: 
245.1053. 
 
Cycloaddition of 35 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 35 (100 mg, 0.24 mmol) 
to afford 34 mg of 1:1 inseparable mixture of 36 and 38 (0.014 mmol, 57% combined yield) 
where 38 was acquired as >10:1 mixture of diastereomer (major diastereomer = trans) as a 
colorless oil.  
 
Methyl (1R,2R)-2-{[(benzyloxy)carbonyl]amino} cyclopentane 
carboxylate (trans-38): 143 was isolated by treating the crude reaction 
mixture (1.0 equiv) with 3-amino-1-propanol (1.0 equiv) in CH2Cl2 (0.10 M). 
The resulting reaction mixture was stirred for 3h at ambient temperature, and filtered through 
short silica gel pad with Et2O. The resulting crude oil was purified by column chromatography 
(SiO2, 30% ethyl acetate in hexanes) to afford the title compound as a white solid. []D 43.5 (c 
0.39, CHCl3); IR (thin film): 3328, 2955, 2360, 2340, 1726, 1683, 1541, 1438, 1372, 1300, 1269, 
1207, 1174, 1036, 748 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.37-7.32 (m, 5H), 5.09 (s, 2H), 4.84 
(br, 1H), 4.20 (p, J = 7.52, 1H), 3.68 (br, 3H), 2.64 (q, J = 8.1, 1H), 2.21-1.69 (m, 5H), 1.57-1.48 
(m, 1H); 
13
C NMR (125 MHz, CDCl3)  175.0, 155.7, 136.4, 128.5, 128.1(2C), 66.7, 56.3, 51.9, 
50.6, 32.9, 28.3, 22.9; HRMS (EI) m/z calcd for C15H19NO4 (M
+
): 277.1314; found: 277.1316. 
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Cycloaddition of 51 followed by MeOH quenching 
 
 
General Procedure C and work-up method 2 were followed employing 51 (115 mg, 0.27 mmol) 
to afford 10 mg of 52 (15%) as a colorless oil and 16 mg of separable diastereomeric mixture 
(cis:trans = 1:1) of 53 (22%) as a colorless oil.  
 
Benzyl (1S,5R)-7-oxo-3-oxa-6-azabicyclo[3.2.0]heptane-6-carboxylate (52): []D 
+51.8 (c 0.26, CHCl3); IR (thin film): 2916, 2852, 1812, 1723, 1643, 1389, 1342, 
1313, 1232, 1202, 1170, 1058, 1008, 910, 768, 740 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.41-7.34 (m, 5H), 5.30 (d, J = 12.3, 1H), 5.24 (d, J = 12.3, 1H), 4.57 (dd, J = 5.4, 3.0, 
1H), 3.50 (dd, J = 9.9, 6.0, 1H), 3.42 (dd, J = 11.1, 3.0, 1H); 
13
C NMR (75 MHz, CDCl3)  164.5, 
148.5, 134.8, 128.7, 128.6, 128.3, 68.6, 68.2, 66.6, 56.7, 55.1; HRMS (EI) m/z calcd for 
C13H13NO4 (M
+
): 247.0845; found: 247.0839. 
 
Methyl (3S,4S)-4-{[(benzyloxy)carbonyl]amino} tetrahydrofuran-3-
carboxylate (trans-53): []D 53.4 (c 0.36, CHCl3); IR (thin film): 3328, 
2954, 2358, 1734, 1534, 1438, 1246, 1069, 1016, 925, 739, 698 cm
1
; 
1
H 
NMR (300 MHz, CDCl3)  7.37-7.36 (m, 5H), 5.11 (s, 2H), 5.07 (br, 1H), 4.56 (br, 1H), 4.17 (t, 
J = 8.7, 1H), 4.00 (dd, J = 9.3, 6.0, 1H), 3.94 (dd, J = 9.0, 6.3, 1H), 3.74 (s, 3H), 3.65 (br, 1H), 
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3.03 (br, 1H); 
13
C NMR (125 MHz, CDCl3)  172.4, 155.5, 136.1, 128.6, 128.3, 128.2, 73.2, 69.7, 
67.0, 55.4, 52.4, 51.; HRMS (Q-TOF) m/z calcd for C14H17NO5Na (M+Na)
 +
: 302.1004; found: 
302.0989. 
 
Methyl (3S,4R)-4-{[(benzyloxy)carbonyl]amino} tetrahydrofuran-3-
carboxylate (cis-53): []D 2.5 (c 0.03, CHCl3); IR (thin film): 3317, 3033, 
2953, 2882, 2360, 1809, 1731, 1535, 1454, 1439, 1378, 1339, 1230, 1176, 
1069, 1028, 914, 741, 699 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.36 (br, 5H), 5.38 (d, J = 8.7, 
1H), 5.13 (d, J = 12.0, 1H), 5.08 (d, J = 12.6, 1H), 4.65 (br 1H), 4.12 (dd, J = 9.0, 6.9, 1H), 4.07-
4.01 (m, 1H), 3.97 (dd, J = 9.0, 5.7, 1H), 3.71 (dd, J = 9.0, 4.8, 1H), 3.65 (s, 3H), 3.33 (q, J = 7.5, 
1H), ; 
13
C NMR (125 MHz, CDCl3)  171.7, 155.7, 136.2, 128.5, 128.2(2C), 72.9, 69.5, 66.9, 
53.3, 52.2, 47.2; HRMS (Q-TOF) m/z calcd for C14H17NO5Na (M+Na)
 +
: 302.1004; found: 
302.0990. 
 
Cycloaddition of 48 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 48 (152 mg, 0.26 mmol) 
to afford 37 mg of 54 (36%) as a white solid. 
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Benzyl (1R,5R)-3-[(4-methylphenyl)sulfonyl]-7-oxo-3,6-diazabicyclo [3.2.0] 
heptane-6-carboxylate (54): []D +53.4 (c 0.77, CHCl3); IR (thin film): 2924, 
1812, 1729, 1455, 1388, 1346, 1320, 1165, 1131, 1062, 1010, 737, 702 cm
1
; 
1
H 
NMR (300 MHz, CDCl3)  7.69 (d, J = 8.4, 2H), 7.42-7.38 (m, 5H), 7.32 (d, J = 8.1, 2H), 5.29 (d, 
J = 12.3, 1H), 5.23 (d, J = 12.3, 1H), 4.42 (t, J = 4.8, 1H), 4.02 (d, J = 11.7, 1H), 3.96 (d, J = 10.8, 
1H), 3.62 (dd, J = 6.6, 5.1, 1H), 2.81-2.71 (m, 2H), 2.42 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  
163.0, 148.2, 144.3, 134.7, 132.2, 129.9, 128.7, 128.6, 128.2, 127.8, 68.4, 55.2, 53.6, 49.3, 46.6, 
21.5; HRMS (EI) m/z calcd for C20H20N2O5S (M
+
): 400.1068; found: 400.1078. 
 
Cycloaddition of 48 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 48 (94 mg, 0.16 mmol) to 
afford 19 mg of 54 (30%) as a colorless oil and an inseparable diastereomeric mixture (cis:trans 
= 1:1.2) of 23 mg of 55 (33%) as a white solid. 
 
Methyl (3R)-4-[(benzyloxycarbonyl)amino]-1-[(4-methylphenyl) sulfonyl] 
pyrrolidine-3-carboxylate (55): IR (thin film): 3345, 3033, 2954, 1734, 1597, 
1532, 1454, 1346, 1237, 1162, 1031, 815, 738 cm
1
; 
1
H NMR (300 MHz, 
CDCl3, cis diastereomer in bold where resolved)  7.71 (d, J = 8.1, 4H), 7.37-7.31 (m, 14H), 
5.19 (d, J = 8.4, 1H), 5.08 (s, 2.4H), 5.05 (s, 2H), 4.96 (d, J = 5.7, 1.2H), 4.47-4.38 (m, 1H), 
4.34-4.25 (m, 1.2H), 3.69-3.64 (m, 2.4H), 3.61 (s, 3.6H), 3.60 (s, 3H), 3.52-3.45 (m, 3.2H), 3.40-
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3.32 (m, 2.2H), 3.30-3.25 (m, 1.2H), 3.12 (dd, J = 14.1, 6.6, 1H), 2.98 (dd, J = 13.8, 6.6, 1.2H), 
2.44 (s, 3.6H), 2.41 (s, 3H); 
13
C NMR (75 MHz, CDCl3, cis diastereomer in bold where 
resolved)  170.0 + 170.7 (1C), 155.5 + 155.4 (1C), 144.1 + 144.0 (1C), 136.0 + 135.9 (1C), 
133.1 + 132.7 (1C), 130.0, 128.6 + 128.5 (1C), 128.3 + 128.2 (1C), 128.1, 127.7 + 127.5 (1C), 
67.1, 53.5 + 52.6 (1C), 52.5 + 52.3 (1C), 51.7 + 48.9 (1C), 48.5 + 48.4 (1C), 46.0, 21.5 ; HRMS 
(Q-TOF) m/z calcd for C21H24N2O6SNa (M+Na)
 +
: 455.1253; found: 455.1206. 
 
Cycloaddition of 65 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 65 (99 mg, 0.22 mmol) to 
afford 32 mg of 73 (53%) as a white solid. 
 
Benzyl (1R,5S)-3,3-dimethyl-7-oxo-6-azabicyclo[3.2.0] heptane-6-carboxylate  
(73): [α]D +19.5 (c 1.22, CHCl3); IR (thin film): 2956, 2869, 1808, 1724, 1459, 
1386, 1325, 1269, 1250, 1216, 1177, 1138, 1058, 1024, 987, 766 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.42-7.33 (m, 5H), 5.30 (d, J = 12.6, 1H), 5.25 (d, J = 12.6, 1H),  4.43 (t, J 
= 5.7, 1H), 3.60 (ddd, J =  9.3, 4.8, 1.5. 1H), 2.01 (t, J = 15, 2H), 1.65-1.58 (m, 2H), 1.09 (s, 3H), 
1.07 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  168.4, 148.8, 135.2, 128.6, 128.4, 128.1, 67.7, 59.0, 
55.7, 42.3, 41.3, 39.7, 30.9, 29.4; HRMS (EI) m/z calcd for C16H19NO3 (M
+
): 273.1365; found: 
273.1355 
Cycloaddition of 65 followed by MeOH quenching 
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General Procedure C and work-up method 2 were followed employing 65 (100 mg, 0.22 mmol) 
to afford 29 mg of 73 (48%) as a colorless oil and 12 mg of 74 (18%) as a colorless oil. 
 
 Methyl (1R,2R)-2-{[(benzyloxy)carbonyl]amino}-4,4-dimethyl cyclo 
pentanecarboxylate (trans-74): [α]D 24.8 (c 0.29, CHCl3); IR (thin film): 
3349, 2954, 2358, 1732, 1534, 1456, 1263, 1169, 1025 cm
1
; 
1
H NMR (300 
MHz, CDCl3)  7.36-7.32 (m, 5H), 5.09 (s, 2H), 4.84 (br, 1H), 4.32 (quint, J = 9.0, 1H), 3.67 (s, 
3H), 2.76 (q, J = 9.0, 1H), 2.04 (dd, J = 12.0, 9.0, 1H), 1.87-1.76 (m, 2H), 1.40 (dd, J = 12.0, 9.0, 
1H), 1.09 (s, 3H), 1.07 (s, 3H); 
13
C NMR (125 MHz, CDCl3)  174.8, 155.6, 136.4, 128.5 (2C), 
128.1, 66.7, 55.6, 51.9, 50.7, 47.5, 43.0, 37.0, 30.5, 29.9; HRMS (Q-TOF) m/z calcd for 
C17H23NO4Na (M+Na)
 +
: 328.1525; found: 328.1521. 
 
Methyl (1R,2S)-2-{[(benzyloxy)carbonyl]amino}-4,4-dimethyl cyclo 
pentanecarboxylate (cis-74): [α]D 32.9 (c 0.56, CHCl3); IR (thin film): 
3357, 2954, 2868, 1728, 1529, 1455, 1370, 1319, 1234, 1053, 1024, 737, 
698 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.36-7.30 (m, 5H), 5.21 (d, J = 9.0, 1H), 5.12 (d, J = 
12.0, 1H), 5.06 (dd, J = 12.0, 1H), 4.47 (quint, J = 9.0, 1H), 3.59 (s, 3H), 3.21 (q, J = 9.0, 1H), 
1.90-1.83 (m, 2H), 1.75 (dd, J = 12.0, 9.0, 1H), 1.56 (dd, J = 12.0, 9.0, 1H), 1.11 (s, 3H), 1.01 (s, 
3H); 
13
C NMR (125 MHz, CDCl3)  175.0, 155.7, 136.5, 128.5, 128.2, 128.1, 66.6, 53.0, 51.6, 
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47.0, 46.5, 43.2, 36.9, 30.0, 29.1; HRMS (Q-TOF) m/z calcd for C17H23NO4Na (M+Na)
 +
: 
328.1525; found: 328.1512 
 
Cycloaddition of 59 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 59 (100 mg, 0.18 mmol) 
to afford 38 mg of 75 (54%) as a white solid. 
 
6-Benzyl 3,3-diethyl (1R,5S)-7-oxo-6-azabicyclo [3.2.0] heptane-3,3,6-tri 
carboxylate (75): []D +18.7 (c 0.73, CHCl3); IR (thin film): 2938, 1814, 1732, 
1453, 1387, 1325, 1261, 1197, 1103, 1054, 1019, 699 cm
1
; 
1
H NMR (300 
MHz, CDCl3)  7.44-7.35 (m, 5H), 5.30 (d, J = 12.3, 1H), 5.21 (d, J = 12.3, 1H),  4.48 (t, J = 4.8, 
1H), 4.19 (q, J = 7.2, 2H), 4.12-3.98 (m, 2H), 3.62 (dd, J = 8.4, 4.5, 1H), 3.16 (d, J = 15, 1H), 
3.01 (d, J = 14.1, 1H), 2.23-2.14 (m, 2H), 1.25 (t, J = 7.2, 3H), 1.17 (t, J = 7.2, 3H); 
13
C NMR 
(75 MHz, CDCl3)  170.5, 170.3, 165.1, 148.4, 135.0, 128.6, 128.5, 128.4, 67.9, 62.2(2C), 60.2, 
57.3, 54.2, 36.3, 33.1, 13.9, 13.8; HRMS (EI) m/z calcd for C20H23NO7 (M
+
): 389.1475; found: 
389.1478. 
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Cycloaddition of 59 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 59 (105 mg, 0.18 mmol) 
to afford 35 mg of 75 (48%) as a colorless oil and 21 mg of an inseparable diastereomeric 
mixture(cis:trans = 1.4:1) of 76 (27%) as a colorless oil. 
 
1,1-Diethyl 3-methyl (3R)-4-[(benzyloxycarbonyl)amino]cyclopentane-
1,1,3-tricarboxylate (76): IR (thin film): 3368, 2983, 1732, 1523, 1453, 1368, 
1258, 1184, 1098, 1026, 740, 699 cm
1
; 
1
H NMR (300 MHz, CDCl3, cis 
diastereomer in bold where resolved)  7.35 (s, 8.6H), 5.50 (d, J = 8.4, 1H), 5.30 (d, J = 7.2, 
0.7H), 5.08 (s, 3.4H), 4.52-4.44 (m, 1H), 4.41-4.34 (m, 0.7H), 3.70 (q, J = 6.9, 6.8H), 3.68 (s, 
2.1H), 3.61 (s, 3H), 3.11 (dd, J = 14.7, 7.8, 1H), 2.82 (br, 0.7H), .71 (dd, J = 14.1, 7.2, 0.7H), 
2.61=2.55 (m, 3.4H), 2.53 (dd, J = 14.1, 6.9, 1H), 2.40 (dd, J = 14.1, 6.0, 1H), 2.24-2.17 (m, 
0.7H), 1.25 (t, J = 7.2, 10.2H); 
13
C NMR (75 MHz, CDCl3, cis diastereomer in bold where 
resolved)  173.1 + 172.6 (1C), 172.0 + 171.8 (1C), 171.4 + 170.7 (1C), 155.6 + 155.5 (1C), 
136.5 + 136.4 (1C), 128.5 + 128.4 (1C), 128.1, 128.0, 66.7, 62.1 + 62.0 (1C), 61.9 + 61.8 (1C), 
58.2 + 57.7 (1C), 54.9 + 53.7 (1C), 52.1 + 51.9 (1C), 50.2 + 47.3 (1C), 39.7 + 39.6(1C), 35.7 + 
34.9 (1C), 13.9; HRMS (Q-TOF) m/z calcd for C21H27NO8Na (M+Na)
+
: 444.1634; found: 
444.1664. 
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Cycloaddition of 72 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 72 (160 mg, 0.28 mmol) 
to afford 76 mg of 77 (0.19 mmol, 68%) as a white solid. 
 
Benzyl (1R,5S)-3,3-diphenyl-7-oxo-6-azabicyclo [3.2.0]heptane-6-carboxylate 
(77): [α]D +17.1 (c 1.05, CHCl3); IR (thin film): 2360, 2106, 1797, 1715, 1642, 
1494, 1448, 1386, 1325, 1243, 1174, 1066, 737 cm
1
; 
1
H NMR (300 MHz, CDCl3) 
 7.39-7.00 (m, 15H), 5.06 (d, J = 12.3, 1H), 4.95 (d, J = 12.3, 1H), 4.53 (t, J = 4.8, 1H), 3.67 
(ddd, J = 8.7, 4.8, 1.2, 1H), 3.55 (d, J = 14.7, 1H), 3.40 (d, J = 14.1, 1H), 2.35 (dd, J = 14.7, 5.3, 
1H), 2.27 (dd, J = 14.4, 9.0, 1H); 
13
C NMR (75 MHz, CDCl3)  165.8, 148.7, 144.3, 135.0, 
128.5(2C), 128.4, 128.3, 126.4, 126.0, 125.9, 125.6, 67.6, 56.9, 55.0, 54.0, 39.3, 36.2; HRMS 
(Q-TOF) m/z calcd for C26H23NO3Na (M+Na
+
): 420.1576; found: 420.1599. 
 
Cycloaddition of 80 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 80 (92 mg, 0.21 mmol) to 
afford 16 mg of   90 (0.061 mmol, 29%) as a colorless oil. 
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Benzyl (1R,6S)-8-oxo-7-azabicyclo[4.2.0]octane-7-carboxylate (90): [α]D +46.9 (c 
0.79, CHCl3); IR (thin film): 3430, 2943, 2360, 1801, 1721, 1644, 1500, 1453, 1386, 
1325, 1279, 1181, 1061, 992, 913, 744 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.43-
7.33 (m, 5H), 5.30 (d, J = 12.3, 1H), 5.24 (d, J = 12.3, 1H), 4.19 (ddd, J = 6.6, 4.6, 3.9, 1H), 3.31 
(td, J = 6.9, 4.2, 1H), 2.11-2.03 (m, 1H), 1.96-1.72 (m, 3H), 1.67-1.48 (m, 4H); 
13
C NMR (75 
MHz, CDCl3)  168.5, 149.1, 135.2, 128.6, 128.4, 128.1, 67.7, 50.4, 47.1, 23.3, 19.4, 18.7, 16.6; 
HRMS (Q-TOF) m/z calcd for C15H17NO3Na (M+Na)
 +
: 282.1106; found: 282.1134. 
 
Cycloaddition of 80 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 80 (100 mg, 0.23 mmol) 
to afford 10 mg of 90 (16%) as a colorless oil and 25 mg of separable diastereomeric mixture 
(cis:trans = 4:1)  91 (37%) as a colorless oil. 
 
Methyl (1R,2R)-2-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylate 
(trans-91): []D 14.8 (c 0.46, CHCl3);IR (thin film): 3338, 2936, 2858, 1735, 
1533, 1452, 1318, 1263, 1231, 1172, 1124, 1046, 698 cm
1
; 
1
H NMR (300 
MHz, CDCl3)  7.36-7.32 (m, 5H), 5.08 (s, 2H), 4.71 (br, 1H), 3,74 (m, 1H), 3.63 (s, 3H), 3.28 
(dt, J = 11.4, 3.0, 1H), 2.11-2.05 (m, 1H), 1.97-1.90 (m, 1H), 1.77-1.70 (m, 2H), 1.63-1.59 (m, 
1H), 1.48-1.33 (m, 1H), 1.26-1.13 (m, 2H); 
13
C NMR (75 MHz, CDCl3)  174.3, 155.4, 136.6, 
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128.5, 128.0, 66.6, 51.8, 49.8, 32.9, 28.6, 24.6, 24.4; HRMS (Q-TOF) m/z calcd for 
C16H21NO4Na (M+Na)
 +
: 314.1368; found: 314.1369. 
 
Methyl (1R,2S)-2-{[(benzyloxy)carbonyl]amino}cyclohexanecarboxylate 
(cis-91): []D 19.0 (c 0.39, CHCl3); IR (thin film): 3353, 2936, 2858, 2360, 
2340, 1725, 1507, 1454, 1312, 1234, 1101, 1042, 991 cm
1
; 
1
H NMR (300 
MHz, CDCl3)  7.38-7.31 (m, 5H), 5.59 (d, J = 8.7, 1H), 5.09 (s, 2H), 3.91 (ddd, J = 13.5, 9.0, 
3.9, 1H), 3.68 (s, 3H), 2.83 (dd, J = 9.3, 4.5, 1H), 2.05-2.00 (m, 1H), 1.82-1.63 (m, 3H), 1.50-
1.26 (m, 4H); 
13
C NMR (75 MHz, CDCl3)  174.2, 155.7, 136.6, 128.5, 128.1, 128.0, 66.6, 51.6, 
49.7, 44.7, 29.7, 27.0, 23.8, 22.5; HRMS (Q-TOF) m/z calcd for C16H21NO4Na (M+Na)
 +
: 
314.1368; found: 314.1359. 
 
Cycloaddition of 85 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 85 (133 mg, 0.23 mmol) 
to afford 33 mg of 92 (0.080 mmol, 35%) as a white solid. 
 
Benzyl (1R,6S)-8-oxo-3-((4-methylphenyl)sulfonyl)-3,7-diazabicyclo[4.2.0]octane-
7-carboxylate (92): [α] +65.7 (c 0.97, CHCl3); IR (thin film): 3438, 1797, 1716, 
1643, 1392, 1335, 1275, 1160, 1070, 915, 814, 732 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.67 (d, J = 8.1, 2H), 7.39-7.36 (m, 5H), 7.31 (d, J = 8.1, 2H), 5.26 (d, J = 12.3, 1H), 
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5.21 (d, J = 12.3, 1H), 4.24 (dt, J = 6.3, 3.6, 1H), 3.76 (dd, J = 12.9, 3.3, 1H), 3.49-3.35 (m, 3H), 
3.15 (td, J = 11.7, 4.8, 1H), 2.42 (s, 3H), 2.35 (qd, J = 15, 3.9, 1H), 2.09-1.97 (m, 1H); 
13
C NMR 
(75 MHz, CDCl3)  164.5, 148.8, 143.9, 134.8, 134.0, 129.8, 128.7, 128.6, 128.2, 127.4, 68.2, 
47.7(2C), 39.6, 38.8, 23.5, 21.5; HRMS (EI) m/z calcd for C21H22N2O5S (M
+
): 414.1249; found: 
414.1240. 
 
Cycloaddition of 85 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 85 (130 mg, 0.22 mmol) 
to afford 26 mg of 92 (29%) as a colorless oil and 43 mg of an inseparable diastereomeric 
mixture (cis:trans = 9.6:1) of 93 (44%) as a white solid. 
 
Methyl (3R,4S)-4-[(benzyloxycarbonyl) amino]-1-[(4-methylphenyl) 
sulfonyl]piperidine-3-carboxylate (cis-93): [α] +6.4 (c 0.27, CHCl3); IR 
(thin film): 3367, 2922, 2851, 1726, 1510, 1454, 1353, 1239, 1164, 1092, 
1036, 930 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.64 (d, J = 8.1, 2H), 7.39-7.28 (m, 5H), 5.73 (d, 
J = 9.0, 1H), 5.06 (s, 2H), 3.97-3.94 (br, 1H), 3.83 (m, 1H), 3.74 (s, 3H), 3.55 (br, 1H), 2.88 (q, J 
= 3.9, 1H), 2.70 (dd, J = 12.3, 2.4, 1H), 2.57 (t, J = 9.6, 1H), 2.46 (s, 3H), 2.18-2.05 (m, 1H), 
1.83 (dq, J = 13.2, 3.9, 1H); 
13
C NMR (75 MHz, CDCl3)  171.6, 155.6, 143.9, 136.2, 129.8, 
128.5, 128.2, 128.1, 127.6, 66.8, 52.3, 47.9, 47.4, 45.2, 43.8, 28.6, 21.5; HRMS (Q-TOF) m/z 
calcd for C22H26N2O6 SNa (M+Na)
 +
: 469.1409; found: 469.1382 
 73 
Cycloaddition of 89 followed by silica gel filtration 
 
General Procedure C and work-up method 1 were followed employing 89 (190 mg, 0.33 mmol) 
to afford 43 mg of 94 (0.11 mmol, 32%) as a colorless oil. 
 
7-Benzyl 3,3-diethyl (1R,6S)-8-oxo-7-azabicyclo [4.2.0] octane-3,3,7-tri 
carboxylate (94): [α]D +67.0 (c 1.41, CHCl3); IR (thin film): 2981, 2357, 1812, 
1729, 1453, 1388, 1333, 1264, 1179, 1056, 1021, 858, 740 cm
1
; 
1
H NMR (300 
MHz, CDCl3)  7.40-7.36 (m, 5H), 5.29 (d, J = 12.3, 1H), 5.24 (d, J = 12.3, 1H), 4.19 (q, J = 7.2, 
4H), 3.43 (td, J = 9.3, 6.9, 1H), 2.51 (dd, J = 14.7, 9.3, 1H), 2.21-2.00 (m, 4H), 1.92-1.85 (m, 
1H), 1.25 (t, J = 7.2, 3H), 1.24 (t, J = 7.2, 3H); 
13
C NMR (75 MHz, CDCl3)  171.3, 171.2, 167.2, 
149.0, 135.0, 128.6, 128.5, 128.2, 67.9, 61.8(2C), 52.0, 49.0, 44.5, 25.4, 24.3, 22.0, 14.0, 13.9; 
HRMS (Q-TOF) m/z calcd for C21H25NO7Na (M+Na)
+
: 426.1529; found: 426.1525 
 
 
 
 
 
 
 
 
 74 
Cycloaddition of 89 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 89 (110 mg, 0.18 mmol) 
to afford 43 mg of inseparable mixture of 94 and 95 (56% combined yield). The resulting 
mixture was taken into 5mL MeOH, and 500 L of iPr2NEt was added. The resulting reaction 
mixture was stirred at ambient temperature for 30 min, then solvent and excessive 
i
Pr2NEt was 
removed in vacuo. The resulting crude mixture was purified by flash chromatography (30% ethyl 
acetate in hexane) to afford an inseparable diastereomeric mixture (cis:trans =  8.4:1) of 95 in 
quantitative yield . 
 
1,1-Diethyl 3-methyl (3R,4S)-4-[(benzyloxycarbonyl)amino]cyclohexane-
1,1,3-tricarboxylate (cis-95):  [α]D +14.7 (c 0.78, CHCl3); IR (thin film): 
3375, 2978, 1805, 1724, 1591, 1520, 1448, 1385, 1331, 1230, 1052, 1021, 
738 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.37-7.32 (m, 5H), 5.20 (br, 1H), 5.08 (s, 2H), 4.21 (q, 
J = 7.2, 2H), 4.19 (q, J = 7.2, 2H), 3.65 (s, 3H), 2.91 (ddd, J = 15, 8.7, 4.2, 1H), 2.38 (dd, J = 
14.7, 4.5, 1H), 2.17-1.95 (m, 4H), 1.68-1.58 (m, 2H), 1.26 (t, J = 7.2, 3H), 1.25 (t, J = 7.2, 3H); 
13
C NMR (75 MHz, CDCl3)  173.0, 171.0, 170.6, 155.6, 136.3, 128.5, 128.3, 128.1, 66.8, 61.7, 
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61.6, 53.4, 51.9, 47.3, 41.9, 28.4, 26.8, 26.1, 14.0, 13.9; HRMS (Q-TOF) m/z calcd for 
C22H29NO8Na (M+Na)
 +
: 435.1893; found: 435.1902. 
 
Cycloaddition of 105 followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 105 (156 mg, 0.22 mmol) 
to afford 16 mg of 106 (14%) and 54 mg of inseparable diastereomeric mixture of 107 (cis:tran = 
1:10.2). 
 
Methyl (3R,4R,6S)-4-[(benzyloxycarbonyl)amino]-6-(2-phenylethyl)-
1-((4-methylphenyl)sulfonyl)piperidine-3-carboxylate (trans-107): 
[α]D 1.1 (c 3.12, CHCl3); IR (thin film): 3362, 2951, 1809, 1734, 1528, 
1497, 1453, 1384, 1318, 1265, 1234, 1157, 1089, 1027, 915, 817, 739 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.69 (d, J = 8.4, 2H), 7.39-7.28 (m, 9H), 7.24-7.11 (m, 5H), 5.05 (s, 2H), 4.54 (br, 1H), 
4.17 (q, J = 6.3, 1H), 4.09-4.03 (m, 2H), 3.62 (s, 3H), 3.28 (dd, J = 13.8, 2.4, 1H), 2.59-2.54 (m, 
2H), 2.44 (s, 3H), 2.25 (td, J = 12.0, 4.2, 1H), 1.97-1.81 (m, 3H), 1.37 (br, 1H); 
13
C NMR (75 
MHz, CDCl3)  171.3, 155.2, 143.7, 140.9, 137.7, 136.2, 129.9, 128.5, 128.4, 128.3, 128.2, 
128.1, 127.1, 126.1, 52.6, 52.2, 47.4, 46.7, 41.3, 34.3, 32.6, 31.9, 21.6; HRMS (Q-TOF) m/z 
calcd for C30H34N2O6 SNa (M+Na)
 +
: 573.2035; found: 573.2059 
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Cycloaddition of 105 catalyzed by TMSQd, followed by MeOH quenching 
 
General Procedure C and work-up method 2 were followed employing 105 (110 mg, 0.15 mmol) 
and TMS-QD to afford 32 mg of 113 (0.062 mmol, 42%) as an amorphous solid. 
 
Methyl (1S,4S,6R)-3-((4-methylphenyl)sulfonyl)-8-oxo-4-(2-phenylethyl)-
3,7-diazabicyclo[4.2.0]octane-7-carboxylate (113): [α]D 58.5 (c 0.48, 
CHCl3); IR (thin film): 2360, 2340, 1811, 1723, 1495, 1454, 1386, 1334, 
1261, 1157 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.61 (d, J = 8.1, 2H), 7.40-7.29 (m, 6H), 7.24-
7.21 (m, 4H), 7.13 (d, J =  8.1, 2H), 5.24 (d, J = 12.3, 1H), 5.18 (d, J = 12.3, 1H), 4.21 (dd, J = 
12.0, 6.3, 1H), 3.94-3.87 (m, 2H), 3.52 (dd, J = 13.8, 5.7, 1H), 3.38 (dd, J = 11.4, 6.3, 1H), 2.67-
2.53 (m, 2H), 2.37 (s, 3H), 2.16-1.96 (m, 3H), 1.88-1.80 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  
163.9, 148.8, 143.6, 140.7, 136.0, 134.8, 129.8, 128.7, 128.6, 128.5, 128.3, 128.1, 127.4, 126.1, 
68.1, 50.4, 47.3, 46.6, 38.4, 35.9, 31.6, 27.7, 21.5; HRMS (EI) m/z calcd for C29H30N2O5 S (M
+
): 
518.1875; found: 518.1869. 
 
tert-Butyl 6-hydroxyhexanoate (28) : To a solution of tert-butyl 6-
benzyloxyhexanoate
i
 (3.8 mmol, 1.1 g) in13 mL methanol was added 
10% Pd/C (125 mg). The resulting reaction mixture was stirred at ambient temperature for 12h. 
                                                 
i
 Org. Biomol. Chem. 2007, 5, 3599-3613 
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The mixture was then filtered through celite using ethyl acetate as an eluent, and the solvent was 
removed in vacuo to afford 710 mg of the title compound as a colorless oil (99% yield). IR (thin 
film): 3425, 2980, 2098, 1642, 1458, 1367, 1254, 1152, 1075 cm
1
; 
1
H NMR (300 MHz, CDCl3) 
 3.66 (q, J = 5.4, 2H), 2.24 (t, J = 7.5, 2H), 1.65-1.55 (m, 4H), 1.45 (s, 9H), 1.43-1.38(m, 2H); 
13
C NMR (75 MHz, CDCl3)  173.3, 80.1, 62.7, 35.5, 32.4, 28.1, 25.2, 24.7;  HRMS (EI) m/z 
calcd for C10H2O3 (M+H)
 +
: 189.1490; found: 189.1494. 
 
tert-Butyl 6-(benzyloxydithiocarbonylamino)-6-p-toluenesul 
fonyl hexanoate (29) : General Procedure A was followed 
employing tert-butyl 6-hydroxyhexanoate (1.8 mmol, 340 mg),  
oxalyl chloride (2.2 mmol, 190 L), DMSO (4.6 mmol, 330 L), and triethylamine (9.3 mmol, 
1.3 mL) in 4 mL CH2Cl2. The resulting aldehyde was used for the next reaction without further 
purification employing benzyl carbamate (1.6 mmol, 300 mg), sodium salt of p-toluenesulfinic 
acid (1.8 mmol, 290 mg) in 9 mL water/HCOOH (1/2 v/v). The resulting white solid was filtered 
off and washed with cold ether to afford 530 mg of the title compound as a yellow oil (58 % 
yield). IR (thin film): 3267, 2924, 2254, 1720, 1596, 1523, 1494, 1453, 1368 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.71 (d, J = 8.1, 2H), 7.41-7.16 (m, 8H), 6.19-6.09 (m, 1H), 4.46 (d, J = 
13.8, 1H), 4.29 (d, J = 13.8, 1H), 2.43 (s, 3H),  2.43-2.37 (m, 2H), 2.22 (t, J = 7.2, 2H), 1.95-1.88 
(m, 1H), 1.74-1.61 (m, 3H), 1.44 (s, 9H; 
13
C NMR (75 MHz, CDCl3, only major rotamer shown) 
 199.8, 172.8, 145.3, 136.5, 133.6, 129.9, 129.2, 129.0, 128.6, 127.6, 77.2, 39.9, 35.1, 33.3, 28.1, 
26.4, 24.6, 24.1, 21.8;  HRMS (Q-TOF) m/z calcd for C25H33NO4S3Na (M+Na)
 +
: 530.1469; 
found: 530.1433. 
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6-(Benzyloxydithiocarbonylamino)-6-p-toluenesulfonyl hexanoic 
acid (30): General Procedure B was followed employing tert-butyl 6-
dithiobenzyloxycarbonylamino-6-tosylhexanoate (1.6 mmol, 810 mg) 
in anhydrous HCOOH (7 mL). After removal of HCOOH in vacuo, resulting crude product was 
purified by flash chromatography (50% ethyl acetate in hexane) to afford to afford 420 mg of the 
title compound as a yellow powder (57 % yield). 
1
H NMR (300 MHz, DMSO-D6)  12.0 (br, 
1H), 10.7 (d, J = 5.7, 1H), 7.66 (d, J = 4.8, 2H), 7.37 (d, J = 4.8, 2H), 7.31-7.22 (m, 5H), 6.05 (t, 
J = 5.7, 1H), 4.45 (d, J = 8.1, 1H), 4.32 (d, J = 8.4, 1H), 2.40 (s, 3H), 2.18 (t, J = 4.5, 2H), 2.08-
2.07 (br, 1H), 1.92-1.89 (br, 1H), 1.54-1.45 (m, 2H), 1.33-1.27 (m, 2H); 
13
C NMR (75 MHz, 
DMSO-D6)  201.0, 174.6, 145.2, 137.3, 134.4, 130.2, 129.5, 129.2, 128.8, 127.7, 75.2, 38.8, 
33.7, 26.0, 24.8, 24.4, 21.7; HRMS (Q-TOF) m/z calcd for C21H25NO3S3Na (M+Na
+
): 474.0843; 
found: 474.0838. 
 
tert-Butyl 6-(benzyloxycarbonylamino)-6-p-toluenesulfonyl hex 
anoate (34) : General Procedure A was followed employing tert-
butyl 6-hydroxyhexanoate (9.6 mmol, 1.8 g),  oxalyl chloride (12 
mmol, 1.0 mL), DMSO (25 mmol, 1.8 mL), and triethylamine (9.3 mmol, 7.0 mL) in 20 mL 
CH2Cl2. The resulting aldehyde was used for the next reaction without further purification 
employing benzyl carbamate (8.6 mmol, 1.3 g), sodium salt of p-toluenesulfinic acid (12 mmol, 
2.1 g) in 51 mL water/HCOOH (1/2 v/v). The resulting white solid was filtered off and washed 
with cold ether to afford 3.5 g of the title compound as a white solid (77 % yield). IR (thin film): 
3316, 3035, 2957, 2869, 1725, 1597, 1530, 1455, 1368, 1236, 1144, 1084, 1060, 817, 739 cm
1
; 
1
H NMR (300 MHz, CDCl3, only major rotamer shown)  7.74 (d, J = 8.1, 2H), 7.33 (br, 5H), 
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5.44 (d, J = 10.8, 1H), 4.92 (d, J = 12.3, 1H), 4.95-4.84 (m, 2H), 2.22 (t, J = 7.2, 2H), 1.82-1.51 
(m, 6H), 1.44 (s, 9H); 
13
C NMR (75 MHz, CDCl3, only major rotamer shown)  177.8, 172.6, 
155.0, 145.0, 135.7, 133.5, 129.7, 129.1, 128.4, 128.2, 128.0, 80.3, 71.2, 67.2, 35.0, 33.3, 28.0, 
26.3, 24.8, 24.4, 23.9, 21.7;  HRMS (Q-TOF) m/z calcd for C25H33NO6SNa (M+Na)
 +
: 498.1926; 
found: 489.1930. 
 
6-(Benzyloxycarbonylamino)-6-p-toluenesulfonyl hexanoic acid 
(35): General Procedure B was followed employing tert-butyl 6-
benzyloxycarbonylamino-6-tosylhexanoate 34 (2.6 mmol, 1.2 g) in 
anhydrous HCOOH (12 mL). After removal of HCOOH in vacuo, the resulting white solid was 
washed with cold ether to afford 750 mg of the title compound as a white solid (69 % yield).
 1
H 
NMR (300 MHz, DMSO-D6)  8.32 (d, J = 5.7, 1H), 7.68 (d,  J = 4.8, 2H), 7.38-7.31 (m, 5H), 
7.20 (d, J = 4.5, 2H), 4.88 (d, J = 18.9, 1H), 4.84 (d, J = 18.9, 1H), 4.75 (t, J = 6.6, 1H), 2.39 (s, 
3H), 2.18 (t,  J = 4.5, 2H), 1.96-1.94 (m, 1H), 1.70-1.64 (m, 1H), 1.51-1.29 (m, 4H); 
13
C NMR 
(75 MHz, DMSO-D6)  174.3, 155.5, 144.5, 136.6, 133.8, 129.6, 129.0, 128.4, 127.9, 127.5, 
127.2, 71.8, 65.8, 33.4, 25.5, 24.6, 23.9, 21.2;  HRMS (Q-TOF) m/z calcd for C21H25NO3Na 
(M+Na
+
): 442.1300; found: 442.1283. 
 
 tert-Butyl 3-(N-p-toluenesulfonyl-N-(2-trimethylsilyloxy ethyl)) 
aminopropanoate (45) : To a solution of N-(2-
trimethylsilyloxyethyl) toluenesulfonamide (45 mmol, 13 g) in 150 mL acetonitrile were added 
potassium carbonate (290 mmol, 40 g) and tert-butyl acrylate (230 mmol, 29 g). The resulting 
reaction mixture was refluxed for 12 h. The reaction mixture was cooled to ambient temperature 
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and filtered. The resulting homogeneous solution was concentrated in vacuo and purified by 
column chromatography (SiO2, 20% ethyl acetate in hexanes) to afford 9.5 g of the title 
compound as a colorless oil (51% yield).
ii
 IR (thin film): 2959, 2360, 2340, 1727, 1367, 1342, 
1253, 1158, 1092, 992, 844, 715 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.71 (d, J = 8.4, 2H), 7.30 
(d, J = 7.8, 2H), 3.71 (t, J = 6.0, 2H), 3.45-3.40 (m, 2H), 3.24 (t, J = 6.0, 2H), 2.64-2.58 (m, 2H), 
2.43 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  170.7, 143.3, 136.6, 129.7, 127.2, 80.8, 61.8, 51.1, 
45.7, 35.6, 28.1, 21.5, 0.71; HRMS (EI) m/z calcd for C19H33NO5SSi (M
+
): 415.1849; found: 
415.1840. 
 
 tert-Butyl 3-(N-p-toluenesulfonyl-N-(2-hydroxyethyl)) amino 
propanoate (46): To a 0 

C solution of tert-butyl 3-(N-p-
toluenesulfonyl-N-(2-(trimethylsilyloxy) ethyl))propanoate 45 (4.0 mmol, 1.4 g) in Et2O (40 mL) 
was added TBAF (1.0 M solution in THF, 4.0 mL). The resulting reaction mixture was stirred for 
20 min, then filtered through a short silica gel pad with Et2O as eluting solvent. The resulting 
homogeneous solution was concentrated in vacuo and purified by column chromatography (SiO2, 
40% ethyl acetate in hexanes) to afford 1.2 g of the title compound as a colorless oil (89% yield). 
IR (thin film): 3440, 2106, 1643, 1334, 1157 cm
1
; 
1
H NMR (300 MHz, CDCl3)  .7.72 (d, J = 
8.1, 2H), 7.33 (d, J = 8.1, 2H), 3.79 (q, J = 5.4, 2H), 3.41 (t, J = 6.9, 2H), 3.21 (t, J = 5.1, 2H), 
2.91 (t, J = 6.3, 1H), 2.63 (t,  J = 6.9, 2H), 2.44 (s, 3H), 1.47 (s, 9H); 
13
C NMR (75 MHz, CDCl3) 
 171.2, 143.7, 135.4, 129.8, 127.3, 81.5, 61.6, 52.4, 46.2, 35.6, 28.0, 21.5; HRMS (Q-TOF) m/z 
calcd for C16H25NO5SNa (M+Na
+
): 366.1351; found: 366.1326. 
                                                 
ii
 27% TMS-deprotected product was also isolated. 
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tert-Butyl 3-(N-(2-(benzyloxycarbonylamino)-2-tosylethyl)-N-p-
toluenesulfonyl)aminopropanoate (47): General Procedure A was 
followed employing tert-butyl 3-(N-p-toluenesulfonyl-N-(2-
hydroxyethyl))aminopropanoate 46 (3.8 mmol, 1.3 g),  oxalyl chloride (4.7 mmol, 410 L), 
DMSO (9.8 mmol, 700 L), and triethylamine (20 mmol, 2.8 mL) in 9 mL CH2Cl2. The resulting 
aldehyde was used for the next reaction without further purification employing benzyl carbamate 
(3.7 mmol, 560 mg), sodium salt of p-toluenesulfinic acid (4.1 mmol, 730 mg) in 21 mL 
water/HCOOH (1/2 v/v). The resulting white solid was filtered off and washed with cold ether to 
afford 1.5 g of the title compound as a white solid (63% yield). IR (thin film): 3423, 2098, 1641, 
1319, 1230, 1147 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.75 (d,  J = 8.4, 2H), 7,69 (d, J = 8.1, 
2H), 7.37-7.31 (m, 5H), 7.25-7.22 (m, 4H), 5.86 (d, J = 9.9, 1H), 5.13 (td, J = 10.8, 3.6, 1H), 
5.49 (d, J = 12.6, 1H), 5.89 (d, J = 12.6, 1H), 3.91 (dd, J = 15.3, 11.3, 1H), 3.67 (dd, J = 15.0, 3.6, 
1H), 3.48 (m, 1H), 3.34 (m, 1H), 2.44 (s, 3H), 2.42 (s, 3H), 1.43 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  170.4, 155.1, 145.4, 144.1, 135.9, 135.7, 133.3, 130.0, 129.8, 129.4, 128.5, 128.2, 
127.9, 127.2, 81.4, 69.5, 67.3, 45.5, 45.3, 35.1, 28.0, 21.8, 21.5; HRMS (Q-TOF) m/z calcd for 
C31H38N2O8S2Na (M+Na
+
): 653.1967; found: 653.1970. 
 
3-(N-(2-(Benzyloxycarbonylamino)-2-toluensulfonylethyl)-N-p-
toluenesulfonyl)aminopropanoic acid (48): General Procedure B was 
followed employing  tert-butyl 3-(N-(2-(benzyloxycarbonylamino)-2-
toluensulfonylethyl)-N-p-toluenesulfonyl)aminopropanoate 47 (2.4 mmol, 1.5 g) in anhydrous 
HCOOH (13 mL). After removal of HCOOH in vacuo, the resulting white solid was washed 
with cold ether to afford 990 mg of the title compound as a white solid (72% yield). IR (thin 
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film): 3329, 1720, 1702, 1526, 1452, 1311, 1234, 1158, 1141, 1084, 1042, 1004, 813, 740, 707  
cm
1
; 
1
H NMR (300 MHz, DMSO-d6)  12.35 (br, 1H), 8.56 (d, J = 10.2, 1H), 7.69 (d, J = 8.1, 
2H), 7.56 (d, J = 8.4, 2H), 7.55-7.17 (m, 9H), 5.11 (td, J = 10.2, 2.1, 1H), 4.94 (d, J = 12.6, 1H), 
4.89 (d, J = 12.6, 1H), 3.75 (dd, J = 14.7, 1.8, 1H), 3.53-3.14 (m, 3H), 2.46-2.37 (m, 2H), 2.43 (s, 
3H), 2.40 (s, 3H); 
13
C NMR (75 MHz, DMSO-d6)  172.1, 155.4, 145.1, 143.8, 136.4, 134.9, 
133.3, 130.0, 129.9, 128.9, 128.3, 127.9, 127.4, 127.0, 71.5, 66.0, 45.8, 45.4, 33.1, 21.2, 20.1; 
HRMS (Q-TOF) m/z calcd for C27H30N2O8S2Na (M+Na
+
): 597.1341; found: 597.1371. 
 
     tert-Butyl 3-(2-benzyloxycarbonylamino-2-p-toluenesulfonyl 
ethoxy) propanoate (50) : General Procedure A was followed 
employing tert-butyl 3-(2-hydroxyethoxy)propanoate
iii
 (25 mmol, 
4.8 g), oxalyl chloride (32 mmol, 2.7 mL), DMSO (65 mmol, 4.5 mL), and triethylamine (130 
mmol, 17 mL) in 60 mL CH2Cl2. The resulting aldehyde was used for the next reaction without 
further purification employing benzyl carbamate (25 mmol, 3.8 g), sodium salt of p-
toluenesulfinic acid (33 mmol, 5.8 g) in 125 mL water/HCOOH (1/2 v/v). The resulting white 
solid was filtered off and washed with cold ether to afford 9.2 g of the title compound as a 
colorless oil (77% yield over 2 steps). IR (thin film): 3345, 2977, 1729, 1531, 1455, 1369, 1318, 
1234, 1145, 1082, 1044 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.73 (d, J = 8.1, 2H), 7.37-7.34 (m, 
4H),  7.28-7.22 (m, 3H), 5.98 (d, J = 10.2, 1H), 5.05-4.99 (m, 2H), 4.94 (d, J = 12.3, 1H), 4.20 
(dd, J = 11.1, 3.6, 1H), 3.86 (dd, J = 11.1, 4.2, 1H), 3.78-3.65 (m, 2H), 2.46-2.44 (m, 2H), 2.42 (s, 
3H), 1.44 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  170.7, 154.9, 145.0, 135.8, 134.2, 129.6, 129.2, 
                                                 
iii
 Synth. Commun. 2007, 37, 1899-1915 
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128.5, 128.2, 128.0, 80.9, 70.8, 67.4, 67.3, 66.4, 35.8, 28.0, 21.7;  HRMS (Q-TOF) m/z calcd for 
C24H31NO7SNa (M+Na
+
): 500.1719; found: 500.1703 
 
3-(2-Benzyloxycarbonylamino-2-p-
toluenesulfonylethoxy)propanoic acid (51) : General Procedure B 
was followed employing  tert-butyl 3-(2-(benzyloxycarbonylamino)-2-
tosylethoxy) propanoate 50 (5.4 mmol, 2.6 g) in anhydrous HCOOH (29 mL). After removal of 
HCOOH in vacuo, the resulting white solid was washed with cold ether to afford 1.9 g of the title 
compound as a white solid (85% yield). IR (thin film): 3349, 1717, 1646, 1531, 1454, 1401, 
1316, 1237, 1142, 1081 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.73 (d, J = 8.4, 2H), 7.36-7.34 (m, 
4H), 7.26-7.16 (m, 3H), 6.05 (d, J = 10.5, 1H), 5.05-4.99 (m, 2H), 4.92 (d, J = 12.6, 1H), 4.21 
(dd, J = 11.1, 3.9, 1H), 3.87 (dd, J = 11.1, 4.2, 1H), 3.80 (m, 2H), 2.60-2.51 (m, 2H), 2.41 (s, 
3H) ; 
13
C NMR (75 MHz, CDCl3)  175.8, 155.0, 145.2, 135.8, 134.0, 129.7, 129.2, 128.5, 128.3, 
128.1, 70.6, 66.8, 66.6, 34.3, 21.7;  HRMS (Q-TOF) m/z calcd for C20H23NO73Na (M+Na
+
): 
444.1093; found: 444.1125. 
 
tert-Butyl 6-hydroxy-4,4-di(ethoxycarbonyl)hexanoate (57): To a 
mixture of NaH 60% dispersion in mineral(4.4 mmol, 115 mg) in 7 mL 
THF at 0 

C was slowly added a solution of diethyl 2-(2-
(benzyloxy)ethyl)malonate
iv
 (4.0 mmol, 1.2 g) in 5 mL THF. Once bubbling had ceased tert-
butyl 3-bromopropionate (4.8 mmol, 800 L) was added dropwise. The resulting reaction 
                                                 
iv J. Am. Chem. Soc. 2009, 131, 2786-2787  
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mixture was refluxed overnight, then cooled to ambient temperature. Upon addition of 20 mL 
water, the resulting biphasic mixture was extracted with 10 mL ethyl acetate (3×). The combined 
organic phase was dried over Na2SO4, then concentrated. The resulting crude product was 
chromatographed (SiO2, 40% ethyl acetate in hexanes) to afford inseparable mixture of diethyl 2-
(2-(benzyloxy)ethyl)malonate and tert-butyl 6-benzyloxy-4,4-di(ethoxycarbonyl)hexanoate in 
1:2 ratio. The resulting mixture was taken into 14 mL anhydrous MeOH, then 114 mg Pd/C was 
added. The heterogeneous mixture was stirred under H2 atmosphere for 48 h. The mixture was 
then filtered through celite using ethyl acetate as the eluent, and the solvent was removed in 
vacuo. The resulting crude oil was purified by column chromatography (SiO2, 25% to 50% ethyl 
acetate in hexanes) to afford 690 mg of the title compound as a colorless oil (53% yield). IR (thin 
film): 3540, 2980, 2937, 1778, 1730, 1452, 1369, 1157, 1102, 1027, 958, 848, 757 cm
1
; 
1
H 
NMR (300 MHz, CDCl3)  4.21 (q, J = 7.2, 4H), 3.73 (q, J = 6.3, 2H), 2.23 (s, 3H), 2.17 (t, J = 
6.3, 2H), 1.79 (t, J = 5.7, 1H), 1.45 (s, 9H), 1.27 (t, J = 7.2, 6H); 
13
C NMR (75 MHz, CDCl3)  
172.0, 171.4, 80.6, 61.5, 58.7, 55.5, 35.7, 30.7, 28.3, 28.0, 14.0; HRMS (EI) m/z calcd for 
C16H29O7 (M+H)
 +
: 333.1913; found: 333.1900. 
 
            tert-Butyl 6-benzyloxycarbonylamino-6-p-toluenesulfonyl-4,4-di 
(ethoxycarbonyl)hexanoate (58): General Procedure A was followed 
employing tert-butyl 6-hydroxy-4,4-di(ethoxycarbonyl)hexanoate 57 (0.51 
mmol, 170 mg),  oxalyl chloride (0.64 mmol, 55 L), DMSO (1.3 mmol, 93 L), and 
triethylamine (2.7 mmol, 373 L) in 1.2 mL CH2Cl2. The resulting aldehyde was used for the 
next reaction without further purification employing benzyl carbamate (0.51 mmol, 77 mg), 
sodium salt of p-toluenesulfinic acid (0.66 mmol, 120 mg) in 2 mL water/HCOOH (1/2 v/v). The 
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resulting white solid was purified by column chromatography (SiO2, 50% ethyl acetate in 
hexanes) to afford 135 mg of the title compound as an amorphous white solid (43% yield). IR 
(thin film): 3430, 2098, 1641, 1527, 1453, 1369, 1316, 1224, 1186, 1147, 1084, 1043 cm
1
; 
1
H 
NMR (300 MHz, CDCl3)  7.74 (d, J = 8.4, 2H), 7.35-7.32 (m, 3H), 7.24-7.13 (m, 4H), 5.33 (d, J 
= 10.5, 1H), 5.04 (td, J = 12.0, 2.4, 1H), 4.89 (d, J =  12.3, 1H), 4.84 (d, J = 12.3, 1H), 4.13 (q, J 
= 7.2, 4H), 2.76 (dd, J = 15, 2.4, 1H), 2.44 (dd, J = 15, 12, 1H), 2.41 (s, 3H), 2.32-2.13 (m, 4H), 
1.45 (s, 9H), 1.20 (q, J = 7.2, 6H); 
13
C NMR (75 MHz, CDCl3)  171.5, 170.4, 170.1, 154.2, 
145.2, 135.7, 133.0, 129.7, 129.4, 128.5, 128.3, 128.1, 80.8, 68.4, 67.2, 62.0, 61.9, 54.9, 30.4, 
29.7, 28.7, 28.1, 21.8, 13.9; HRMS (EI) m/z calcd for C31H41NO16S (M
 +
): 619.2451; found: 
619.2450. 
 
6-Benzyloxycarbonylamino-6-p-toluenesulfonyl-4,4-
di(ethoxycarbonyl)hexanoic acid (59): General Procedure B was followed 
employing  tert-butyl 6-(benzyloxycarbonylamino)-6-p-toluenesulfonyl-4,4-
di(ethoxycarbonyl)hexanoate 58 (0.96 mmol, 590 mg) in anhydrous HCOOH (5.2 mL). After 
removal of HCOOH in vacuo, the resulting white solid was washed with cold ether to afford 430 
mg of the title compound as a white solid (79% yield). 
1
H NMR (300 MHz, DMSO-D6)  12.25 
(br, 1H), 8.47 (d, J = 9.9, 1H), 7.67 (d, J = 8.1, 2H), 7.40 (d, J = 8.4, 2H), 7.38-7.32 (m, 3H), 
7.21-7.19 (m, 2H), 4.86 (d, J =  12.6, 1H), 4.80 (d, J = 12.6, 1H), 4.74 (t, J = 10.5, 1H), 4.14-3.95 
(m, 4H), 2.50 (t, J = 7.2, 2H), 2.40 (s, 3H), 2.28-1.94 (m, 4H), 1.13 (t, J = 7.2, 3H), 1.12 (t, J = 
7.2, 3H); 
13
C NMR (75 MHz, DMSO-D6)  173.0, 169.6, 169.4, 154.9, 144.8, 136.2, 132.8, 
129.7, 129.0, 128.2, 127.8, 127.5, 68.3, 65.8, 61.5, 61.3, 54.3, 28.9, 28.1, 26.6, 21.1, 13.6, 13.5; 
HRMS (Q-TOF) m/z calcd for C27H33NO10SNa (M+Na
+
): 586.1723; found: 586.1728. 
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6-Benzyloxy-4,4-dimethylhexanoic acid (61): To a solution of 5,5-
dimethyl-2-oxepanone
v
 (40 mmol, 5.7 g) in 60 mL toluene were added 
potassium hydroxide (200 mmol, 11 g) and benzyl chloride (14 mL, 15g) successively. The 
resulting reaction mixture was refluxed overnight, then cooled to ambient temperature. The 
resulting reaction mixture was added 100 mL water, then washed with 30 mL hexane (2×). The 
resulting homogeneous mixture was acidified with H2SO4 until it became heterogeneous, then 
extracted with 30 mL ethyl acetate. This step was repeated 3 times. The combined organic phase 
was dried over Na2SO4 then concentrated. The resulting crude oil was purified by column 
chromatography (SiO2, 50% ethyl acetate in hexanes) to afford 6.1 g of the title compound as a 
colorless oil (50% yield). IR (thin film): 3434, 2961, 2869, 2091, 1727, 1643, 1454, 1390, 1367, 
1310, 1254, 1153, 1028, 952, 847 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.35-7.30 (m, 5H), 4.50 
(s, 2H), 3.54 (t, J = 7.2, 2H), 2.38-2.32 (m, 2H), 1.64-1.57 (m, 4H), 0.92 (s, 6H); 
13
C NMR (75 
MHz, CDCl3)  178.3, 138.5, 131.6, 128.4, 127.6, 127.5, 73.1, 67.2, 40.6, 36.7, 31.9, 29.0, 27.1; 
HRMS (EI) m/z calcd for C15H21O3 (M
+
) 249.1499; found: 249.1490. 
 
tert-Butyl 6-benzyloxy-4,4-dimethylhexanoate (62): To a solution of 
6-benzyloxy-4,4-dimethylhexanoic acid 61 (20 mmol, 4.9 g) in 84 mL 
CH2Cl2 were added MgSO4 (80 mmol, 9.6 g) and tert-butyl alcohol 
(100 mmol, 9.5 mL). To this reaction mixture was added conc. H2SO4 (20 mmol, 1.0 mL). The 
resulting heterogeneous mixture was vigorously stirred for 48 h. The reaction mixture was then 
cooled to 0 

C followed by slow addition of 100 mL saturated aqueous solution of NaHCO3. The 
                                                 
v
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resulting heterogeneous mixture was stirred vigorously at ambient temperature until all salts 
were dissolved. The resulting biphasic mixture was extracted with CH2Cl2 (3×). The combined 
organic phase was dried over Na2SO4 then concentrated. The resulting crude oil was purified by 
column chromatography (SiO2, 10% ethyl acetate in hexanes) to afford 2.9 g of the title 
compound as a colorless oil (48% yield). IR (thin film): 3434, 3031, 2960, 2869, 2091, 1727, 
1643, 1454, 1390, 1367, 1310, 1254, 1153, 1028, 952, 847, 735 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.35-7.27 (m, 5H), 4.50 (s, 2H), 3.53 (t, J = 7.8, 2H), 2.23-2.17 (m, 2H), 1.61-1.51 (m, 
4H), 1.45 (s, 9H), 0.90 (s, 6H); 
13
C NMR (75 MHz, CDCl3)  173.7, 138.6, 128.4, 127.6, 127.5, 
80.0, 73.0, 67.3, 40.8, 37.0, 31.9, 30.8, 28.1, 27.1; HRMS (Q-TOF) m/z calcd for C19H30O3Na 
(M+Na)
+
: 329.2093; found: 329.2103. 
 
tert-Butyl 6-hydroxy-4,4-dimethylhexanoate (63): To a solution of tert-
butyl 6-benzyloxy-4,4-dimethylhexanoate 62 (9.5 mmol, 2.9 g) in 40 mL 
methanol  was added 10% Pd/C (323 mg). The resulting reaction mixture 
was stirred at ambient temperature for 12h. The mixture was then filtered through celite using 
ethyl acetate as an eluent, and the solvent was removed in vacuo to afford 2.2 g of the title 
compound as a colorless oil (97% yield). IR (thin film): 3377, 2959, 2933, 1729, 1470, 1390, 
1367, 1305, 1254, 1154, 1041, 745 cm
1
; 
1
H NMR (300 MHz, CDCl3)  3.71 (t, J = 7.8, 2H), 
2.23-2.18 (m, 2H), 1.57-1.50 (m, 4H), 1.45 (s, 9H), 0.91 (s, 6H); 
13
C NMR (75 MHz, CDCl3)  
173.7, 80.1, 59.6, 44.1, 36.9, 31.9, 30.8, 28.1, 27.1; HRMS (EI) m/z calcd for C12H25O3 (M+H)
+
: 
217.1803; found: 217.1796. 
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         tert-Butyl 6-benzyloxycarbonylamino-6-p-toluenesufonyl-4,4,-
dimethylhexanoate (64): General Procedure A was followed 
employing tert-butyl 6-hydroxy-4,4-dimethylhexanoate 63 (4.6 mmol, 
1.0 g),  oxalyl chloride (5.8 mmol, 500 L), DMSO (12 mmol, 843 L), and triethylamine (24 
mmol, 3.4 mL) in 11 mL CH2Cl2. The resulting aldehyde was used for the next reaction without 
further purification employing benzyl carbamate (4.6 mmol, 700 mg), sodium salt of p-
toluenesulfinic acid (6.0 mmol, 1.1 g) in 26 mL water/HCOOH (1/2 v/v). The resulting white 
solid was washed with cold ether to afford 1.5 g of the title compound as a white solid (76% 
yield). IR (thin film): 3324, 2964, 1728, 1597, 1528, 1455, 1392, 1369, 1314, 1232, 1144, 1086, 
1047, 913, 846, 815, 742 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.74 (t, J = 8.4, 2H), 7.36-7.34 (m, 
3H), 7.24-7.19 (m, 4H), 5.33 (d, J = 10.8, 1H), 4.95-4.91 (m, 1H), 4.91 (d, J = 12.3, 1H), 4.84 (d, 
J = 12.3, 1H), 2.42 (s, 3H), 2.25-2.18 (m, 2H), 1.60-1.55 (m, 4H), 1.45 (s, 9H), 0.94 (s, 3H), 0.92 
(s, 3H); 
13
C NMR (75 MHz, CDCl3)  173.2, 154.3, 145.0, 135.7, 133.2, 129.7, 129.4, 128.5, 
128.3, 128.0, 80.3, 69.1, 67.3, 37.1, 36.8, 32.8, 30.6, 28.1, 26.7, 21.7; HRMS (Q-TOF) m/z calcd 
for C27H37NO6SNa (M+Na)
+
: 526.2239; found: 526.2188. 
 
6-Benzyloxycarbonylamino-6-p-toluenesufonyl-4,4,-
dimethylhexanoic acid (65): General Procedure B was followed 
employing  tert-butyl 6-benzyloxycarbonylamino-6-p-toluenesufonyl-
4,4,-dimethylhexanoate 64 (2.9 mmol, 1.5 g) in anhydrous HCOOH (15 mL). After removal of 
HCOOH in vacuo, the resulting white solid was washed with cold ether to afford 1.1 g of the title 
compound as a white solid (85% yield). IR (thin film): 3439, 2961, 2099, 1704, 1640, 1531, 
1453, 1398, 1302, 1232, 1141, 1084, 1047, 910, 813, 737 cm
1
; 
1
H NMR (300 MHz, DMSO-D6) 
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 12.04 (br, 1H), 8.42 (d, J = 9.6, 1H), 7.67 (d, J = 8.1, 2H), 7.40-7.30 (m, 5H), 7.19-7.17 (m, 
2H), 4.89 (d, J = 12.6, 1H), 4.83 (d, J = 12.6, 1H), 2.39 (s, 3H), 2.19-2.10 (m, 2H), 1.85 (d, J = 
13.8, 1H), 1.60 (dd, J = 14.4, 9.6, 1H), 1.45-1.38 (m, 2H), 0.80 (s, 6H); 
13
C NMR (75 MHz, 
CDCl3)  179.2, 154.4, 145.1, 135.7, 135.0, 132.9, 129.7, 129.5, 129.3, 128.5, 128.3, 128.0, 
127.9, 69.1, 67.2, 37.1, 36.3, 32.7, 26.8, 21.7; HRMS (Q-TOF) m/z calcd for C23H29NO6SNa 
(M+Na)
+
: 470.1613; found:470.1621. 
 
 5,5-Diphenyl-2-oxepanone (67): To a solution of 4,4-diphenylcyclohexanone (3.3 
mmol, 830 mg) in 8 mL CH2Cl2 was added 70-75% m-CPBA (5.0 mmol, 860 mg). 
The resulting heterogeneous reaction mixture was stirred overnight in dark, then 
filtered through sintered glass filter. The resulting homogeneous solution was diluted with 20 mL 
CH2Cl2, and cooled to 0 

C. The resulting solution was washed with saturated aqueous solution 
of Na2SO3 and saturated aqueous solution of NaHCO3 successively. The resulting solution was 
dried over Na2SO4 and concentrated in vacuo. The resulting crude product was purified by 
column chromatography (SiO2, 33% ethyl acetate in hexanes) to afford 670 mg of the title 
compound as a white solid (76% yield). IR (thin film): 3440, 2969, 2360, 1733, 1643, 1494, 
1474, 1444, 1390, 1336, 1282, 1201, 1142, 1066, 1034, 975, 913, 882, 749, 702 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.36-7.31 (m, 4H), 7.26-7.16 (m, 5H), 4.30 (t, J = 4.7, 2H), 2.74-2.70 (m, 
4H), 2.60-2.56 (m, 2H); 
13
C NMR (75 MHz, CDCl3)  175.9, 145.7, 128.8, 127.2, 126.6, 65.4, 
48.7, 39.9, 33.3, 30.8; HRMS (EI) m/z calcd for C18H18O2(M
 +
): 266.1306; found:266.1306. 
 
6-Benzyloxy-4,4-diphenylhexanoic acid (68): To a solution of 5,5-
diphenyl-2-oxepanone 67 (2.5 mmol, 670 mg) in 4.2 mL toluene were 
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added potassium hydroxide (13 mmol, 710 mg) and benzyl chloride (7.5 mmol, 860 L) 
successively. The resulting reaction mixture was refluxed overnight, then cooled to ambient 
temperature. The resulting reaction mixture was added 20 mL water, then washed with 5 mL 
hexane (2×). The resulting homogeneous mixture was acidified with H2SO4 until it became 
heterogeneous, then extracted with 10 mL ethyl acetate. This step was repeated 3 times. The 
combined organic phase was dried over Na2SO4 then concentrated. The resulting crude oil was 
purified by column chromatography (SiO2, 25% ethyl acetate in hexanes) to afford 870 mg of the 
title compound as a white solid (93% yield). IR (thin film): 3432, 3060, 2949, 1706, 1647, 1495, 
1446, 1305, 1100, 1073, 736 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.34-7.25 (m, 2H), 7.25-7.16 
(m, 10H), 4.36 (s, 2H), 3.25 (t, J = 7.1, 2H), 2.52-2.44 (m, 4H), 2.14-2.06 (m, 2H); 
13
C NMR (75 
MHz, CDCl3)  179.5, 147.2, 138.2, 128.3, 128.1, 127.6(2C), 127.5, 126.1, 73.1, 67.2, 47.8, 37.1, 
32.9, 29.4; HRMS (Q-TOF) m/z calcd for C25H26NO3Na (M+Na)
+
: 397.1780; found: 397.1763. 
 
tert-butyl 6-benzyloxy-4,4-diphenylhexanoate (69): To a solution of 6-
benzyloxy-4,4-diphenylhexanoic acid 68 (2.3 mmol, 870 mg) in 10 mL 
CH2Cl2 were added MgSO4 (9.2 mol, 1.1 g) and tert-butyl alcohol (12 mmol, 1.1 mL). To this 
reaction mixture was added conc. H2SO4 (2.3 mmol, 120 L). The resulting heterogeneous 
mixture was vigorously stirred for 48 h. The reaction mixture was then cooled to 0 

C followed 
by slow addition of 12 mL saturated aqueous solution of NaHCO3. The resulting heterogeneous 
mixture was stirred vigorously at ambient temperature until all salts were dissolved. The 
resulting biphasic mixture was extracted with CH2Cl2 (3×). The combined organic phase was 
dried over Na2SO4 then concentrated. The resulting crude oil was purified by column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to afford 600 mg of the title compound as 
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a white solid (61% yield). IR (thin film): 3404, 2975, 1728, 1600, 1495, 1453, 1367, 1308, 1254, 
1151, 1102, 1030, 753, 735 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.34-7.29 (m, 2H), 7.25-7.17 
(m, 10H), 4.35 (s, 2H), 3.25 (t, J = 7.2, 2H), 2.48-2.40 (m, 4H), 2.00-1.94 (m, 2H), 1.40 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  173.2, 147.5, 138.3, 128.3, 128.0, 127.7, 127.5(2C), 125.9, 80.2, 
73.0, 67.3, 47.7, 37.2, 33.0, 30.7, 28.1; HRMS (Q-TOF) m/z calcd for C29H34O3Na (M+Na
+
): 
453.2406; found:453.2413. 
 
tert-Butyl 6-hydroxy-4,4-diphenylhexanoate (70): To a solution of tert-
butyl 6-benzyloxy-4,4-diphenylhexanoate 69 (1.4 mmol, 610 mg) in 6 mL 
methanol  was added 10% Pd/C (48 mg). The resulting reaction mixture 
was stirred at ambient temperature for 12h. The mixture was then filtered through celite using 
ethyl acetate as an eluent, and the solvent was removed in vacuo to afford 470 mg of the title 
compound as a white solid (100% yield). IR (thin film): 3432, 2098, 1643, 1446, 1368, 1151 
cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.30-7.29 (m, 3H), 7.21-7.19 (m, 5H), 39.50-3.44 (m, 2H), 
2.45-2.38 (m, 4H), 1.98-1.94 (m, 2H), 1.41 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  173.2, 147.4, 
128.2, 127.7, 126.1, 80.4, 59.6, 47.7, 40.3, 33.0, 30.7,  28.1; HRMS (Q-TOF) m/z calcd for 
C22H28O3Na (M+Na
+
): 363.1936; found: 363.1907. 
 
         tert-Butyl 6-benzyloxycarbonylamino-6-p-toluenesufonyl-4,4,-
diphenylhexanoate (71): General Procedure A was followed 
employing tert-butyl 6-hydroxy-4,4-diphenylhexanoate 70 (1.4 mmol, 
470 mg),  oxalyl chloride (1.7 mmol, 150 L), DMSO (3.6 mmol, 250 L), and triethylamine 
(7.3 mmol, 1.0 mL) in 3.4 mL CH2Cl2. The resulting aldehyde was used for the next reaction 
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without further purification employing benzyl carbamate (1.2 mmol, 180 mg), sodium salt of p-
toluenesulfinic acid (1.6 mmol, 280 mg) in 6.8 mL water/HCOOH (1/2 v/v). The resulting crude 
product was purified by column chromatography (SiO2, 33% ethyl acetate in hexanes) to afford 
290 mg of the title compound as a white solid (33% yield). IR (thin film): 3429, 3062, 2977, 
2254, 1726, 1643, 1526, 1497, 1448, 1392, 1368, 1314, 1268, 1229, 1146, 1084, 1046, 912, 846, 
814, 733 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.61 (d, J = 8.1, 2H), 7.36-7.33 (m, 2H), 7.27-7.08 
(m, 12H), 4.87 (d, J = 10.5, 1H), 4.79-4.58 (m, 3H), 3.18 (d, J = 14.4, 1H), 2.51-2.33 (m, 3H), 
2.38 (s, 3H), 2.02-1.84 (m, 2H), 1.41 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  172.7, 153.8, 146.2, 
146.0, 144.9, 135.7, 132.9, 129.6, 129.3, 128.4, 128.3(2C), 128.2, 128.0, 127.6(2C), 126.5, 126.3, 
80.5, 69.0, 66.9, 48.0, 34.3, 32.7, 30.4, 28.1, 21.7; HRMS (Q-TOF) m/z calcd for C37H41NO6SNa 
(M+Na
+
): 650.2552; found: 650.2517. 
 
6-Benzyloxycarbonylamino-6-p-toluenesufonyl-4,4,-diphenylhexanoic 
acid (72): General Procedure B was followed employing  tert-butyl 6-
benzyloxycarbonylamino-6-p-toluenesufonyl-4,4,-diphenylhexanoate 71 
(0.33 mmol, 208 mg) in anhydrous HCOOH (1.7 mL). After removal of HCOOH in vacuo, the 
resulting crude product was purified by column chromatography (SiO2, 66% ethyl acetate in 
hexanes) to afford 89 mg of the title compound as a white solid (47% yield). IR (thin film): 3318, 
3059, 2957, 1715, 1526, 1497, 1447, 1409, 1314, 1229, 1143, 1050, 757, 700 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.38-7.31 (m, 4H), 7.25-7.00 (m, 10H), 4.80-4.76 (m, 1H), 4.74 (d, J = 12, 
1H), 4.59 (d, J = 12, 1H), 3.19 (d, J = 14.4, 1H), 2.57-2.40 (m, 3H), 2.37 (s, 3H), 2.17-2.00 (m, 
2H); 
13
C NMR (75 MHz, CDCl3)  177.9, 154.0, 146.0, 145.9, 135.7, 132.8, 129.6, 129.3, 128.5, 
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128.4, 128.3, 128.2, 128.1, 127.6, 127.5, 126.6, 126.4, 68.8, 67.0, 48.0, 34.3, 32.4, 29.1, 21.7; 
HRMS (Q-TOF) m/z calcd for C33H33NO6SNa (M+Na)
+
: 594.1926; found:594.1959. 
 
           tert-Butyl 7-(benzyloxycarbonylamino)-7-p-toluenesulfonyl 
heptanoate (79): General Procedure A was followed employing tert-
butyl 7-hydroxyheptanoate
vi
 (2.5 mmol, 510 mg),  oxalyl chloride 
(3.1 mmol, 270 L), DMSO (6.5 mmol, 460 L), and triethylamine (13 mmol, 1.8 mL) in 6 mL 
CH2Cl2. The resulting aldehyde was used for the next reaction without further purification 
employing benzyl carbamate (2.1 mmol, 320 mg), sodium salt of p-toluenesulfinic acid (2.1 
mmol, 380 mg) in 12 mL water/HCOOH (1/2 v/v). The resulting white solid was filtered off and 
washed with cold ether to afford 1.1 g of the title compound as a white solid (86 % yield). IR 
(thin film): 3432, 2977, 2866, 2099, 1706, 1643, 1530, 1455, 1393, 1315, 1233, 1143, 1084, 
1039, 911, 742 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.74 (d, J = 11.1, 1H), 4.92 (d, J = 12, 1H), 
4.86 (d, J = 12, 1H), 4.84 (td, J = 11.1, 3.3, 1H), 2.42 (s, 3H), 2.30-2.12 (m, 1H), 2.20 (t, J = 7.2, 
2H), 1.80-1.56 (m, 4H), 1.45 (s, 9H), 1.42-1.35 (m, 3H); 
13
C NMR (75 MHz, CDCl3)  172.9, 
154.9, 145.0, 135.6, 133.5, 129.7, 129.2, 128.5, 128.3, 128.1, 80.1, 71.2, 67.3, 35.3, 28.5, 28.1, 
26.5, 25.0, 24.7, 21.7; HRMS (Q-TOF) m/z calcd for C26H35NO6SNa (M+Na)
+
: 512.2083; 
found:512.2072. 
 
7-(Benzyloxycarbonylamino)-7-p-toluenesulfonyl heptanoic acid 
(80): General Procedure B was followed employing tert-butyl 7-
                                                 
vi
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benzyloxycarbonylamino-7-tosylheptanoate 79 (1.8 mmol, 880 mg) in anhydrous HCOOH (8 
mL). After removal of HCOOH in vacuo, the resulting white solid was washed with cold ether to 
afford 590 mg of the title compound as a white solid (76% yield). IR (thin film): 3311, 3062, 
2935, 2863, 1710, 1597, 1531, 1455, 1405, 1315, 1235, 1143, 1084, 1045, 737 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.74 (d, J = 8.1, 2H), 7.36-7.34 (m, 3H), 7.24-7.22 (m, 4H), 5.40 (d, J = 
10.8, 1H), 4.93 (d, J = 12.0, 1H), 4.88-4.81 (m, 2H), 2.42 (s, 3H), 2.35 (t, J = 7.5, 2H), 2.29-2.20 
(m, 1H), 1.77-1.39 (m, 7H), ; 
13
C NMR (75 MHz, CDCl3)  178.9, 154.9, 145.1, 135.7, 133.4, 
129.7, 129.2, 128.5, 128.3, 128.0, 71.2, 67.3, 33.6, 28.3, 26.3, 25.0, 24.2, 21.7; HRMS (Q-TOF) 
m/z calcd for C22H27NO6SNa (M+Na)
+
: 456.1457; found: 456.1478. 
 
               tert-Butyl 3-(N-p-toluenesulfonyl-N-(3-trimethylsilyloxy 
propyl))aminopropanoate (82): To a solution of N-(3-
trimethylsilyloxypropyl) toluenesulfonamide (2.5 mmol, 760 mg) in 17 mL acetonitrile were 
added potassium carbonate (17 mmol, 2.3 g) and tert-butyl acrylate (13 mmol, 1.6 g). The 
resulting reaction mixture was refluxed for 12 h. The reaction mixture was cooled to ambient 
temperature and filtered. The resulting homogeneous solution was concentrated in vacuo and 
purified by column chromatography (SiO2, 20% ethyl acetate in hexanes) to afford 550 mg of the 
title compound as a colorless oil (51% yield). IR (thin film): 3432, 2957, 2872, 1727, 1643, 1599, 
1456, 1391, 1368, 1342, 1251, 1212, 1159, 1092, 954, 865, 842, 816, 749, 711 cm
1
; 
1
H NMR 
(300 MHz, CDCl3)  7.71 (d, J = 8.4, 2H), 7.30 (d, J = 8.4, 2H), 3.58 (t, J = 6.0, 2H), 3.38 (t, J = 
7.5, 2H), 3.20 (t, J = 7.2, 2H), 2.57 (t, J = 7.8, 2H), 2.43 (s, 3H), 1.81-1.72 (m, 2H), 1.45 (s, 9H), 
0.10 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  170.6, 143.2, 136.5, 129.7, 127.2, 81.0, 59.7, 46.1, 
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44.4, 35.4, 31.7, 28.1, 21.5, 0.58. Mass spectrum was not acquired due to the instability of the 
compound. 
 
         tert-Butyl 3-(N-p-toluenesulfonyl-N-(3-hydroxypropyl))amino 
propanoate (83): To a 0 

C solution of tert-butyl 3-(N-p-
toluenesulfonyl-N-(3-trimethylsilyloxypropyl))propanoate 82 (1.3 mmol, 550 mg) in Et2O (13 
mL) was added TBAF (1.0 M solution in THF, 1.3 mL). The resulting reaction mixture was 
stirred for 20 min, then filtered through a short silica gel pad with Et2O as eluting solvent. The 
resulting homogeneous solution was concentrated in vacuo and purified by column 
chromatography (SiO2, 50% ethyl acetate in hexanes) to afford 410 mg of the title compound as 
a colorless oil (89% yield). IR (thin film): 3428, 2977, 2934, 2879, 1724, 1642, 1560, 1457, 1392, 
1368, 1333, 1255, 1214, 1157, 1090, 1055, 968, 844, 815, 713 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.71 (d, J = 8.4, 2H), 7.32 (d, J = 8.1, 2H), 3.75 (q, J = 5.7, 2H), 3.40 (t, J = 7.2, 2H), 
3.24 (t, J = 6.6, 2H), 2.55 (t, J = 7.5, 2H), 2.44 (s, 3H), 2.31-2.26 (m, 1H), 1.78 (p, J = 6.0, 2H), 
1.45 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  163.6, 136.5, 129.0, 122.8, 120.2, 74.2, 51.7, 38.8, 
38.0, 28.6, 24.3, 21.0, 14.5; HRMS (Q-TOF) m/z calcd for C17H27NO5SNa (M+Na)
+
: 380.1508; 
found: 380.1501. 
 
                         tert-Butyl 3-(N-(3-(benzyloxycarbonylamino)-3-
p-toluenesulfonylpropyl)-N-p-toluenesulfonyl)aminopropanoate 
(84): General Procedure A was followed employing tert-butyl 3-
(N-p-toluenesulfonyl-N-(3-hydroxypropyl))aminopropanoate 83 (1.3 mmol, 410 mg),  oxalyl 
chloride (1.6 mmol, 140 L), DMSO (3.3 mmol, 240 L), and triethylamine (6.7 mmol, 940 L) 
 96 
in 3 mL CH2Cl2. The resulting aldehyde was used for the next reaction without further 
purification employing benzyl carbamate (1.3 mmol, 200 mg), sodium salt of p-toluenesulfinic 
acid (1.7 mmol, 300 mg) in 18 mL water/HCOOH (1/2 v/v). The resulting crude product was 
purified by column chromatography (SiO2, 30 % ethyl acetate in hexanes) to afford 570 mg of 
the title compound as a white solid (68% yield). IR (thin film): 3325, 2978, 1727, 1597, 1455, 
1394, 1369, 1319, 1232, 1158, 1087, 1046 cm
1
; 
1
H NMR (300, MHz, CDCl3)  7.73 (d, J = 8.4, 
2H), 7.68 (d, J = 8.4, 2H), 7.37-7.28 (m, 5H), 7.25-7.22 (m, 3H), 5.44 (d, J = 10.2, 1H), 4.89 (d, J 
= 12, 1H), 4.87 (d, J = 12, 1H), 4.85 (td, J = 10.2, 2.7, 1H), 3.37 (t, J = 7.5, 2H), 3.29 (t, J = 7.8, 
2H), 2.57-2.53 (m, 3H), 2.43 (s, 3H), 2.42 (s, 3H), 2.11-2.00 (m, 1H); 
13
C NMR (75 MHz, 
CDCl3)  170.7, 154.7, 145.3, 143.7, 135.8, 135.6, 133.1, 129.9, 129.8, 129.3, 128.5, 128.3, 
128.1, 127.2, 81.3, 69.2, 67.4, 45.7, 44.9, 35.5, 28.0, 27.0, 21.7, 21.5; HRMS (Q-TOF) m/z calcd 
for C32H40N2O8S2Na (M+Na)
+
: 667.2124; found: 667.2151. 
 
3-(N-(3-(Benzyloxycarbonylamino)-3-toluensulfonylpropyl)-N-p-
toluenesulfonyl)aminopropanoic acid (85): General Procedure B 
was followed employing  tert-butyl 3-(N-(3-
(benzyloxycarbonylamino)-3-p-toluensulfonylpropyl)-N-p-toluenesulfonyl)aminopropanoate 84 
(0.16 mmol, 100 mg) in anhydrous HCOOH (2 mL). After removal of HCOOH in vacuo, the 
resulting crude product was purified by column chromatography (SiO2, 80 % ethyl acetate in 
hexanes) to afford 68 mg of the title compound as a white solid (72% yield). IR (thin film): 3419, 
2098, 1642, 1320, 1157 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.73 (d, J = 8.1, 2H), 7.69 (d, J = 
8.4, 2H), 7.37-7.29 (m, 5H), 7.24-7.22 (m, 3H), 5.45 (br, 1H), 4.95-4.87 (m, 3H), 3.42 (t, J = 6.9, 
2H), 3.34 (br, 2H), 2.69 (t, J = 6.9, 2H), 2.60-2.52 (m, 1H), 2.44 (s, 3H), 2.42 (s, 3H), 2.13-1.92 
 97 
(br, 1H); 
13
C NMR (75 MHz, CDCl3)  154.9, 145.4, 143.9, 135.7, 135.6, 133.1, 130.0, 129.8, 
129.3, 128.5, 128.3, 128.2, 128.1, 127.3, 69.3, 67.4, 46.1, 44.8, 34.2, 26.9, 21.8, 21.5; HRMS 
(Q-TOF) m/z calcd for C28H32N2O8S2Na (M+Na)
+
: 611.1498; found: 611.1514. 
 
tert-Butyl 7-hydroxy-4,4-di(ethoxycarbonyl)heptanoate (87): To a 
mixture of NaH 60% dispersion in mineral(8.4 mmol, 200 mg) in 14 
mL THF at 0 

C was slowly added a solution of diethyl 2-(3-
(benzyloxy)propyl)malonate
vii
 (6.5 mmol, 2.0 g) in 14 mL THF. Once bubbling had ceased tert-
butyl 3-bromopropionate (4.2 mmol, 700 L) was added dropwise. The resulting reaction 
mixture was refluxed overnight, then cooled to ambient temperature. Upon addition of 30 mL 
water, the resulting biphasic mixture was extracted with 15 mL ethyl acetate (3×). The combined 
organic phase was dried over Na2SO4, then concentrated. The resulting crude product was 
chromatographed (SiO2, 40% ethyl acetate in hexanes) to afford inseparable mixture of diethyl 2-
(3-(benzyloxy)propyl)malonate and tert-butyl 7-benzyloxy-4,4-di(ethoxycarbonyl)heptanoate in 
~1:2 ratio. The resulting mixture was taken into 22 mL anhydrous MeOH, then 180 mg Pd/C was 
added. The heterogeneous mixture was stirred under H2 atmosphere for 48 h. The mixture was 
then filtered through celite using ethyl acetate as the eluent, and the solvent was removed in 
vacuo. The resulting crude oil was purified by column chromatography (SiO2, 25% to 50% ethyl 
acetate in hexanes) to afford 1.0 g of the title compound as a colorless oil (45% yield). IR (thin 
film): 3542, 2980, 1732, 1454, 1369, 1301, 1254, 1158, 1096, 1058, 849 cm
1
; 
1
H NMR (300 
MHz, CDCl3)  4.20 (q, J = 7.2, 4H), 3.64 (q, J = 6.3, 2H), 2.20 (s, 4H), 1.97-1.91 (m, 2H), 1.55-
                                                 
vii
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1.47 (m, 2H), 1.44 (s, 9H), 1.26 (t, J = 7.2, 6H); 
13
C NMR (75 MHz, CDCl3)  172.1, 171.3, 80.6, 
62.7, 61.3, 56.6, 30.6, 29.2, 28.1, 27.8, 27.4, 14.1; HRMS (Q-TOF) m/z calcd for C17H30O7Na 
(M+Na)
+
: 369.1889; found:369.1916 
 
       tert-Butyl 7-benzyloxycarbonylamino-7-p-toluenesulfonyl-4,4-
di(ethoxycarbonyl)heptanoate (88): General Procedure A was 
followed employing tert-butyl 7-hydroxy-4,4-
di(ethoxycarbonyl)heptanoate 87 (2.9 mmol, 1.0 g),  oxalyl chloride (3.6 mmol, 310 L), DMSO 
(7.5 mmol, 530 L), and triethylamine (15 mmol, 2.1 mL) in 7 mL CH2Cl2. The resulting 
aldehyde was used for the next reaction without further purification employing benzyl carbamate 
(2.4 mmol, 820 mg), sodium salt of p-toluenesulfinic acid (3.1 mmol, 550 mg) in 13 mL 
water/HCOOH (1/2 v/v). The resulting white solid was purified by column chromatography 
(SiO2, 25% ethyl acetate in hexanes) to afford 1.4 g of the title compound a colorless oil (79% 
yield). IR (thin film): 3333, 2980, 1732, 1525, 1453, 1369, 1317, 1224, 1148, 1084, 1044, 750 
cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.71 (d, J = 8.1, 2H), 7.35-7.32 (m, 3H), 7.21-7.18 (m, 4H), 
5.50 (d, J = 10.5, 1H), 4.92 (d, J = 12.3, 1H), 4.82 (d, J = 12.3, 1H), 4.80 (td, J = 10.5, 3.0, 1H), 
4.18 (t, J = 6.9, 4H), 2.38 (s, 3H), 2.56-2.14 (m, 5H), 2.06-1.70 (m, 3H), 1.42 (s, 9H), 1.23 (t, J = 
6.9, 6H); 
13
C NMR (75 MHz, CDCl3)  171.8, 170.5, 154.9, 144.9, 135.6, 133.4, 129.6, 129.1, 
128.4, 128.2, 127.9, 80.6, 71.2, 67.1, 61.5, 56.4, 30.5, 29.0, 28.1, 27.9, 21.8, 21.6, 13.9; HRMS 
(Q-TOF) m/z calcd for C32H43NO10SNa (M+Na)
+
: 656.2505; found:656.2516 
 
7-Benzyloxycarbonylamino-7-p-toluenesulfonyl-4,4-
di(ethoxycarbonyl)heptanoic acid (89): General Procedure B was 
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followed employing  tert-butyl 7-(benzyloxycarbonylamino)-7-p-toluenesulfonyl-4,4-
di(ethoxycarbonyl)heptanoate 88 (2.3 mmol, 1.4 g) in anhydrous HCOOH (12 mL). After 
removal of HCOOH in vacuo, the resulting crude product was purified by column 
chromatography (SiO2, 66% ethyl acetate in hexanes) to afford 1.0 g of the title compound as an 
amorphous white solid (73% yield). IR (thin film): 3366, 2097, 1641, 1453, 1404, 1314, 1237, 
1143, 1086, 1036 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.72 (d, J = 8.4, 2H), 7.38-7.34 (m, 3H), 
7.27-7.13 (m, 3H), 5.64 (d, J = 9.6, 1H), 4.95 (d, J = 12.3, 1H), 4.86 (d, J = 12.3, 1H), 4.83 (td, J 
= 10.8, 3.0, 1H), 4.21 (q, J = 7.2, 4H), 2.41 (s, 3H), 2.38-2.31 (m, 2H), 2.24-2.15 (m, 3H), 2.09-
1.97 (m, 2H), 1.84-1.70 (m, 1H), 1.26 (t, J = 7.2, 6H); 
13
C NMR (75 MHz, CDCl3)  177.0, 
170.5, 155.0, 145.2, 135.7, 133.3, 129.8, 129.2, 128.5, 128.3, 128.0, 71.3, 67.3, 61.7, 56.4, 29.3, 
29.1, 27.9, 21.9, 21.7, 14.0; HRMS (Q-TOF) m/z calcd for C28H35NO10SNa (M+Na)
+
: 600.1879; 
found:600.1905. 
 
Methyl (S)-3-(p-toluenesulfonamido)-5-phenylpentanoate (100): To a 0 

C 
solution of methyl (S)-3-amino-5-phenylpentanoate
viii
 (4.6 mmol, 950 mg) in 
10 mL CH2Cl2 were added triethylamine (14 mmol, 1.9 mL) and p-toluenesulfonyl chloride (5.0 
mmol, 960 mg). The ice bath was removed, and the resulting reaction mixture was stirred at 
ambient temperature overnight followed by addition of 10 mL water. The resulting biphasic 
mixture was extracted with 10 mL CH2Cl2 (3×). The combined organic phase was dried over 
Na2SO4 then concentrated. The resulting crude oil was purified by column chromatography 
(SiO2, 20% to 30% ethyl acetate in hexanes) to afford 1.1 g of the title compound as a yellowish 
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oil (67% yield). [α]D 2.0 (c 2.78, CHCl3); IR (thin film): 3287, 3027, 2951, 1736, 1599, 1495, 
1438, 1329, 1158, 1091, 816 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.76 (d, J = 8.4, 2H), 7.32-
7.16 (m, 5H), 7.06 (d, J = 8.4, 2), 5.33 (d, J = 9.6, 1H), 3.62 (s, 3H), 3.56 (m, 1H), 2.65 (ddd, J = 
13.8, 9.3, 6.0, 1H), 2.52 (dd, J = 9.3, 6.6, 1H), 2.44 (s, 3H), 2.42 (d, J = 4.8, 1H), 1.90-1.72 (m, 
2H) ; 
13
C NMR (75 MHz, CDCl3)  171.7, 143.4, 140.9, 138.1, 129.7, 128.4, 128.3, 127.1, 126.0, 
51.8, 50.3, 38.3, 36.4, 32.1, 21.5; HRMS (Q-TOF) m/z calcd for C19H23NO4SNa (M+Na)
+
: 
384.1245; found: 384.1276. 
 
                  (S)-N-(1-(tert-Butyldimethylsilyloxy)-5-phenylpentan-3-yl)- p-
toluenesulfonamide (101): To a suspension of LAH (1.0 mmol, 40 mg) in 4 
mL THF at 0 

C was added a solution of methyl (S)-3-(p-
toluenesulfonamido)-5-phenylpentanoate 100 (0.93 mmol, 340 mg) in 6 mL THF dropwise. The 
ice bath was removed, and the resulting reaction mixture was stirred for 20 min. The reaction 
mixture was quenched with 10 mL 1N HCl at 0 

C, then extracted with 10 mL ethyl acetate (3×). 
The combined organic phase was dried over Na2SO4 then concentrated. The resulting crude (S)-
N-(1-hydroxy-5-phenylpentan-3-yl)-p-toluenesulfonamide was taken into 2 mL DMF, followed 
by addition of imidazole (2.2 mmol, 150 mg) and tert-butyldimethylsilyl chloride (1.0 mmol, 
160 mg) into the resulting solution. The resulting reaction mixture was stirred at ambient 
temperature overnight, followed by addition of 10 mL water. The resulting heterogeneous 
mixture was extracted with 20 mL ethyl acetate, then the organic phase was washed with 10 mL 
water (3×). The resulting organic phase was dried over Na2SO4 then concentrated to afford 300 
mg of the title compound as a white solid (72% over 2 steps). [α]D  (c 0.45, CHCl3); IR 
(thin film): 3260, 2953, 2929, 2857, 2358, 1428, 1320, 1253, 1156, 1094, 999, 835, 811, 777 
 101 
cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.76 (d, J = 8.1, 2H), 7.30-7.19 (m, 5H), 7.13 (d, J = 8.1, 
2H), 5.70 (br, 1H), 3.70 (ddd, J = 12.3, 8.1, 4.5, 1H), 3.54 (q, J = 5.4, 1H), 3.41 (m, 1H), 2.73-
2.54 (m, 2H), 2.43 (s, 3H), 1.91-1.74 (m, 2H), 1.66-1.45 (m, 2H) ; 
13
C NMR (75 MHz, CDCl3)  
142.9, 141.6, 138.1, 129.5, 128.3, 128.2, 127.0, 125.7, 60.2, 52.5, 36.3, 35.4, 31.7, 25.8, 21.4, 
18.0, -5.61, -5.67; HRMS (Q-TOF) m/z calcd for C24H37NO3SSiNa (M+Na)
+
: 470.2161; found: 
470.2145. 
 
                    (S)-tert-Butyl 3-(N-(1-(tert-butyldimethylsilyloxy)-5-
phenylpentan-3-yl)-p-toluenesulfonamido)propanoate (102): To 
a solution of (S)-N-(1-(tert-butyldimethylsilyloxy)-5-phenylpentan-
3-yl)-p-toluenesulfonamide 101 (0.67 mmol, 300 mg) in 3 mL acetonitrile were added potassium 
carbonate (4.4 mmol, 610 mg) and tert-butyl acrylate (3.4 mmol, 430 mg). The resulting reaction 
mixture was refluxed for 12 h. The reaction mixture was cooled to ambient temperature and 
filtered. The resulting homogeneous solution was concentrated in vacuo and purified by column 
chromatography (SiO2, 20% ethyl acetate in hexanes) to afford 300 mg of the title compound as 
a white solid (78% yield). [α]D 7.0 (c 1.17, CHCl3); IR (thin film): 3435, 2954, 2931, 2858, 
1728, 1642, 1460, 1391, 1368, 1343, 1255, 1159, 1098, 837, 814, 777 cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  7.71 (d, J = 8.1, 2H), 7.31-7.25 (m, 2H), 7.21-7.17 (m, 3H), 7.11 (d, J = 8.4, 2H), 3.92 
(quint, J = 6.9, 1H), 3.49 (t, J = 6.6, 2H), 3.33 (ddd, J = 6.6, 3.3, 2.4, 2H), 2.72 (td, J = 7.5, 4.5, 
2H), 2.58 (ddd, J = 9.9, 6.6, 3.9, 2H), 2.43 (s, 3H), 1.79-1.54 (m, 4H), 1.45 (s, 9H), 0.90 (s, 9H), 
0.04 (s, 3H), 0.03 (s, 3H)  ; 
13
C NMR (75 MHz, CDCl3)  171.9, 143.1, 141.5, 137.7, 129.6, 
128.4(2C), 127.3, 125.9, 80.9, 60.1, 55.9, 39.6, 37.2, 36.1, 35.2, 33.1, 28.1, 25.9, 21.5, 18.3, -5.4, 
-5.5; HRMS (Q-TOF) m/z calcd for C31H49NO5SSiNa (M+Na)
+
: 598.2998; found: 598.2952. 
 102 
                      (S)-tert-Butyl 3-(N-(1-hydroxy-5-phenylpentan-3-yl)-
p-toluenesulfonamidopropanoate (103): To a solution of (S)-tert-
butyl 3-(N-(1-(tert-butyldimethylsilyloxy)-5-phenylpentan-3-yl)-p-
toluenesulfonamido)propanoate 102 (0.52 mmol, 300 mg) in 5 mL THF was added TBAF (1.0 
M solution in THF, 520 L). The resulting reaction mixture was stirred for 90 min at ambient 
temperature, then filtered through a short silica gel pad with Et2O as eluting solvent. The 
resulting homogeneous solution was concentrated in vacuo and purified by column 
chromatography (SiO2, 50% ethyl acetate in hexanes) to afford 170 mg of the title compound as 
a white solid (72% yield). [α]D 35.9 (c 0.59, CHCl3); IR (thin film): 3542, 2934, 1725, 1599, 
1455, 1368, 1328, 1157, 816, 752, 699 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.65 (d, J = 8.1, 2H), 
7.36-7.30 (m, 2H), 7.26-7.16 (m, 3H), 6.95 (d, J = 8.1, 2H), 3.94 (m, 1H), 3.86-3.79 (m, 1H), 
3.70-3.63 (m, 1H), 3.43 (ddd, J = 15.3, 9.9, 5.1, 1H), 3.29 (ddd, J = 15.3, 9.6, 6.0, 1H), 2.82-2.57 
(m, 2H), 2.65 (dd, J = 9.9, 6.0, 1H), 2.44 (s, 3H), 2.41-2.33 (m, 1H), 2.22 (ddd, J = 13.8, 10.2, 
6.3, 1H), 1.89 (m, 1H), 1.38-1.61 (m, 2H), 1.59-1.48 (m, 2H), 1.45 (s, 9H), 1.41-1.24 (m, 2H); 
13
C NMR (75 MHz, CDCl3)  170.8, 143.6, 140.9, 137.1, 129.8, 128.4, 128.2, 127.0, 126.1, 81.1, 
58.3, 54.6, 39.0, 37.3, 35.6, 35.1, 33.1, 28.1, 21.5; HRMS (Q-TOF) m/z calcd for 
C25H35NO5SSiNa (M+Na)
+
: 484.2134; found: 484.2150. 
 
 tert-Butyl 3-(N-((3S)-1-(benzyloxycarbonylamino)-5-phenyl-1-p-
toluenesulfonylpentan-3-yl)-p-toluenesulfoneamido)propanoate 
(104): General Procedure A was followed employing (S)-tert-butyl 3-
(N-(1-hydroxy-5-phenylpentan-3-yl)-p-toluenesulfonamidopropanoate 103 (1.0 mmol, 470 mg),  
oxalyl chloride (1.3 mmol, 110 L), DMSO (2.6 mmol, 190 L), and triethylamine (5.2 mmol, 
 103 
730 L) in 3 mL CH2Cl2. The resulting aldehyde was used for the next reaction without further 
purification employing benzyl carbamate (1.0 mmol, 140 mg), sodium salt of p-toluenesulfinic 
acid (1.4 mmol, 250 mg) in 7 mL THF/water/HCOOH (1/2 v/v). The resulting crude product was 
purified by column chromatography (SiO2, 20% to 33 % ethyl acetate in hexanes) to afford 430 
mg of the title compound as viscous oil (58% yield over two steps). HRMS (Q-TOF) m/z calcd 
for C40H48N2O8SNa (M+Na)
+
: 771.2750; found: 771.2729. 
 
 3-(N-((3S)-1-(Benzyloxycarbonylamino)-5-phenyl-1-p-
toluenesulfonylpentan-3-yl)-p-toluensulfonamido)propanoic acid 
(105): General Procedure B was followed tert-butyl 3-(N-((3S)-1-
(benzyloxycarbonylamino)-5-phenyl-1-p-toluenesulfonylpentan-3-yl)-p-toluenesulfoneamido) 
propanoate 104 (0.58 mmol, 430 mg) in anhydrous 3 mL HCOOH. After removal of HCOOH in 
vacuo, the resulting crude product was purified by column chromatography (SiO2, 60 % ethyl 
acetate in hexanes) to afford 240 mg of the title compound as a viscous oil (60% yield). HRMS 
(Q-TOF) m/z calcd for C36H40N2O8SNa (M+Na)
+
: 715.2124; found: 715.2094. 
 
 tert-Butyl 8-hydroxy-4,4-di(ethoxycarbonyl)octanoate (116): To 
a mixture of NaH 60% dispersion in mineral(2.5 mmol, 100 mg) in 5 
mL DMF at 0 

C was slowly added a solution of diethyl 2-(4-
(benzyloxy)butyl)malonate
ix
 (2.1 mmol, 670 mg) in 5 mL DMF. Once bubbling had ceased tert-
butyl 3-bromopropionate (2.5 mmol, 420 L) was added dropwise. The resulting reaction 
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mixture was stirred at 60 

C overnight, then cooled to ambient temperature. Upon dilution with 
30 mL water and quenched with 30 mL water at 0 

C, the resulting biphasic mixture was washed 
with 30 mL water (3×). The resulting organic phase was dried over Na2SO4, then concentrated. 
The resulting crude product was chromatographed (SiO2, 33% ethyl acetate in hexanes) to afford 
inseparable mixture of diethyl 2-(4-(benzyloxy)butyl)malonate and tert-butyl 8-benzyloxy-4,4-
di(ethoxycarbonyl)octanoate in ~1:2 ratio. The resulting mixture was taken into 10 mL 
anhydrous MeOH, then 90 mg Pd/C was added. The heterogeneous mixture was stirred under H2 
atmosphere for 48 h. The mixture was then filtered through celite using ethyl acetate as the 
eluent, and the solvent was removed in vacuo. The resulting crude oil was purified by column 
chromatography (SiO2, 25% to 50% ethyl acetate in hexanes) to afford 300 mg of the title 
compound as a colorless oil (40% yield). IR (thin film): 3582, 3438, 2981, 2938, 1731, 1462, 
1369, 1251, 1156, 1096, 1030, 860 cm
1
; 
1
H NMR (300 MHz, CDCl3)  4.19 (q, J = 7.2, 4H), 
3.65 (q, J = 6.3, 2H), 2.18 (s, 4H), 1.91-1.85 (m, 2H), 1.65-1.53 (m, 2H), 1.44 (s, 9H), 1.35-1.31 
(m, 2H), 1.26 (t, J = 7.2, 3H) ; 
13
C NMR (75 MHz, CDCl3)  172.2, 171.3, 80.5, 62.3, 61.3, 56.9, 
32.7, 32.4, 30.7, 28.1, 27.7, 20.2, 14.1; HRMS (Q-TOF) m/z calcd for C18H32O7Na (M+Na)
+
: 
383.2046; found: 383.2061 
 
     tert-Butyl 8-benzyloxycarbonylamino-8-p-toluenesulfonyl-
4,4-di(ethoxycarbonyl)octanoate (117): General Procedure A 
was followed employing tert-butyl 8-hydroxy-4,4-
di(ethoxycarbonyl)octanoate 116 (0.83 mmol, 300 mg),  oxalyl chloride (1.0 mmol, 90 L), 
DMSO (2.1 mmol, 160 L), and triethylamine (4.3 mmol, 610 L) in 4 mL CH2Cl2. The 
resulting aldehyde was used for the next reaction without further purification employing benzyl 
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carbamate (0.78 mmol, 280 mg), sodium salt of p-toluenesulfinic acid (1.2 mmol, 210 mg) in 4.8 
mL water/HCOOH (1/2 v/v). The resulting white solid was purified by column chromatography 
(SiO2, 33% ethyl acetate in hexanes) to afford 400 mg of the title compound a colorless oil (74% 
yield). IR (thin film): 3332, 2979, 1730, 1526, 1454, 1369, 1316, 1232, 1183, 1146, 1086, 1027, 
741 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.73 (d, J = 8.1, 2H), 7.37-7.32 (m, 4H), 7.24-7.22 (m, 
3H), 5.23 (d, J = 10.8, 1H), 4.93 (d, J = 12.3, 1H), 4.89-4.82 (m, 2H), 4.18 (q, J = 7.2, 4H), 2.44 
(br, 1H),  2.42 (s, 3H), 2.22-2.16 (m, 5H), 1.98-1.69 (m, 3H), 1.44 (s, 9H), 1.36-1.34 (m, 1H), 
1.24 (t, J = 7.2, 6H); 
13
C NMR (75 MHz, CDCl3)  172.0, 170.9 (2C), 154.8, 145.1, 135.6, 133.4, 
129.7, 129.2, 128.5, 128.3, 128.0, 80.5, 70.9, 67.3, 61.4, 56.6, 32.4, 30.6, 28.0, 27.8, 26.7, 21.7, 
20.1, 14.1; HRMS (Q-TOF) m/z calcd for C33H45NO10SNa (M+Na
+
): 670.2662; found:670.2690 
 
8-Benzyloxycarbonylamino-8-p-toluenesulfonyl-4,4-
di(ethoxycarbonyl)octanoic acid (118): General Procedure B was 
followed employing  tert-butyl 8-(benzyloxycarbonylamino)-8-p-
toluenesulfonyl-4,4-di(ethoxycarbonyl)octanoate 117 (0.73 mmol, 470 mg) in anhydrous 
HCOOH (4 mL). After removal of HCOOH in vacuo, the resulting crude product was purified 
by column chromatography (SiO2, 66% ethyl acetate in hexanes) to afford 290 mg of the title 
compound as a viscous colorless oil (68% yield). IR (thin film): 3324, 2980, 1727, 1528, 1453, 
1404, 1315, 1233, 1187, 1142, 1085, 1053 cm
1
; 
1
H NMR (300 MHz, CDCl3)  7.73 (d, J = 8.1, 
2H), 7.37-7.35 (m, 3H), 7.24-7.20 (m, 4H), 5.30 (d, J = 10.8, 1H), 4.93 (d, J = 12.3, 1H), 4.89-
4.80 (m, 2H), 4.21-4.14 (m, 4H), 2.42 (s, 3H), 2.36-2.31 (m, 2H), 2.22-2.18 (m, 4H), 2.01-1.70 
(m, 4H), 1.24 (t, J = 7.2, 6H); 
13
C NMR (75 MHz, CDCl3)  177.7, 170.8 (2C), 155.0, 145.1, 
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135.6, 133.3, 129.7, 129.2, 128.5, 128.3, 128.0, 70.8, 67.3, 61.5, 56.5, 32.3, 29.1, 27.3, 26.6, 21.7, 
19.9, 14.0; HRMS (Q-TOF) m/z calcd for C29H37NO10SNa (M+Na)
+
: 614.2036; found:614.2089 
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2.0  IMINIUM ION-MEDIATED [4+2] CYCLOADDITION 
2.1 N-ALKENYLIMINIUM ION DIELS-ALDER REACTION 
2.1.1 Introduction 
2.1.1.1 Aza Diels-Alder reaction 
Nitrogen-containing heterocyclic compounds are critical components of an enormous number of 
natural products and synthetic pharmaceutical ingredients.
46
 In this context, piperidines have also 
gained a considerable attention as they have been found as common building blocks in large 
numbers of naturally/unnaturally occurring biologically active molecules.
47
 As a result, there 
have been developed numerous strategies for the efficient construction of the piperidine 
structures. Among them, hetero Diels-Alder reactions
48,49
 with nitrogen-containing dienophiles 
or dienes, known as aza Diels-Alder reaction,
50
 has been one of the standard methods to 
construct the nitrogen-containing six-membered ring structures as they allow formation of the 
cyclic structures with high degrees of substitutions in highly stereoselective fashion.
51
 For the 
nitrogen-containing dienophiles, imines have been frequently used as dienophiles in HOMOdiene-
controlled normal electron-demand aza Diels-Alder reactions
52
 due to their electron-deficient 
nature. However, use of imines as dienophiles was found to require activation by a Lewis or 
Brønsted acid because of their relatively low reactivity. This energetic requirement for imine 
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activation has been utilized for the realization of catalytic, asymmetric aza Diels-Alder reactions. 
Feng and co-workers
53
 reported a chiral Lewis acid mediated catalytic and asymmetric 
cycloaddition protocol for the synthesis of 2,5-disubstituted dihydropyridinones. They showed 
that dihydoropyridinone 122 was acquired in moderate to high yields (up to 92%) with good 
enantioselectivities (up to 90% ee) from Danishefsky’s diene  120 and the aldimine dienophile 
121 (eq 8). 
 
 
(8) 
 
 
 
 
 
Chiral Brønsted acid salt 126 was used by Akiyama and co-workers
54
 in the context of 
aza Diels-Alder reactions using Brassard's diene 123
55
 and aldimine 124 (eq 9). They showed 
that pyridinium salt 126 successfully catalyzed the [4+2] cycloaddition to provide piperidinone 
derivatives 125 in high yields and with excellent enantioselectivities (up to 99% ee). 
 
                   (9) 
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For the nitrogen containing dienes, aza Diels-Alder reactions employing imines as a 4-
electron component have been also investigated in the context of development of 
enantioselective aza Diels-Alder reaction. For example, 2-azadienes
56
 have been used for rapid 
construction of polysubstituted tetrahydroquinolines. The chiral Brønsted acid-catalyzed 
enantioselective three-component Povarov reaction developed by Zhu and co-workers
57
 to 
provide enantioenriched polysubstituted tetrahydroquinoline 127 (eq 10) is one of the notable 
examples of the enantioselective aza Diels-Alder reactions with 2-azadiene.  
 
             (10) 
 
 
 
 
 
Aside from 2-azadienes, 1-azadienes has been also the subject of research in development 
of enantioselective aza Diels-Alder reactions. Carretero and co-workers
58
 showed that the low 
reactivity of 1-azadiene could be overcome by employing N-sulfonyl-1-aza-1,3-dienes such as 
129 and electron-rich vinyl ether dienophiles such as 130. They reported a chiral ligand 
(DBFOX-Ph)-Ni complex mediated catalytic, asymmetric aza Diels-Alder reaction for the 
synthesis of enantioenriched piperidine 131 (eq 11). 
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       (11) 
 
 
 
 
2.1.1.2 Aza Diels-Alder reactions with N-alkenyl iminium ions as 4-electron components 
In spite of the many successful examples of 1- or 2-azadienes in realization of aza Diels-Alder 
reactions, we were surprised that the studies on aza Diels-Alder reactions with N-alkenyl 
iminium ion as 4-electron component remain undocumented except a few examples in synthetic 
studies.
59,60
 As a strategy to expand the scope of 4-electron component aza-Diels-Alder reaction, 
our group previously reported a novel N-alkenyl iminium ion cycloaddition reaction (AIC 
reaction) where N-alkenyl iminium ions were used in [4+2] cycloaddition as 4-electron 
components. In this report, Nelson and co-workers
61
 reported that N-alkenyl iminium ion 133, 
which was prepared in situ at 78 °C by N,O-acetal ionization of tosyl-protected alkenylaminal 
132, could be successfully engaged in [4+2] cycloaddition with dienophile 134 to afford various 
N-heterocyclic compounds, such as 135 and 136 (Figure 24). According to this reaction design, 
they showed that N-alkenyl aminal 137 was successfully converted into piperidine derivatives 
138 and 139 with good to excellent diastereoselectivities (eq 12). 
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Figure 24. Design of N-alkenyl iminium ion cycloaddition 
 
 
(12) 
 
 
 
2.1.2 Development of strategy for further investigation on AIC reaction 
In spite of our successful demonstration of N-alkenyl iminium ion to participate in [4+2] 
cycloaddition, there was still a requirement for the further investigation on the AIC reaction in 
many aspects. One of them was the scope of Lewis acid catalysis. Since TiCl4, which is a strong 
Lewis acid, was selected for the ionization of N,O-acetal 137, the AIC reaction had its limitation 
in the application for complex molecule syntheses. Therefore, employing milder Lewis acids 
than TiCl4, as well as the development of processes which are compatible with the use of a 
reduced amount of the Lewis acid, was highly desirable. To achieve these objectives, the 
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systematic investigation on the AIC reaction for a more detailed understanding of the AIC 
reaction was essential. For the systematic investigation on the AIC reaction, we identified three 
obvious variables which could make an impact on the ionization process of the diene precursor 
140 (Figure 25). They were Lewis acids (L.A.), leaving group (L.G.), and nitrogen protecting 
group (P). The leaving group in 140 and the Lewis acid should be directly related to the 
ionization process of 140, since activation of the leaving group by the Lewis acid should depend 
on both Lewis acid strength and leaving group ability. The nitrogen protecting group in 140 was 
also supposed to be relavent to the ionization process, because the nitrogen protecting group 
would control the donation of the nitrogen lone pair to the leaving group to ionize 140. 
Thereofore, it was evident that the identity of the Lewis acid, the leaving group, and the nitrogen 
protecting group should make an impact on the ionization process of 140 to 141. We also 
speculated that, other than obvious variables such as the identity of L.A./L.G./P, there were 
potentially a number of unclear variables which could make impacts on the ionization process. 
For example, there might be an optimal Lewis acid to coordinate to 140, where L.G and P should 
provide unique coordination geometry depending on the identity of P and the L.G and the 
conformation of 140.  
 
 
Figure 25. Evaluation of the reaction parameters in ionization process of 140 
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Based on this hypothesis, we decided to prepare various diene precursors 142 with 
different leaving groups, and planned to apply these diene precursors to the AIC reaction with 
different Lewis acids in order to find the optimal combination of the Lewis acid and the leaving 
group for the synthesis of 143 (Figure 26). For the leaving group, we planned to employ 
methoxy, acetoxy, sulfone, and cyanide groups. These leaving groups were chosen to represent a 
range of leaving group ability,
62
 as well as the potential coordination sites for the Lewis acids. 
The protecting group (methylcarbamate), the dienophile (cyclohexene), the nucleophile 
(allyltrimethylsilane), and the reaction temperature (78 C) were chosen based on the results 
from the previous study,
61
 and kept constant for the systematic analysis of the reactions 
 
 
Figure 26. Design of the model reaction for investigation on AIC reaction 
2.1.3 Preliminary results 
2.1.3.1 Syntheses of diene precursors 
The diene precursors 147a-c with acetoxy leaving group were synthesized by protecting 
allylamine followed by alkylation and isomerization. The methylcarbamate group was chosen as 
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a protecting group, and diene precursors with Boc or Cbz groups were also prepared for future 
study. Alkylation of the protected allylamine was performed without difficulty according to the 
procedures in the literature.
63
 With the protected allylamine, alkylation of the protected 
allylamine 145 was performed employing formaldehyde and cesium carbonate to afford the 
desired hydroxyalkylated carbamate, followed by acylation to afford 146a-c in 63%, 61%, and 
62% yield, respectively, for 2 steps. The isomerization reaction
64
 was performed using the 
Grubbs’ 2nd generation catalyst in the presence of vinyloxytrimethylsilane to afford diene 
precursors 147a-c in 78%, 67%, and 85% yield, respectively (Scheme 24). 
 
Scheme 24. Synthesis of the N-alkenyl iminium ion precursors 147a-c. 
 
The diene precursors with different leaving groups, such as sulfone and cyanide group, 
were prepared via different ways from previous methods for 147a-c since typical alkylation/ 
isomerization protocol was ineffective. For the diene precursor with a sulfone leaving group, 
initial attempts to alkylate the protected allylamine 145a with sodium hydride and chloromethyl 
phenyl sulfone were unsuccessful, probably due to the acidic protons in chloromethyl phenyl 
sulfone. Eventually, we were able to prepare the desired compound 150 by alkylation of the 
protected allylamine 145a with chloromethyl phenyl sulfide to afford 148 in 38% yield, and 
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oxidation of the resulting sulfide 148 with Oxone provided the corresponding sulfone 149 in 
57% yield .
65
 The terminal olefin moiety of 149 was isomerized under the Grubbs’ 2nd catalyst 
condition to afford the desired diene precursor 150 in 92% yield (Scheme 25). 
 
Scheme 25. Synthesis of the N-alkenyl iminium ion precursor 150 
 
 
For the diene precursor 153 with the cyanide leaving group, initial attempts to prepare 
the desired compound through alkylation of the protected allylamine under the condition of 
sodium hydride and chloroacetonitrile were unsuccessful. This problem was simply solved by 
alkylation of the allylamine with chloroacetonitrile first in the presence of triethylamine and the 
catalytic amount of sodium iodide,
66
 then protection of the resulting crude alkylated allylamine 
151 with methylchloroformate and triethylamine to afford 152 in 20% yield for 2 steps. The 
terminal olefin moiety of 152 was isomerized by typical olefin isomerization procedure to afford 
the desired diene precursor 153 in 81% yield (Scheme 26). 
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Scheme 26. Synthesis of the N-alkenyl iminium ion precursor 153 
 
2.1.3.2 Lewis acid screening 
With the desired diene precursors, we planned to screen Lewis acids to find the optimal Lewis 
acids for the fragmentation of the diene precursors. For this purpose, a model reaction was 
investigated as shown in Figure 27. Compound 147a was selected as a representative diene 
precursor. To suppress possible dimerization of the diene precursor 147a,
61
 an excess amount of 
cyclohexene was used as a dienophile. We hypothesized that, upon in situ generation of iminium 
ion 154, cycloaddition between 154 and cyclohexene should be completed in 24 h at 78 C to 
afford the cyclic iminium ion 155. We also speculated that 155 should be stable at 78 C and 
the introduced allyltrimethylsilane should trap the resulting cyclic iminium ion 155 to afford the 
desired product 144. For the screening of Lewis acids, TMSOTf, Cu(II)OTf2, Sn(OTf)2, Et2AlCl, 
Sc(OTf)3, Bi(OTf)3, SnCl4, and TiCl4 were chosen to test an overall range of Lewis acid strength 
and coordination geometry of the Lewis acids. The preliminary results of the Lewis acid 
screening are shown in Table 7. Et2ACl and Sn(OTf)2 (Table 7, entry b and c) were not effective 
for ionization of 147a since most of 147a was recovered after the reactions. Cu(OTf)2, Sc(OTf)3, 
and Bi(OTf)3 (Table 7, entry d, e, and f) were found to be efficient to consume 147a, but they 
failed to provide the desired cycloaddition product. The reactions with TMSOTf, SnCl4, and 
TiCl4 (Table 7, entry a, h, and g) afforded the desired product 144. It was notable that, despite the 
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weaker Lewis acid strength compared to that of TiCl4, SnCl4 proved to be more efficient in the 
AIC reaction providing 31% yield of the desired product 144.  Based on this result, we believed 
that the Lewis acid strength was not the only factor which makes an impact on the efficiency of 
the AIC reaction. Another notable observation was that, for the reactions which provided the 
desired product 144, there was an unidentified material in the 
1
H NMR spectrum of the reactions, 
which was not able to be isolated via flash chromatography. From these results, SnCl4 was 
chosen as a Lewis acid for the ionization of the diene precursor 147a in further investigations. 
 
 
Figure 27. Model reaction to screen Lewis acids 
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Table 7. Preliminary result for Lewis acid screening 
 
2.1.3.3 Hydride-quenched reaction 
Since SnCl4 was found to be effective in consumption of the diene precursor 147a, we supposed 
that the ionization process of 147a to the corresponding N-alkenyl iminium ion 154 was not 
responsible for the low yield (31%) of the AIC reaction. On this hypothesis, we decided to look 
closer into the cycloaddition step of 154 with cyclohexene rather than in situ generation of 154. 
To focus on the cycloaddition of 154 only, we sought the reaction where the intermediate cyclic 
iminium ion 155 could be quantitatively converted into an analyzable entity. Reduction of 155 to 
157 by triethylsilane was chosen to achieve such an objective (Scheme 27). Employing an excess 
amount of triethylsilane provided 34% of 157, which is a comparable yield to the result of the 
AIC reaction (31%) in which allyltrimethylsilane was used to quench the reaction provide 144. 
Reducing the amount of hydride to 50 mol% did not change the yield much, providing 31% of 
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157. However, a further decrease in the amount of the hydride to 25 mol% resulted in a 
significant decrease of the yield, providing 24% of 157. In this case, 8% of cyclic enamine 158 
was also isolated. With the closer look into the hydride-quenched reaction with 25 mol% hydride, 
a minor product was found in the crude 
1
H NMR spectrum of the reaction along with the desired 
product 157 and the unknown product (Figure 28). This minor product was carefully isolated and 
characterized, and assigned as oxazinone 160. Based on this result, we assigned the unknown 
product as 159, which was believed to be unstable on the silica gel and could not be isolated by 
flash chromatography. 
 
Scheme 27. AIC reaction with Et3SiH quenching 
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Figure 28.
 1
H NMR of 0.25 equiv hydride quenching reaction 
 
2.1.4 Two reaction pathways 
The structural confirmation of 160 led us to hypothesize that there was an additional reaction 
pathway, an oxo-Diels-Alder reaction pathway, which was a well-known process in the 
literature.
67,68
 We supposed that, after in situ generation of iminium ion 154 with the assistance 
of SnCl4, 154 reacted with cyclohexene to afford Diels-Alder intermediate 155 and oxo-Diels-
Alder intermediate 161. Under the sub-stoichiometric amount of triethylsilane condition, 155 
was reduced to provide 157 consuming all of the hydride, and the rest of 155 was tautomerized 
to provide the observe by-product 158. In the same way, 161 provided the unstable 159 and the 
observed by-product 160 (Figure 29). To test this hypothesis, an excessive amount of 
triethylamine was used to quench the AIC reaction of 147a, in place of triethylsilane, to facilitate 
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the nucleophilic demethylation process of 161.
69
 As expected, 38% of oxazinone 160 as well as 
31% of cyclic enamine 158 was isolated (eq 13). Therefore, the existence of the two reaction 
pathways (Diels-Alder pathways and oxo-Diels-Alder pathway) was confirmed. The proposed 
role of triethylamine was shown in Figure 30. 
 
Figure 29. Two reaction pathways in the AIC reaction 
 
          (13) 
 
 
 
 
Figure 30. Role of triethylamine in the two reaction pathways in AIC reaction 
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With a better understanding on the AIC reaction, a range of reaction parameters were 
studied to address their impact on the product distribution. First, a range of reaction temperatures 
from 78 C to 0 C was tested (Table 8). N-protecting groups and leaving groups other were 
also studied (Table 9 and 10). It appeared that the Diels-Alder:oxo-Diels-Alder product ratio did 
not show strong dependence on either reaction parameter. However, it was shown that diene 
precursor 147c with Cbz group is superior to other diene precursors with different protecting 
groups in terms of yield, probably due the stability of the Cbz groups to the Lewis acid 
conditions. For this reason, diene precursor 147c, instead of 147a, was selected as a 
representative diene precursor for the subsequent study. 
 
Table 8. Temperature dependence of the AIC reaction 
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Table 9. Protecting group dependence of the AIC reaction 
 
 
Table 10. Leaving group dependence of the AIC reaction 
 
2.1.5 Conclusion 
Through the systematic investigation, SnCl4 was found to be an effective and mild Lewis acid to 
activate the acetoxy leaving group of methylcarbamate-protected N-alkenylaminal to generate 
the N-alkenyl iminium ion species. It was also found that the N-alkenylaminal iminium ion was 
engaged in [4+2] cycloaddition as a 4-electron component with cyclohexene through two 
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different reaction pathways, the Diels-Alder pathway and the oxo-Diels-Alder pathway. 
Unfortunately, simple modification of the reaction conditions (reaction temperature, different 
nitrogen protecting group, different leaving group) was not effective to control the course of the 
reaction. 
2.2 OXO-DIELS-ALDER REACTION 
2.2.1 Strategy for turning off the Diels-Alder pathway 
As shown in the previous discussion, Diels-Alder and oxo-Diels-Alder pathways were equally 
favored in most cases of the AIC reactions. This equal distribution of the reaction pathways 
could be attributed to equal energies of the two dienes to s-cis conformations (Figure 31). Based 
on this hypothesis, we investigated methods to eliminate one reaction and to favor the other 
reaction pathway. We envisioned that elimination of the Diels-Alder pathway out of two reaction 
pathways could be easily achieved by employing a new type of diene precursors which could not 
function as a Diels-Alder diene, such as 164 (Figure 32). In this way, we supposed that the 
iminium ion 165 from 164 would function as the only 4-electron component in the oxo-Diels-
Alder reaction.  
 
 
Figure 31. Accessibility to Diels-Alder/oxo-Diels-Alder reactions in AIC reaction 
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Figure 32. Strategy to turn off Diels-Alder pathway in AIC reaction 
2.2.2 oxo-Diels-Alder reaction 
To verify this hypothesis, the oxo-diene precursor 167 was quickly prepared. The synthesis of 
167 was achieved by heating a solution of acetic acid, acetic anhydride, paraformaldehyde,
61
 and 
Cbz-protected N-butylamine 166 in 51% yield (eq 14). With the desired oxo-diene precursor 167, 
we applied the reaction condition for the AIC reaction of 147c (1.0 equiv SnCl4, 10 equiv 
cyclohexene, 78 C) to the oxo-diene precursor 167. As we expected, the oxo-diene precursor 
167 was engaged in [4+2] cycloaddition with cyclohexene as a dienophile to provide the desired 
oxo-Diels-Alder product 168 in good yield (78~81%). Further optimization of the reaction 
revealed that the reaction was complete in 3 h, and TMSOTf was more efficient than SnCl4 in the 
oxo-Diels-Alder reaction of 167 (eq 15). Therefore, it was concluded that our strategy to turn off 
the Diels-Alder pathway in the AIC reaction was successful.  
 
(14) 
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            (15) 
 
 
 
With the successful demonstration of oxo-Diels-Alder reaction of 167, we expanded the 
scope of the 2-electron components. Various cyclic/acyclic dienes were chosen as 2-electron 
components, since we planned to probe the potential [4+2] process where the iminium ion 169 
functions as 2-electron component (Figure 33). After applying our standard conditions for the 
oxo-Diels-Alder reaction (1.0 equiv TMSOTf, 1 or 10 equiv dienophiles, 78 C, 3 h, then 5.0 
equiv triethylamine) to 167,  we found that iminium ion 169 exclusively functioned as 4-
electron component in the current reaction conditions (Table 11). When 1,3-cyclohexadiene was 
used as a dienophile, the desired product 170 was acquired with good yield (68%) and 
diastereoselectivity (>15:1). In the case of the reaction with 1,3-cyclooctadiene as dienophile, the 
desired product 171 was also acquired in good yield (60%) and diastereoselectivity (>15:1). 
When 2,3-dimethyl 1,3-butadiene, an acyclic dienophile, was employed, the yield of the product 
172 was 50% compared to 170 (68%) and 171 (60%). It was believed that the sterically hindered 
2,3-dimethyl 1,3-butadiene created unfavorable steric interaction to decrease efficiency of the 
cycloaddition. 
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Figure 33. Function of iminium ion 169 as 2- vs. 4-electron component 
 
Table 11. Result of the oxo-Diels-Alder reactions of 167 with various dienophiles 
 
 
2.2.3 Catalytic oxo-Diels-Alder reaction 
Since the silylium cation was able to act as a good Lewis acid to convert the oxo-diene precursor 
167 to the corresponding iminium ion 169, we became interested in how to regenerate the 
silylium cation in the course of the reaction to realize a catalytic system in the AIC reaction 
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(Figure 34). After examination of the mechanism of oxo-Diels-Alder reaction, we envisaged that 
the silylium cation would be regenerated if we were to employ the diene precursor with 2-
(trimetylsilyl)ethycarbamate (Teoc) protecting group as 173,
70
 instead of the Cbz protecting 
group. We expected that dealkylation of 175 will regenerate the silylium cation, which would re-
enter the reaction cycle to activate another oxo-diene precursor 173 to generate iminium ion 174 
(Figure 35). 
 
Figure 34. Generation of the oxo-diene 169 with TMSOTf 
 
 
Figure 35. Strategy for the realization of the catalytic oxo-Diels-Alder reaction 
 
To verify our hypothesis, the 2-(trimetylsilyl)ethycarbamate-protected oxo-D.A diene 
precursor 173 was prepared as shown in Scheme 28. Treatment of 2-trimethylsily 1-ethanol with 
triphosgene and K2CO3, followed by addition of n-butylamine afforded 2-
(trimetylsilyl)ethycarbamate-protected amine 176
71
 in 46% yield for 2 steps. This protected 
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amine 176 was treated with paraformaldehyde in the presence of Cs2CO3 to provide aminal 177 
in 83% yield. Finally, the free hydroxyl group of 177 was acetylated with acetyl chloride and 
triethylamine to provide the desired protected aminal 173. 
 
Scheme 28 Synthesis of the oxo-diene precursor 173 
 
 
With minor variation of the currently optimized AIC reaction condition (10 mol% 
TMSOTf, ambient temperature, 12 h reaction time), we were able to show that 173 engaged in 
the AIC reaction with cyclohexene to provide the desired oxo-Diels-Alder product 168 in 81% 
yield as a single diastereomer (eq 16). Compared to the reaction temperature of the AIC reaction 
using a full equivalent of the silylium cation activator at 78 C, a higher reaction temperature 
(ambient temperature) was required in the catalytic AIC reaction. We believe that the 
requirement of ambient reaction temperature was to promote dealkylation without aid of base to 
regenerate the silylium cation. It turned out that increased reaction temperature did not erode the 
efficiency of the reaction and stereoselectivity.  
 
 (16) 
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2.2.4 Conclusion 
As a simple and efficient strategy to turn off the Diels-Alder pathway in the AIC reaction, a new 
diene precursor was prepared for the in situ generation of the iminium ion species as an oxo-
diene. The in situ prepared oxo-diene was successfully engaged in a [4+2] cycloaddition as a 4-
electron component with cyclohexene to provide the desired oxo-Diels-Alder product in good 
yield and good diastereoselectivity. With the further examination of the mechanism of [4+2] 
cycloaddition of the oxo-diene, the catalytic oxo-Diels-Alder reaction was realized with the 
reduced amount of Lewis acid (10 mol% TMSOTf) as a catalyst. The catalytic oxo-Diels-Alder 
reaction exhibited good chemical yield and diastereoselectivity. 
2.3 ALDIMINE-MEDIATED AIC REACTION 
2.3.1 Strategy for turning off the oxo-Diels-Alder pathway 
After the successful realizations of the oxo-Diels-Alder reaction and its catalytic variant, we 
turned our attention to suppression of the oxo-Diels-Alder pathway in the AIC reaction. We 
envisioned that -substituted N-alkenyl iminium ion 178, when it is to function as oxo-diene, 
should create unfavorable steric interaction between the -substituent R2 and the approaching 
dienophile. It was also supposed that s-cis conformation of oxo-diene should be unfavorable 
because of the steric interaction between R2 and carbonyl group in 178 (Figure 36). We supposed 
that this unfavorable steric interaction between R2 and the dienophile would differentiate the 
energy of the transition states 179 and 180, setting the course of the reaction in favor of the 
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Diels-Alder pathway over the oxo-Diels-Alder pathway. In addition, to increase product diversity 
of the AIC reaction, it was highly desirable to have access to a family of N-alkenyl iminium ion 
precursors which have an -substitution (Figure 37).  
 
 
Figure 36. Strategy to turn off oxo-Diels-Alder reaction in AIC reaction 
 
 
 
Figure 37. Diversity of the AIC reaction from -substituted N-alkenyl iminium ions 
 
Unfortunately, we found that preparation of diene precursors to -substituted N-alkenyl 
iminium ion 178 was synthetically challenging. All of the efforts to prepare the desired -
substituted alkenyl acetoxy/hydroxyl aminal have resulted in poor yield or no reaction, probably 
due to the instability of the desired product -substituted alkenyl aminal species. Therefore, a 
complementary approach circumventing the unstable aminal species was required to access -
substituted N-alkenyl iminium ion 178. We decided to look into aldimine species as a precursor 
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to -substituted N-alkenyl iminium ion 178, since aldimine species have been used for in situ 
preparation of -substituted acyl iminium ion species through acylation of aldimines.72,73 Based 
on those examples, we hypothesized that aldimine 181 would be acylated with acyl halide to 
provide the -halo amide 182. After acylation, we supposed that the 182 would undergo 
ionization via activation of the halide group 183 by a Lewis acid to provide -substituted N-
alkenyl iminium ion 183 (Figure 38). To test this strategy, the known alkenyl aldimine species 
185 was prepared from allyl aldimine 184 according to the literature procedure
74
 as a mixture of 
3:1 E/Z isomers. Vinyl aldimine 187, which was also known in the literature,
75
 was also prepared 
from 186 (Scheme 29).  
 
 
Figure 38. Strategy to access -substituted N-alkenyl iminium ion 183 
 
Scheme 29. Syntheses of the aldimine species 185 and 187 
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2.3.2 Aldimine-mediated AIC (AAIC) reaction 
2.3.2.1 Acylation of aldimine 
With the required aldimines 185 and 187, we planned to probe the acylation step of 185 and 187. 
First, the acylation of 185 was examined by 
1
H NMR study (Figure 39). According to the 
analogous examples of acylation of aldimines,
72
 
1
H NMR study of acylation 185 was designed as 
addition of 1.1  equiv of acetyl chloride to the solution of 185 in CDCl3 at ambient temperature. 
Upon addition of acetyl chloride, the resulting solution was monitored by 
1
H NMR over time. It 
showed that, upon addition of 1.1 equivalent of acetyl chloride, aldimine 185 underwent N-
acylation smoothly to -chloroamide 188 in 30 min at ambient temperature. However, an 
unknown species was also observed, and this unknown species sustained in the reaction mixture 
for elongated time. This unknown species was assumed to be an unacylated cis-isomer of 185 
from its 
1
H NMR spectrum. Based on these observations, it was concluded that acylation of 185 
with acetyl chloride was fast and efficient, although the complete interpretation of the 
1
H NMR 
spectrum of acylated 185 was complicated by E/Z isomerism of 185. 
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Figure 39. Acylation of the aldimine 185 
 
On the hypothesis that the heterogeneous nature of the E/Z-aldimine 185 complicated the 
complete interpretation of acylation of 185, we turned our attention to aldimine 187. Due to the 
absence of E/Z isomerism, we expected the homogeneous nature of vinyl aldimine 187 would 
allow complete interpretation of the acylation process (Figure 40). To test this hypothesis, 
acylation of vinyl aldimine 187 was studied by 
1
H NMR. As expected, treatment of 187 with 1.1 
equiv of acetyl chloride resulted in complete conversion to -chloroamide 189 in 35 minutes 
with virtually no by-product (Figure 41). Therefore, vinyl aldimine 187 was proven to undergo a 
simplie acylation process to provide -chloroamide 189. Therefore, aldimine 187 was chosen for 
the further study of AAIC reaction.  
 
 135 
 
Figure 40. Properties of aldimine 185 and 187 
 
Ha + Ha’
Hb
Hc
Ac
Ha + Ha’
HbHc
 
Figure 41. Acylation of the aldimine 187 
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2.3.2.2 Cycloaddition step 
With the working procedure for acylation of aldimine 187 to provide -chloro amide 189, the 
aldimine-mediated AIC (AAIC) reaction was designed to employ 187 as precursor for the N-
alkenyl iminium ion 189 (Figure 42).  We supposed that an appropriate Lewis acid would 
activate the chloride in 189 to afford N-alkenyl iminium ion 190, which would undergo [4+2] 
cycloaddition with an appropriate dienophile to afford 191. We planned to quench the reaction 
with triethylamine to facilitate tautomerization of 191 to provide 192 as a desired product. Based 
on this hypothesis, the first AAIC reaction was tested by employing cyclohexene as a dienophile, 
since cyclohexene was proven to function as an efficient dienophile in our previous researches. 
Firstly, -chloro amide 189 was prepared via acylation with acetyl chloride. The solution of 189 
was then cooled to 78 C and then 1.1 equiv Lewis acid (SnCl4 or TMSOTf) was added in the 
presence of 10 equiv cyclohexene. After overnight stirring, the reaction mixture was quenched 
with 5.0 equiv triethylamine. Upon analysis of the crude 
1
H NMR spectrum of the reaction, only 
a complex mixture was recovered from the reaction mixture (eq 17). From the result, we 
supposed that the reactivity of an -substituted N-alkenyl iminium ion was different from that of 
-unsubstituted N-alkenyl iminium ion. 
 
 
Figure 42. Design of AAIC reaction 
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(17) 
 
 
Based on the observation that cyclohexene, an electronically unactivated species, was a 
poor dienophile in the AAIC reaction with -substituted N-alkenyl iminium ion 190, we turned 
our attention to a more electron-rich dienophile. Dihydorpyrrole 193 was selected as a 
representative electron-rich dienophile, and it was subjected to the same AAIC reaction 
condition (acylation of 187 for 30 min, addition of dienophile and Lewis acid at 78 C, 
overnight reaction, and then quenching with triethylamine).  It was found that the desired product 
194 was recovered from the reaction mixture with no indication of presence of the oxo-Diels-
Alder product. Further optimization of the reaction conditions revealed that the reaction was 
complete in 3 h under TMSOTf conditionsd at 35 C, providing a 70% yield of  194 (eq 18). 
From these observations, it was concluded that placement of an -substitution on the N-alkenyl 
iminium ion efficiently suppressed the oxo-Diels-Alder reaction pathway. It was also found that 
an electron-rich dienophile was superior as a dienophile partner for the -substituted N-alkenyl 
iminium ion.  
 
   
   (18) 
     
 
  
 
 138 
With the successful AAIC reaction with dihydropyrrole 193 as a dienophile, the scope of 
the dienophiles was investigated to expand the diversity of the reaction. Electron-rich olefins 
such as ethyl vinyl ether, dihydrofuran, and N-tosylindole were selected as potential dienophiles. 
Those dienophiles were tested with the currently optimized reaction (acylation of 187 for 30 min, 
addition of dienophile and Lewis acid at 78 C, overnight reaction, then quenching the reaction 
with triethylamine). To our disappointment, none of the dienophiles provided the desired 
products. In the case of ethyl vinyl ether, unexpected aldehyde product 195 was acquired as a by-
product. In case of the reaction with N-tosyl indole, for example, bis-N-tosylindole species 196 
was acquired. Dihydrofuran provided only complex mixture as products (Table 12). Based on the 
results from Table 12, we tried to understand why the reactions failed to provide the desired 
products in the cases of electron-rich dienophiles other than dihydropyrrole 193. Observation of 
the by-products 196 suggested the reaction pathways employing N-tosylindole. One of the 
possible explanations for the formation of this unexpected product is presented in Figure 43. 
After N-tosylindole reacts with 190, the resulting iminium ion 197 immediately could undergoes 
proton transfer to 198, which lost vinyl acylamine.
76
 The resulting carbocation 199, which 
enjoyed stabilization from neighboring phenyl and indole groups, reacts with another equivalent 
of N-tosylindole to afford the observed by-product 196. Therefore, we suspected that the 
electron-rich dienophiles could function as nucleophiles, not the expected 2-electron 
components, in the AAIC reaction condition. 
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Table 12. AAIC reactions of 187 with electron-rich olefins as dienophiles 
 
  
 
Figure 43. Probable reaction pathway of the AAIC reaction between 187 and tosyl-
indole 
 
With the hypothesis that the dienophiles could act as a nucleophiles in the AAIC reaction 
conditions, we decided to take a close look at the cycloaddition step of the AAIC reaction with 
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dihydropyrrole 193. Since it was confirmed that the cycloaddition is complete in 3 hours at 35 

C, we tried to collect information on the actual reaction pathway of the cycloaddition. This was 
achieved by analysis of the reaction products obtained by quenching the reaction at different time 
intervals with NaCNBH3. The result of those studies is shown in Figure 44. Isolation of 200 from 
both reactions suggested that cycloaddition proceeded via a stepwise pathway rather than 
concerted pathway. It was also notable that product 202, which should be from the reduction of 
cyclic iminium species 201, was not observed in any case. This observation suggested that there 
was no appreciable accumulation of the cyclic iminium species 201, which could be explained 
by fast internal proton transfer (Figure 45). From the results above, we believed that the AAIC 
reaction proceeds as follows: acylation of aldimine 187 provided -chloroamide 189. This -
chloroamide 189 was activated by TMSOTf to afford acyl iminium ion 190, and the nucleophilic 
attack of the dihydropyrrole 193 on 190 provided the relatively stable intermediate 203. This 
intermediate 203 proceeded to slow ring closing process to afford the cyclic enamine product 
194 without accumulation of cyclic iminium ion species 201. 
 
 
Figure 44. Results of the hydride-quenched AAIC reaction for the aldimine 190 
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Figure 45. Probable reaction pathway of the hydride-quenched AAIC reaction 
 
2.3.3 Conclusion 
As a strategy to turn off the oxo-Diels-Alder pathway, an -substituted N-alkenyl iminium ion 
was proposed. The in situ preparation of an N-alkenyl iminium ion was achieved by acylation of 
aldimine and activation of the chloride in the resulting -chloro amide. The aldimine-mediated 
AIC reaction (AAIC) reaction successfully afforded the desired product with the limited scope of 
electron-rich dienophiles. Later, it was discovered that the electron-rich dienophiles functioned 
as nucleophiles rather than 2-electron component in the AAIC reaction condition. 
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2.4 CONCLUSION 
The systematic studies on the AIC reactions revealed that there exists two reaction pathways 
(Diels-Alder pathway and oxo-Diels-Alder pathway). It was also shown that control of the 
reaction pathway could be achieved by modification of diene precursors. To turn off the Diels-
Alder pathway, the Cbz-protected alkyl aminal species was prepared as the oxo-diene precursor. 
Further examination of the mechanism of [4+2] cycloaddition of the oxo-diene, the catalytic oxo-
Diels-Alder reaction was realized with the reduced amount of Lewis acid (10 mol% TMSOTf) as 
a catalyst. As a strategy to turn off the oxo-Diels-Alder pathway, an -substituted N-alkenyl 
iminium ion was proposed. It was shown that acylation of aldimine afforded the desired -chloro 
amide species, which was a precursor for -substituted N-alkenyl iminium ion. However, an d-
substituted N-alkenyl iminium ion from acylation of the aldimine functioned as a simple imine 
electrophile, not a 4-electron component in Diels-Alder reaction. 
 
2.5 EXPERIMENTAL 
 
N-Acetoxymethyl-N-allyl methylcarbamate (146a): To a solution 
of 160 mg (1.1 mmol, 1.0 equiv) of N-allyl-N-hydroxymethyl 
methylcarbamate in 10 mL CH2Cl2 at 0 C were added 460 L of 
triethylamine (3.2 mmol, 3.0 equiv) and 79 L of acetyl chloride (1.1 mmol, 1.1  equiv). The 
reaction mixture was then warmed up to ambient temperature and stirred for 3 h. The reaction 
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was quenched with 10 mL of saturated aqueous NaHCO3 and extracted with 10 mL of CH2Cl2 
(3). The combined organic portions were dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by flash chromatography (50% ethyl acetate in hexane) to afford 
170 mg (82%) of the title compound as a colorless oil. IR (thin film): 2960, 1719, 1476, 1446, 
1402, 1367, 1245, 1204, 1165, 1109, 1016, 943, 838, 776 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 
50 °C)  5.86-5.73 (m, 1H), 5.35 (br, 2H), 5.19 (brd, J = 8.1 Hz, 1H), 5.16 (brd, J = 9.9 Hz, 
1H), 3.70 (d, J = 6.0 Hz, 2H), 3.75 (s, 3H), 2.03 (s, 1H); 
13
C NMR (75 MHz, CDCl3 at 50 °C)  
170.5, 156.3, 133.4, 117.0, 71.8, 53.0, 49.7, 20.7; HRMS (Q-TOF) m/z calcd for C8H13NO4 
:187.0845; found: 187.0845. 
 
 N-Acetoxymethyl-N-allyl tert-butylcarbamate (146b): To a solution 
of 310 mg (1.6 mmol, 1.0 equiv) of N-allyl-N-hydroxymethyl tert-
butylcarbamate in 10 mL CH2Cl2 at 0 C were added 700 L of triethylamine 
(4.9 mmol, 3.0 equiv) and 130 L of acetyl chloride (1.8 mmol, 1.1  equiv). The reaction mixture 
was then warmed up to ambient temperature and stirred for 3 h. The reaction was quenched with 
10 mL of saturated aqueous NaHCO3 and extracted with 10 mL of CH2Cl2 (3). The combined 
organic portions were dried over Na2SO4 and concentrated in vacuo. The crude product was 
purified by flash chromatography (20% ethyl acetate in hexane) to afford 310 mg (80%) of the 
title compound as a colorless oil. IR (thin film): 2979, 2934, 1743, 1712, 1476, 1406, 1248, 
1207, 1157, 1014, 942, 875, 777 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  5.83-5.77 (m, 
1H), 5.34 (s, 2H), 5.18 (dd, J = 11.1, 1.2 Hz, 1H), 5.13 (td, J = 2.7, 1.2 Hz, 1H),  3.94 (d,  J = 5.7 
Hz, 2H), 2.05 (s, 3H), 1.49 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  170.7, 154.9, 133.9, 116.6, 
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81.0, 72.2, 49.7, 28.3, 20.9; HRMS (Q-TOF) m/z calcd for C11H19NO4Na: 252.1212; found: 
252.1202. 
 
 N-Acetoxymethyl-N-allyl benzylcarbamate (146c): To a solution of 
350 mg (1.7 mmol, 1.0 equiv) of N-allyl-N-hydroxymethyl benzylcarbamate
x
 in 
10 mL CH2Cl2 at 0 C were added 660 L of triethylamine (4.7 mmol, 3.0 
equiv) and 120 L of acetyl chloride (1.7 mmol, 1.1  equiv). The reaction mixture was then 
warmed to ambient temperature and stirred for 3 h. The reaction was quenched with 10 mL of 
saturated aqueous NaHCO3 and extracted with 10 mL of CH2Cl2 (3). The combined organic 
portions were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by 
flash chromatography (20% ethyl acetate in hexane) to afford 170 mg (80%) of the title 
compound as a colorless oil. IR (thin film): 3582, 2950, 1742, 1716, 1649, 1414, 1366, 1243, 
1202, 1157, 1015, 944 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  7.36-7.3 (m, 5H), 5.86-5.75 
(m, 1H), 5.40 (s. 2H), 5.21 (s, 2H), 5.18 (brd, J = 9.6 Hz, 2H),  4.02 (d, J = 6.0 Hz, 2H), 2.05 (s, 
3H); 
13
C NMR (75 MHz, CDCl3 at 50 °C)  170.6, 155.8, 136.3, 133.4, 128.5, 128.2, 127.9, 
117.2, 71.8, 67.8, 49.8, 20.8; HRMS (EI) m/z calcd for C12H13NO2: 203.0946; found: 203.0954. 
 
N-Allyl-N-(phenylthio)methyl methylcarbamate (148): To a 
suspension of activated NaH (160 mg, 4.0 mmol) in 3 mL DMF at 0 C was 
added N-allyl methylcarbamate (230 mg, 2.0 mmol) in 2 mL DMF dropwise. 
The resulting reaction mixture was stirred for 20 min at 0 C, followed by 
                                                 
x
 Tetrahedron Lett. 2009, 50, 2653-2655 
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addition of chloromethyl phenyl sulfide (1.0 mL, 8.0 mmol). The resulting reaction mixture was 
stirred overnight at ambient temperature. The reaction was diluted with 20 mL of ethyl acetate, 
then washed with 60 mL of water (3). The combined organic portions were dried over Na2SO4 
and condensed in vacuo. The resulting yellow oil was purified by flash chromatography (20% 
ethyl acetate in hexane) to afford 180 mg (38%) of the title compound as yellow oil. IR (thin 
film): 3075, 2990, 2953, 1702, 1644, 1582, 1461, 1398, 1342, 1284, 1232, 1131, 1099, 1024, 
992, 923, 828, 769, 746 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  7.56-7.47 (m, 2H), 7.35-
7.27 (m, 3H), 5.82-5.69 (m, 1H), 5.13 (dd, J = 10.5, 1.2 Hz, 1H), 5.09 (dd, J = 17.4, 1.2 Hz, 1H), 
4.78 (s, 2H), 4.00 (brd, J = 5.7 Hz, 2H), 3.55 (br, 3H); 
13
C NMR (75 MHz, CDCl3 at 50 °C)  
156.1, 133.3, 132.9, 129.0, 128.8, 127.6, 117.5, 52.6, 52.4, 47.9; HRMS (EI) m/z calcd for 
C12H15N2O4NaS: 292.0619; found: 292.0637. 
 
N-Allyl-N-(phenylsulfonyl)methyl methylcarbamate (149): To 
a solution of 148 (180 mg, 0.75 mmol) in 30 mL methanol was added 1.4 
g of oxone in 18 mL water at the ambient temperature. The resulting 
reaction mixture was stirred for 3 h then quenched with 40 mL of 
saturated aqueous NaHCO3 and extracted with 50 mL of CH2Cl2 (3). The combined organic 
portions were dried over Na2SO4 and condensed in vacuo. The resulting yellow oil was purified 
by flash chromatography (50% ethyl acetate in hexane) to afford 120 mg (57%) of the title 
compound as yellow oil. IR (thin film): 3067, 3005, 2955, 1716, 1645, 1584, 1461, 1395, 1322, 
1145, 1083, 997, 924, 891, 840, 770, 745 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  7.94-7.91 
(m, 2H), 7.69-7.64 (m, 1H), 7.60-7.55 (m, 2H), 5.82-5.69 (m, 1H), 5.24 (dd, J = 9.3, 0.9 Hz, 1H), 
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5.20 (dd, J = 16.2, 0.9 Hz, 1H), 4.65 (s, 2H), 4.19 (d, J = 6.0 Hz, 2H), 3.36 (br, 3H); 
13
C NMR 
(75 MHz, CDCl3 at 50 °C)  154.9, 138.2, 133.9, 131.8, 129.1, 128.9, 119.0, 66.9, 52.9, 49.7 
 
N-Allyl-N-cyanomethyl methylcarbamate (152): To a suspension of 
K2CO3 (7.0 g, 51 mmol), NaI (7.5 g, 50 mmol) and triethylamine (14 mL, 
0.10 mol) in 50 mL of anhydrous DMF at 0 C were added chloroacetonitrile 
(1.9 g, 25 mmol) and allylamine (1.87 mL, 25 mmol). The resulting mixture 
was stirred for 20 h at ambient temperature. To the reaction mixture were added 30 mL of ethyl 
acetate and 1 g of celite, then the resulting solid was removed by filtration. 30 mL of ice-cold 
water was added to the filtrate, and the aqueous layer was separated, cooled to 0 C with ice 
bath, saturated with NaCl, then extracted with 20 mL of ethyl acetate (3). The combined 
organic portions were dried over Na2SO4 and concentrated in vacuo. The resulting crude oil was 
taken up to 20 mL of CH2Cl2 and cooled down to 0 C. To the resulting solution was added 5 mL 
of triethylamine (36 mmol), then slowly added 2.1 mL of methyl chloroformate (28 mmol). The 
resulting reaction mixture was stirred for 3 h at ambient temperature. The reaction was diluted 
with 50 mL of ethyl acetate, and 30 mL of water, and the mixture was extracted with 30 mL of 
ethyl acetate three times. The combined organic portions were dried over Na2SO4 then 
concentrated in vacuo. The resulting crude oil was purified by flash chromatography (30% ethyl 
acetate in hexane) to afford 784 mg (20% over 2 steps) of the title compound as a colorless oil. 
IR (thin film):3085, 2989, 2960, 2249, 1712, 1647, 1541, 1468, 1401, 1356, 1295, 1253, 1195, 
1149, 1106, 999, 938, 899, 834, 772 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  5.84-5.75 (m, 
1H), 5.30 (dd, J = 10.2, 0.9 Hz, 1H), 5.27 (dd, J = 4.8, 0.9 Hz, 1H), 4.18 (br, 2H), 4.03 (brd, J = 
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5.4 Hz, 2H), 3.79 (brd, J =  4.2 Hz, 3H); 
13
C NMR (75 MHz, CDCl3 at 50 °C)  155.7, 131.8, 
119.2, 115.4, 53.5, 49.9, 34.6; HRMS m/z calcd for C7H10N2O2: 154.0742; found: 154.0739. 
 
General Procedure D: Isomerization of terminal olefin to afford corresponding internal 
olefin 
 
A two-necked roundbottomed flask was fitted with a condenser and charged with terminal olefin 
G (1.0 equiv), vinyloxytrimethylsilane (1.0 equiv) and the Grubbs’ 2nd generation catalyst 
(Grubbs’ II, 5 mol%, 0.05 equiv) in CH2Cl2 (concentration of G = 0.015 M). The resulting 
solution was placed in a preheated 50 °C oil bath stirred at 45-50 °C until the reaction was 
complete (determined by 
1
H NMR analysis of reaction aliquots). The reaction was cooled to 
ambient temperature, the reaction mixture was concentrated and purified by column 
chromatography (10-30% ether in hexanes eluents) to afford the isomerized product H. 
 
N-Acetoxymethyl N-(E)-prop-1-enyl methylcarbamate (147a): 
General Procedure D was followed employing 238 mg of 146a (1.6 mmol). 
Purification by flash chromatography (20% ethyl acetate in hexane) gave 
186 mg (78%) of the title compound. IR (thin film): 3091, 3005, 2960, 2892, 
1722, 1668, 1488, 1398, 1375, 1323, 1289, 1219, 1135, 1093, 997, 967, 944, 900, 849, 767 cm
1
; 
1
H NMR (300 MHz, CDCl3)  6.71 (br, 1H), 5.61 (s, 2H), 5.20-5.08 (m, 1H), 3.82 (s, 1H), 2.09 
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(s,3H), 1.07 (dd, J = 6.9, 1.8 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  170.4, 154.2, 126.8, 107.5, 
70.1, 53.6, 20.9, 15.2 
 
 N-Acetoxymethyl N-(E)-Prop-1-enyl tert-butylcarbamate (147b): 
General Procedure D was followed employing 305 mg of 146b (1.3 mmol). 
Purification by flash chromatography (15% ethyl acetate in hexane) gave 205 
mg (67%) of the title compound. IR (thin film): 2979, 2934, 1745, 1718, 1671, 
1485, 1396, 1370, 1334, 1288, 1224, 1152, 1016, 948, 878 cm
1
; 
1
H NMR (300 MHz, CDCl3)  
6.73 (br, 1H), 5.58 (s, 2H), 5.10-5.03 (m, 1H), 2.09 (s, 3H), 1.70 (dd, J =  6.6 Hz, 1.5 Hz, 3H), 
1.51 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  170.5, 152.4, 127.1, 106.2, 82.14, 70.0, 28.2, 20.9, 
15.3; HRMS (EI) m/z calcd for C11H19NO4: 229.1314; found: 229.1315. 
 
 N-Acetoxymethyl N-(E)-prop-1-enyl benzylcarbamate (147c): 
General Procedure D was followed employing 468 mg of 146c (1.8 mmol). 
Purification by flash chromatography (15% ethyl acetate in hexane) gave 396 
mg (85%) of the title compound. IR (thin film): 3036, 2960, 1723, 1670, 1456, 
1410, 1364, 1334, 1281, 1219, 1152, 1098, 1018, 951, 738 cm
1
; 
1
H NMR (300 MHz, CDCl3)  
7.38 (m, 5H), 6.74 (br, 1H), 5.63 (s, 2H), 5.24 (s, 2H), 5.18-5.08 (m, 1H), 2.08 (s, 3H), 1.70 (d, J 
=  6.3 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  170.4, 154.2, 135.7, 128.6, 128.4, 128.2, 126.6, 
107.5, 69.87, 68.25, 20.9, 15.2; HRMS (EI) m/z calcd for C14H17NO4: 263.1577; found: 
263.1152. 
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N-(Phenylsulfonyl)methyl-N-(E)-Prop-1-enyl 
methylcarbamate (150): General Procedure D was followed employing 
133 mg of 149 (0.49 mmol). Purification by flash chromatography (30% 
ethyl acetate in hexane) gave 123 mg (92%) of the title compound. IR 
(thin film): 3009, 2957, 2364, 1722, 1670, 1558, 1540, 1507, 1446, 1391, 1369, 1333, 1289, 
1208, 1147, 1083, 995, 943, 901, 766, 744 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  7.90 (d, 
J = 7.2 Hz, 2H), 7.67-7.62 (m, 1H), 7.54 (t, J = 7.2 Hz, 2H), 6.65 (d, J = 14.4 Hz, 1H), 5.35-5.28 
(m, 1H), 4.92 (s, 2H), 3.51 (br, 3H), 1.64 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3 at 
50 °C)  153.6, 138.8, 133.9, 129.0, 128.9, 126.4, 109.1, 66.9, 53.5, 14.9; HRMS (EI) m/z calcd 
for C12H15NO4S: 269.0722; found: 269.0710. 
 
N-Cyanomethyl-N-(E)-prop-1-enyl methylcarbamate (153): 
General Procedure D was followed employing 48 mg of 152 (0.31 mmol). 
Purification by flash chromatography (30% ethyl acetate in hexane) gave 39 
mg (81%) of the title compound. IR (thin film): 3091, 3004, 2960, 2892, 
2246, 1722, 1668, 1448, 1397, 1375, 1323, 1289, 1271, 1219, 1135, 1093, 997, 966, 944, 900, 
849, 767, 713 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C C)  6.77 (brd, J = 13.8 Hz, 1H), 5.12-
5.01 (m, 1H), 4.44 (s, 2H), 3.83 (s, 3H), 1.75 (dd, J = 6.6, 1.5 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3 at 50 °C)  153.4, 126.2, 114.7, 106.9, 53.8, 32.7, 14.9; HRMS (EI) m/z calcd for 
C7H10N2O2: 154.0742; found: 154.0748. 
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General Procedure E: Acyliminium ion cycloaddition followed by allyltrimethylsilane 
addition 
 
 To 2 mM solution of cyclohexene (10 equiv) in CH2Cl2 at 78 C was added 1.0 equiv of the 
Lewis acid. To this solution was added 0.2 mM solution of unsubstituted acetoxy diene precursor 
I (1.0 equiv) in CH2Cl2 dropwise. The resulting reaction mixture was stirred for 12 h at 78 C. 
The reaction was quenched with 5.0 equiv of allyltrimethylsilane and stirred for 1 h, then added 
water at 78 C. The resulting biphasic mixture was allowed to warm up to ambient temperature. 
The reaction mixture was extracted with CH2Cl2 (3). The combined organic portions were dried 
over Na2SO4, then concentrated in vacuo. The crude oil was purified by flash chromatography to 
afford the desired product J. 
 
           (3S,4S,4aR,8aS)- 2-Methoxycarbonyl-3-allyl-4-methyl-
decahydroisoquinoline (156): General Procedure E was followed with 
167L of cyclohexene (2.2 mmol, 12 equiv) in 1 mL CH2Cl2, 26 L of 
SnCl4, and 32 mg of 147a (0.17 mmol, 1.0 equiv) solution in CH2Cl2 to 
afford 13 mg (31%) of the title compound. IR (thin film): 2929, 2860, 1700, 1450, 1412, 1354, 
1314, 1261, 1233, 1174, 1113, 993, 958, 911, 843, 765 cm
1
; 
1
H NMR (300 MHz, CDCl3)  5.67 
(br, 1H), 5.03 (brd, J = 17.4 Hz, 1H), 5.0 (brd, J = 10.2 Hz, 1H), 4.26 (br, 1H), 3.79 (m, 1H), 
3.65 (s, 3H), 3.01 (br, 1H), 2.43-2.32 (m, 1H), 2.72-2.15 (m, 2H), 1.83-1.19 (m, 10H), 0.85 (d, J 
= 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  156.9, 135.5, 116.4, 55.4, 52.3, 44.3, 36.9, 35.0, 
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29.3, 28.8, 27.6, 26.2, 25.3, 19.6, 15.8; HRMS m/z calcd for C15H26NO2 (M+H)
+
: 252.1964; 
found: 252.1951. 
 
General Procedure F: Acyliminium ion cycloaddition followed by triethylsilane reduction 
 
 To 2 mM solution of cyclohexene (10 equiv) in CH2Cl2 at 78 C was added 1.0 equiv of the 
Lewis acid. To this solution was added 0.2 mM solution of unsubstituted acetoxy diene precursor 
I (1.0 equiv) in CH2Cl2 dropwise. The resulting reaction mixture was stirred for 1h at 78 C. 
The reaction was quenched with 5.0 equiv of triethylsilane and stirred for 15 min, followed by 30 
min stirring at 0 C.  The reaction was then added with water at 0 C. The resulting biphasic 
mixture was allowed to warm up to ambient temperature. The reaction mixture was extracted 
with CH2Cl2 (3). The combined organic portions were dried over Na2SO4, then concentrated in 
vacuo. The crude oil was purified by flash chromatography to afford the corresponding Diels-
Alder product K. 
 
(4S,4aS,8aS)-2-Methoxycarbonyl-4-methyl-
decahydroisoquinoline (157): General Procedure F was followed with 
203 L of cyclohexene (2.0 mmol, 10 equiv) in 1.0 mL CH2Cl2, 24 L of 
SnCl4, and 38 mg of 147a (0.20 mmol, 1.0 equiv) solution in CH2Cl2 to 
afford 16 mg (34%) of the title compound as a single diastereomer. IR (thin film): 2929, 1859, 
2359, 1706, 1471, 1448, 1413, 1380, 1343, 1300, 1268, 1230, 1215, 1188, 1143, 1108, 1056, 
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957, 766 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  3.92 (br, 1H), 3.82 (brd, J =  12 Hz, 1H), 
3.68 (s, 3H), 3.00 (dd, J = 12.9, 3.6 Hz, 1H), 2.49 (br, J = 11.4 Hz, 1H), 1.90 (m, 2H), 1.69 (m, 
2H), 1.56-1.28 (m, 7H), 0.87 (d, J = 6.3 Hz, 3H); 
13
C NMR (75 MHz, CDCl3 at 50 °C)  156.4, 
52.3, 50.6, 49.5, 41.7, 36.2, 28.2, 27.7, 26.1, 25.7, 21.1, 16.5; HRMS (EI) m/z calcd for 
C12H21NO2: 211.1572; found: 215.1563. 
 
General Procedure G: Acyliminium ion cycloaddition to afford Diels-Alder and oxo-Diels-
Alder product 
 
 To 2 mM solution of cyclohexene (10 equiv) in CH2Cl2 at 78 C was added 1.0 equiv of the 
Lewis acid. To this solution was added 0.2 mM solution of unsubstituted acetoxy diene precursor 
I (1.0 equiv) in CH2Cl2 dropwise. The resulting reaction mixture was stirred for 3 h at 78 C. 
The reaction was quenched with 5.0 equiv of triethylamine and allowed to warm up to ambient 
temperature. The reaction mixture was diluted twice with CH2Cl2 and water, and extracted with 
CH2Cl2 (3). The combined organic portions were dried over Na2SO4, then concentrated in 
vacuo. The crude oil was purified by flash chromatography to afford the corresponding Diels-
Alder product L and oxo-Diels-Alder product 160. 
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AIC reaction of 147a 
 
 General Procedure G was followed employing 80 mg of 147a as a diene precursor (0.43 mmol, 
1.0 equiv), 50 L of SnCl4 (0.43 mmol, 1.0 equiv), and 436 L of cyclohexene (4.3 mmol, 10 
equiv) to afford 28 mg of 158 (31%) as a colorless oil and 32 mg of 160 (38%) as a colorless oil. 
 
(4aR,8aS)-1,2,4a,5,6,7,8,8a-Octahydro-2-methoxycarbonyl-4-
methylisoquinoline (158): IR (thin film): 2929, 1714, 1669, 1445, 1395, 
1221, 1180 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  6.55 (br, 1H), 
3.76 (s, 3H), 3.52 (brd, J = 4.8 Hz, 2H), 2.10-2.06 (m, 1H), 2.03-1.96 (m, 1H), 1.73-1.70 (m, 
2H), 1.66 (s, 3H), 1.63-1.46 (m, 4H), 1.42-1.33 (m, 2H); 
13
C NMR (75 MHz, CDCl3 at 50 °C)  
119.5, 117.7, 105.1, 64.2, 52.6, 44.3, 37.7, 32.6, 27.7, 24.8, 23.2, 18.5; HRMS (EI) m/z calcd for 
C12H19NO2: 209.1415; found: 209.1411. 
 
 (4aS,8aS)-3-(E-Prop-1-enyl)-octahydro-1,3-benzoxazin-2-one 
(160): IR (thin film): 3346, 2933, 2859, 1700, 1534, 1447, 1340, 1266, 
1233, 1189, 1134, 983, 948, 766 cm
1
 ; 
1
H NMR (300 MHz, CDCl3)  7.17 
(dd, J = 14.4, 1.5 Hz, 1H), 4.96-1.85 (m, 1H), 4.47 (br quint, 1H), 3.47 (dd, 
J = 11.7, 5.7 Hz, 1H), 3.15 (dd, J = 11.7, 2.1 Hz, 1H), 2.10-1.02 (m, 2H), 1.80-1.76 (m, 1H), 1.72 
(dd, J = 6.6, 1.8 Hz, 3H), 1.66-1.48 (m, 5H), 1.44-1.31 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  
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151.5, 129.3, 104.8, 74.7, 47.9, 31.8, 29.8, 25.1, 24.2, 19.6, 15.2; HRMS (EI) m/z calcd for 
C11H17NO2: 195.1259; found: 195.1255. 
 
AIC reaction of 147b 
 
General Procedure G was followed employing 99 mg of 147b as a diene precursor (0.43 mmol, 
1.0 equiv), 50 L of SnCl4 (0.43 mmol, 1.0 equiv), and 436 L of cyclohexene (4.3 mmol, 10 
equiv) to afford 37 mg of 162 (34%) as a colorless oil and 19 mg of 160 (23%) as a colorless oil. 
 
(4aR,8aS)-1,2,4a,5,6,7,8,8a-Octahydro-2-tert-butyloxycarbonyl-4-
methylisoquinoline (162): IR (thin film): 2920, 2851, 1701, 1667, 1453, 
1396, 1366, 1317, 1288, 1254, 1220, 1162, 954 cm
1
; 
1
H NMR (300 MHz, 
CDCl3 at 50 °C)  6.55 (br, 1H), 3.47 (brd, J = 7.8Hz, 2H), 2.07-2.06 (m 
,1H), 1.98-1.96 (m, 1H), 1.70 (s, 3H), 1.64-1.58 (m, 4H), 1.51 (s, 9H), 1.48-1.44 (m, 4H); 
13
C 
NMR (75 MHz, CDCl3 at 50 °C)  128.0, 120.1, 116.6, 64.0, 43.5, 37.8, 32.6, 28.5, 27.8, 27.7, 
24.6, 23.1, 18.6; HRMS m/z calcd for C15H25NO2: 251.1885; found: 251.1884. 
 
AIC reaction of 39c 
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General Procedure G was followed employing 113 mg of 147c as a diene precursor (0.43 mmol, 
1.0 equiv), 50 L of SnCl4 (0.43 mmol, 1.0 equiv), and 436 L of cyclohexene (4.3 mmol, 10 
equiv) to afford 50 mg of 163 (41%) as a colorless oil and 28 mg of 160 (33%) as a colorless oil. 
 
 (4aR,8aS)-1,2,4a,5,6,7,8,8a-Octahydro-2-benzyloxycarbonyl-4-
methylisoquinoline (163): IR (thin film): 2928, 2855, 1705, 1447, 1409, 
1343, 1220, 1176 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 °C)  7.38-7.29 
(m, 5H), 6.59 (br, 1H), 5.20 (s, 2H), 3.55 (brd, J = 6.9 Hz, 2H), 2.11-2.07 (m 1H), 2.04-1.95 (m, 
1H), 1.79-1.70 (m, 2H), 1.69 (s, 3H), 1.61-1.60 (m, 2H), 1.51-1.41 (m, 4H); 
13
C NMR (75 MHz, 
CDCl3 at 50 °C)  153.5, 136.9, 128.5, 128.03, 128.00, 119.3, 117.9, 105.2, 67.3, 44.4 37.8, 32.5, 
27.8, 27.7, 24.5. 23.0, 18.6; HRMS (EI) m/z calcd for C18H23NO2: 285.1729; found: 285.1728. 
 
N-Acetoxymethyl N-butyl benzylcarbamate (167): To a mixture 
of 590 mg paraformaldehyde (20 mmol, 1.1 equiv) and 3.7 g benzyl N-n-
butylamine (18 mmol, 1.0 equiv) was added 12 mL of acetic anhydride 
and 8 mL of acetic acid. The resulting mixture was stirred at 70-80 °C for 3 hours. The reaction 
was cooled to room temperature; the reaction mixture was diluted with 20 mL CH2Cl2 and 
washed with 20 mL water. The resulting solution was dried over Na2SO4, then concentrated in 
vacuo. Column purification (20% ethyl acetate in hexane) afforded 2.56 g of the title compound 
(51%) as colorless oil. IR (thin film): 2960, 1716, 1477, 1454, 1420, 1367, 1243, 1203, 1161, 
1014, 942 cm
1
; 
1
H NMR (300 MHz, CDCl3, only major rotamer shown)  7.37 (br, 5H), 5.39 (s, 
2H), 5.19 (s, 2H), 3.37 (t, J = 6.9, 2H), 2.06 (s, 3H), 1.55 (br, 2H), 1.33-1.26 (m, 2H), 0.93 (br, 
3H); 
13
C NMR (75 MHz, CDCl3, only major rotamer shown)  170.4, 155.2, 136.1, 128.2, 127.8, 
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127.5, 72.0, 67.1, 47.3, 30.4, 20.6, 20.0, 13.5; HRMS m/z calcd for C15H21NO4Na: 302.1368; 
found: 302.1375 
 
General Procedure H: Cycloaddition of 167 to oxo-Diels-Alder product 
 
To 2.0 mM dienophile (1-10 equiv) in CH2Cl2 at 78 C was added 1.0 equiv of the Lewis acid. 
To this solution was added 1.0 equiv of 0.2 mM solution of diene precursor 167 in CH2Cl2 
dropwise. The resulting reaction mixture was stirred for 3 h at 78 C. The reaction was 
quenched with 5.0 equiv of triethylamine and allowed to warm up to ambient temperature. The 
reaction mixture was diluted twice with CH2Cl2 and water, and extracted with CH2Cl2 (3). The 
combined organic portions were dried over Na2SO4, then concentrated in vacuo. The crude oil 
was purified by flash chromatography to afford the corresponding oxo-Diels-Alder product M. 
 
(4aS,8aS)-3-Butyloctahydro-2H-1,3-benzoxazin-2-one (168): General 
Procedure H was followed employing 140 mg of 167 as a diene precursor (0.50 
mmol, 1.0 equiv), 100 L of TMSOTf (0.55 mmol, 1.1  equiv), and 510 L of 
cyclohexene (5.0 mmol, 10 equiv) to afford 86 mg of 168 (81%) as a colorless 
oil after flash chromatography (50% ethyl acetate in hexane). IR (thin film): 2932, 2862, 1692, 
1488, 1450, 1340, 1251, 1233, 1186, 1116, 1099, 984, 759 cm
1
; 
1
H NMR (300 MHz, CDCl3)  
4.44 (br, 1H), 3.47 (dd, J = 11.7, 5.1, 1H), 3.30 (m, 2H), 2.94 (dd, J = 11.7, 2.1, 1H), 2.04-1.99 
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(m, 1H), 1.97-1.89 (m, 1H), 1.78-1.45 (m, 8H), 1.40-1.27 (m, 3H), 0.93 (t, J = 7.2, 3H); 
13
C 
NMR (75 MHz, CDCl3)  153.3, 74.6, 50.1, 48.8, 32.1, 29.9, 28.9, 24.6, 24.2, 19.7, 19.3, 13.7; 
HRMS (Q-TOF) m/z calcd for C12H21NO2Na: 234.1470; found: 234.1471 
 
(4aS,8aS)-3-Butyl-3,4,4a,5,6,8a-hexahydro-2H-1,3-Benzoxazin-2-one 
(170): General Procedure H was followed employing 200 mg of 167 as a diene 
precursor (0.72 mmol, 1.0 equiv), 140 L of TMSOTf (0.79 mmol, 1.1  equiv), 
and 75 L of cyclohexene (0.79 mmol, 1.1  equiv) to afford 100 mg of 170 
(68%) as a colorless oil after flash chromatography (66% ethyl acetate in hexane). IR (thin film): 
2929, 1691, 1487, 1453, 1243, 1161, 1114, 1099, 1079, 986, 757  cm
1
; 
1
H NMR (300 MHz, 
CDCl3)  5.98 (dt, J = 10.2, 3.6, 1H), 5.85 (dq, J = 9.9, 2.1, 1H), 4.73 (t, J = 3.9, 1H), 3.49 (dd, J 
= 12.0, 5.7, 1H), 3.41-3.25 (m, 2H), 3.10 (dd, J = 12.0, 4.2, 1H), 2.26-2.06 (m, 3H), 1,83 (m, 1H), 
1.68-1.51 (m, 4H), 1.41-1.26 (m, 2H), 0.94 (t, J = 7.2, 3H); 
13
C NMR (75 MHz, CDCl3)  152.7, 
132.1, 124.8, 72.2, 49.1, 48.6, 30.3, 29.2, 24.1, 21.6, 19.9, 13.9; HRMS (Q-TOF) m/z calcd for 
C12H19NO2Na: 232.1313; found: 232.1318.  
 
(4aS,10aS,Z)-3-Butyl-3,4,4a,5,6,7,8,10a-octahydro-2H-cycloocta-E-1,3-
oxazin-2-one (171): General Procedure E was followed employing 100 mg of 
167 as a diene precursor (0.36 mmol, 1.0 equiv), 71 L of TMSOTf (0.39 
mmol, 1.1  equiv), and 450 L of cyclohexene (3.6 mmol, 10 equiv) to afford 
55mg of 171 (60% yield) as a colorless oil after flash chromatography (50% ethyl acetate in 
hexane). 
1
H NMR (300 MHz, CDCl3)  5.88 (ddd, J = 9.6, 8.1, 1.5, 1H), 5.54 (dd, J = 8.1, 1.5, 
1H), 5.24 (t, J = 6.0, 1H), 3.39 (ddd, J = 13.5, 8.4, 6.6, 1H), 3.18 (ddd, J = 14.4, 8.1, 6.3, 1H), 
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2.98 (s, 1H), 2.95 (s, 1H), 2.36 (dddd, J = 12.0, 9.6, 7.5, 4.8, 1H), 2.23-2.01 (m, 2H), 1.86-1.72 
(m, 3H), 1.58-1.43 (m, 2H), 1.35-1.19 (m, 4H), 1.16-1.08 (m, 1H), 0.90 (t, J = 7.2, 3H); 
13
C 
NMR (75 MHz, CDCl3)  152.7, 132.6, 126.5, 75.7, 49.1, 47.7, 36.6, 29.0, 28.9, 27.9, 27.3, 24.2, 
19.8, 13.7; HRMS (Q-TOF) m/z calcd for C14H23NO2Na: 260.1626; found: 260.1610.  
 
3-Butyl-6-(2-isopropylenyl)-6-methyl-1,3-oxazinan-2-one (172): General 
Procedure H was followed employing 100 mg of 167 as a diene precursor (0.36 
mmol, 1.0 equiv), 71 L of TMSOTf (0.39 mmol, 1.1  equiv), and 410 L of 
cyclohexene (3.6 mmol, 10 equiv) to afford 38 mg of 172 (50%) as a colorless oil after flash 
chromatography (50% ethyl acetate in hexane). IR (thin film): 2959, 2933, 2872, 1692, 1487, 
1452, 1300, 1267, 1159, 1105, 962, 906, 759 cm
1
; 
1
H NMR (300 MHz, CDCl3)  5.03 (br, 1H), 
4.96 (br, 1H), 3.45 (dt, J = 13.8, 7.5, 1H), 3.26-3.08 (m, 3H), 2.13 (ddd, J = 17.7, 8.1, 4.5, 1H), 
1.91 (ddd, J = 13.8, 11.1, 5.7, 1H), 1.78 (s, 3H), 1.60-1.51 (m, 2H), 1.47 (s, 3H), 1.37-1.25 (m, 
2H), 0.93 (t, J = 7.2, 3H); 
13
C NMR (75 MHz, CDCl3)  153.1, 145.2, 112.0, 82.1, 49.0, 42.3, 
30.3, 29.1, 26.7, 19.9, 18.7, 13.8; HRMS (EI) m/z calcd for C12H21NO2: 211.1572; found: 
211.1571 
 
N-Hydroxymethyl N-butyl 2-trimethylsilylethylcarbamate 
(177):  To a solution of 31 mg of 2-trimethylsilylethyl-N-n-
butylcarbamate
xi
 (0.14 mmol, 1.0 equiv) and 5 mg of paraformaldehyde 
(0.16 mmol, 1.1 equiv) in 2.0 mL THF was added 140 mg of Cs2CO3 (0.43 mmol, 3.0 equiv). 
                                                 
xi
 Appl. Biochem. Biotechnol. 2008, 150, 337-344 
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The resulting reaction mixture was stirred for 5 h at ambient temperature.  The reaction mixture 
was quenched with 5 mL saturated aqueous solution of NH4Cl. The resulting biphasic mixture 
was extracted with 10 mL ethyl acetate (3×). The combined organic phase was dried over 
Na2SO4, then concentrated. The resulting crude product was chromatographed (SiO2, 33% ethyl 
acetate in hexanes) to afford 26 mg of the title compound (75%) as a colorless oil. IR (thin film): 
3432, 2957, 1685, 1484, 1425, 1251, 1156, 1041, 935, 839 cm
1
; 
1
H NMR (300 MHz, CDCl3)  
4.77 (d, J = 7.5, 2H), 4.21 (dd, J = 17.1, 8.4, 2H), 3.33 (t, J = 6.3, 2H), 1.61-1.51 (m, 2H), 1.38-
1.26 (m, 2H), 1.04 (dddd, J = 13.2, 8.4, 6.9, 3.6, 2H), 0.93 (t, J = 7.2, 3H) ; 
13
C NMR (75 MHz, 
CDCl3, only major rotamer shown)  157.2, 72.6, 63.7, 46.7, 31.4, 19.9, 17.7, 13.7, 1.6 
 
N-Acetoxymethyl N-butyl 2-trimethylsilylethylcarbamate  
(173): To a solution of 310 mg (1.2 mmol, 1.0 equiv) of 172 in 12 mL 
CH2Cl2 at 0 C were added 520 L of triethylamine (3.7 mmol, 3.0 
equiv) and 100 L of acetyl chloride (1.4 mmol, 1.1 equiv). The reaction mixture was then 
warmed up to ambient temperature and stirred for 3 h. The reaction was quenched with 12 mL of 
saturated aqueous NaHCO3 and extracted with 10 mL of CH2Cl2 (3). The combined organic 
portions were dried over Na2SO4 and concentrated in vacuo. The crude product was purified by 
flash chromatography (15% ethyl acetate in hexane) to afford 300 mg (83%) of the title 
compound as a colorless oil. IR (thin film): 2957, 1743, 1715, 1477, 1420, 1366, 1250, 1203, 
1164, 1100, 1049, 1014, 941, 840, 775 cm
1
; 
1
H NMR (300 MHz, CDCl3)  5.35 (br, 2H), 4.25-
4.16 (m, 2H), 3.32 (br, 2H), 2.07 (s, 3H), 1.53 (tt, J = 14.7, 7.2, 2H), 1.34-1.27 (m, 2H), 1.01 (dd, 
J = 17.1, 4.2, 2H), 0.92 (t, J = 7.5, 3H) ; 
13
C NMR (75 MHz, CDCl3, only major rotamer shown) 
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 170.9, 155.8, 72.4, 64.2, 47.2, 30.6, 21.0, 19.8, 17.6, 13.7, 1.6; HRMS (Q-TOF) m/z calcd for 
C13H27NO4SiNa: 312.1607; found: 312.1595 
 
Catalytic oxo-Diels-Alder reaction 
 
 To a mixture of 145 mg of 173 (0.50 mmol, 1.0 equiv) and cyclohexene (510 L, 10 equiv) in 
CH2Cl2 (2mM) at ambient temperature was added 9.1 L of TMSOTf (10 mol%). The resulting 
reaction mixture was stirred for 12 h at ambient temperature. The reaction was quenched with 
5.0 equiv of triethylamine and allowed to warm up to ambient temperature. The reaction mixture 
was diluted twice with CH2Cl2 and water, and extracted with CH2Cl2 (3). The combined 
organic portions were dried over Na2SO4, then concentrated in vacuo. The crude oil was purified 
by flash chromatography (50% ethyl acetate in hexane) to afford 86 mg of 168 (81%) as a 
colorless oil. 
 
AAIC reaction of 187 
 
To a solution of 91 mg of 187 (0.69 mmol, 1.7 equiv) in 4 mL CH2Cl2 was added 50 L acetyl 
chloride (0.76 mmol, 1.8 equiv) dropwise. The resulting reaction mixture was stirred for 30 min 
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at ambient temperature. The resulting reaction mixture was cooled to 78 C, then 50 L of 
dihydropyrrole 193 (0.39 mmol, 1.0 equiv) and 140 L of TMSOTf (0.76 mmol, 1.8 equiv) was 
added sequentially. The resulting reaction mixture was stirred at 35 C for 12h.  The reaction 
was quenched with 490 L of triethylamine (8.3 equiv) and allowed to warm up to ambient 
temperature. The reaction mixture was diluted twice with CH2Cl2 and water, and extracted with 
CH2Cl2 (3). The combined organic portions were dried over Na2SO4, then concentrated in 
vacuo. The crude oil was purified by flash chromatography (80% ethyl acetate in hexane) to 
afford 82 mg of 194 (70%) as a colorless oil. 
 
(3aS,4R,7aS)-2,3,3a,4,5,7a-Hexahydro-1-methoxycarbonyl-
4-phenyl-5-acetyl-1H-Pyrrolo[3,2-c]pyridine (194): IR (thin film): 
3336, 2955, 1698, 1644, 1538, 1493, 1451, 1379, 1332, 1254, 1193, 
1126, 1044, 980, 771, 702 cm
1
; 
1
H NMR (300 MHz, CDCl3 at 50 

C)  7.36-7.23 (m, 5H), 7.10 
(d, J = 8.4, 1H), 5.66 (br, 1H), 5.30 (d, J = 6.6, 1H), 4.24 (t, J = 4.5, 1H), 3.68 (s, 3H), 2.81 (q, J 
= 6.0, 1H), 2.13 (m, 5H), 1.87 (dd, J = 12.9, 6.0, 2H); 
13
C NMR (75 MHz, CDCl3 at 50 

C)  
169.3, 156.0, 141.3, 128.7, 128.5, 127.0, 125.7, 121.7, 117.0, 56.4, 56.1, 52.3, 44.7, 44.1, 26.8, 
22.9, 17.3 
 
AAIC reaction followed by NaBH3CN reduction 
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 To a solution of 50 mg of 187 (0.38 mmol, 1.7 equiv) in 3 mL CH2Cl2 was added 34 L acetyl 
chloride (0.38 mmol, 1.0 equiv) dropwise. The resulting reaction mixture was stirred for 30 min 
at ambient temperature. The resulting reaction mixture was cooled to 78 C, then 48 mg of 
dihydropyrrole 193 (0.38 mmol, 1.0 equiv) in 1 mL CH2Cl2 and 70 L of TMSOTf (0.38 mmol, 
1.8 equiv) was added sequentially. The resulting reaction mixture was stirred at 50 C for 10 
min or 40 min.  Then 760 L of 1.0 M solution of NaBH3CN (0.76 mmol, 2.0 equiv) was added 
dropwise to the cold reaction mixture, followed by stirring for 30 min. To the resulting reaction 
mixture was added 10 mL saturated aqueous solution of NaHCO3. The resulting biphasic mixture 
was warmed to ambient temperature, and extracted with 10 mL CH2Cl2 (3). The combined 
organic portions were dried over Na2SO4, then concentrated in vacuo. The crude oil was 
analyzed by 
1
H NMR to determine the ratio of 194 and 200 (1:2 when reaction time =10 min, 2:1 
when reaction time = 40 min). 
IR (thin film): 2953, 2876, 1694, 1625, 1451, 1390, 1318, 1284, 
1192, 1127, 1028, 976, 846, 771, 740, 702 cm
1
; 
1
H NMR (300 MHz, 
CDCl3 at 50 

C)  7.37-7.23 (m, 5H), 6.34 (dd, J = 15.6, 8.7, 1H), 5.60 (d, 
J = 11.4, 1H), 4.84 (d, J = 2.7, 1H), 4.80 (d, J = 3.9, 1H), 3.66 (s, 3H), 
3.43-3.30 (m, 1H), 3.27-3.21 (m, 1H), 3.00 (br, 1H), 2.17 (s, 3H), 2.06-1.96 (m, 2H), 1.88-1.74 
(m, 2H); 
13
C NMR (75 MHz, CDCl3 at 50 

C)  170.0, 155.3, 138.4, 133.1, 128.5, 128.4, 127.8, 
107.3, 59.4, 52.1, 50.2, 45.4, 38.9, 29.1, 22.9; HRMS (Q-TOF) m/z calcd for C17H22N2O3Na: 
325.1528; found: 325.1538 
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